miRNAs mediated drug resistance in hematological malignancies

miRNAs mediated drug resistance in hematological malignancies

Despite improvements in the therapeutic approaches for hematological malignancies in the last decades, refractory disease still occurs, and cancer drug resistance still remains a major hurdle in the clinical management of these cancer patients. The investigation of this problem has been extensive an...

Full description

Saved in:
Bibliographic Details
Published in:Seminars in cancer biology Vol. 83; pp. 283 - 302
Main Authors: Peixoto da Silva, Sara, Caires, Hugo R., Bergantim, Rui, Guimarães, José E., Vasconcelos, M. Helena
Format: Journal Article
Language:English
Published: England Elsevier Ltd 01-08-2022
Subjects:
Cancer drug resistance
Drug sensitivity
Hematological malignancies
microRNAs
microRNAs
Cancer drug resistance
Hematological malignancies
Drug sensitivity
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract Despite improvements in the therapeutic approaches for hematological malignancies in the last decades, refractory disease still occurs, and cancer drug resistance still remains a major hurdle in the clinical management of these cancer patients. The investigation of this problem has been extensive and different mechanism and molecules have been associated with drug resistance. MicroRNAs (miRNAs) have been described as having an important action in the emergence of cancer, including hematological tumors, and as being major players in their progression, aggressiveness and response to treatments. Moreover, miRNAs have been strongly associated with cancer drug resistance and with the modulation of the sensitivity of cancer cells to a wide array of anticancer drugs. Furthermore, this role has also been reported for miRNAs packaged into extracellular vesicles (EVs-miRNAs), which in turn have been described as essential for the horizontal transfer of drug resistance to sensitive cells. Several studies have been suggesting the use of miRNAs as biomarkers for drug response and clinical outcome prediction, as well as promising therapeutic tools in hematological diseases. Indeed, the combination of miRNA-based therapeutic tools with conventional drugs contributes to overcome drug resistance. This review addresses the role of miRNAs in the pathogenesis of hematological malignances, namely multiple myeloma, leukemias and lymphomas, highlighting their important action (either in their cell-free circulating form or within circulating EVs) in drug resistance and their potential clinical applications.
AbstractList Despite improvements in the therapeutic approaches for hematological malignancies in the last decades, refractory disease still occurs, and cancer drug resistance still remains a major hurdle in the clinical management of these cancer patients. The investigation of this problem has been extensive and different mechanism and molecules have been associated with drug resistance. MicroRNAs (miRNAs) have been described as having an important action in the emergence of cancer, including hematological tumors, and as being major players in their progression, aggressiveness and response to treatments. Moreover, miRNAs have been strongly associated with cancer drug resistance and with the modulation of the sensitivity of cancer cells to a wide array of anticancer drugs. Furthermore, this role has also been reported for miRNAs packaged into extracellular vesicles (EVs-miRNAs), which in turn have been described as essential for the horizontal transfer of drug resistance to sensitive cells. Several studies have been suggesting the use of miRNAs as biomarkers for drug response and clinical outcome prediction, as well as promising therapeutic tools in hematological diseases. Indeed, the combination of miRNA-based therapeutic tools with conventional drugs contributes to overcome drug resistance. This review addresses the role of miRNAs in the pathogenesis of hematological malignances, namely multiple myeloma, leukemias and lymphomas, highlighting their important action (either in their cell-free circulating form or within circulating EVs) in drug resistance and their potential clinical applications.
Author Caires, Hugo R.
Bergantim, Rui
Guimarães, José E.
Vasconcelos, M. Helena
Peixoto da Silva, Sara
Author_xml – sequence: 1
  givenname: Sara
  orcidid: 0000-0003-2030-6368
  surname: Peixoto da Silva
  fullname: Peixoto da Silva, Sara
  organization: i3S – Instituto de Investigação e Inovação em Saúde, University of Porto, 4200-135 Porto, Portugal
– sequence: 2
  givenname: Hugo R.
  orcidid: 0000-0001-7657-7410
  surname: Caires
  fullname: Caires, Hugo R.
  organization: i3S – Instituto de Investigação e Inovação em Saúde, University of Porto, 4200-135 Porto, Portugal
– sequence: 3
  givenname: Rui
  orcidid: 0000-0002-7811-9509
  surname: Bergantim
  fullname: Bergantim, Rui
  organization: i3S – Instituto de Investigação e Inovação em Saúde, University of Porto, 4200-135 Porto, Portugal
– sequence: 4
  givenname: José E.
  surname: Guimarães
  fullname: Guimarães, José E.
  organization: i3S – Instituto de Investigação e Inovação em Saúde, University of Porto, 4200-135 Porto, Portugal
– sequence: 5
  givenname: M. Helena
  orcidid: 0000-0002-7801-4643
  surname: Vasconcelos
  fullname: Vasconcelos, M. Helena
  email: hvasconcelos@ipatimup.pt
  organization: i3S – Instituto de Investigação e Inovação em Saúde, University of Porto, 4200-135 Porto, Portugal
BackLink https://www.ncbi.nlm.nih.gov/pubmed/33757848$$D View this record in MEDLINE/PubMed
BookMark eNqFkEtLw0AQxxep2Id-Bc3RS-JsMs0mBw-l-IKiIArels1mUrfkUXcTwW_vltZePc3A_B_Mb8pGbdcSY1ccIg48vdlEjhqtWk02iiHmESQRcDxhEw55GibpHEa7HTGci_xjzKbObQAgR45nbJwkYi4yzCbstjGvzwsXNFQa1VMZlHZYB5accf0uPjBt8EmN6ru6Wxut6qBRtVm3_mbInbPTStWOLg5zxt7v796Wj-Hq5eFpuViFOhG8D1FgnCJqEqjznIoSK-7707iCoigz4jwGTHVRlVqBQkqLuPKejFeq4EWcJTN2vc_d2u5rINfLxjhNda1a6gYn4zmgEAIBvVTspdp2zlmq5NaaRtkfyUHu2MmNPLKTO3YSEunZeefloWQoPI6j7w-WFyz2AvKvfhtvdx6CzymNJd3LsjP_lvwC1-WGIw
CitedBy_id crossref_primary_10_1007_s12032_023_02278_1
crossref_primary_10_2478_prolas_2022_0049
crossref_primary_10_3390_molecules28010116
crossref_primary_10_1007_s13577_022_00728_y
crossref_primary_10_1093_nar_gkac812
crossref_primary_10_1097_MD_0000000000035984
crossref_primary_10_1016_j_biopha_2024_116846
crossref_primary_10_2174_1567201820666230504120841
crossref_primary_10_1007_s12033_023_00990_x
crossref_primary_10_1016_j_ecoenv_2021_112372
crossref_primary_10_3390_biomedicines10082004
crossref_primary_10_1186_s12951_022_01406_9
crossref_primary_10_1016_j_phrs_2023_106777
crossref_primary_10_3389_fcell_2021_722960
Cites_doi 10.1158/1078-0432.CCR-12-1922
10.1038/s41375-018-0140-y
10.1016/j.leukres.2008.12.015
10.1182/blood-2014-12-618025
10.1007/s12032-010-9807-6
10.1080/10428194.2016.1272681
10.1016/j.biopha.2018.06.093
10.3389/fgene.2019.00626
10.1016/j.gpb.2015.02.001
10.1093/abbs/gmr128
10.1038/leu.2014.279
10.1016/j.drup.2012.01.003
10.1038/onc.2012.295
10.1007/s13577-020-00367-1
10.3390/cancers12020449
10.1515/cclm-2018-0838
10.1038/onc.2011.611
10.1002/jcb.26800
10.1016/j.clml.2018.02.004
10.1186/1476-4598-9-123
10.1182/blood-2014-06-581926
10.3324/haematol.2017.168070
10.3109/10428194.2012.659736
10.1111/cas.12339
10.1080/10428194.2018.1543875
10.1182/blood-2014-04-566778
10.1016/j.cbi.2018.06.006
10.2147/CMAR.S174476
10.1016/j.biopha.2017.11.002
10.1016/j.canlet.2020.03.020
10.1093/nar/gky1023
10.4161/cc.25251
10.1038/leu.2012.65
10.1126/scitranslmed.aao6321
10.1186/s12943-015-0322-4
10.1038/s41568-018-0005-8
10.1038/ni1575
10.1002/kjm2.12057
10.1016/j.pharmthera.2012.08.003
10.1073/pnas.1702914114
10.3390/cancers6031769
10.1371/journal.pone.0016007
10.1111/cas.12160
10.1515/dmdi-2014-0026
10.1158/0008-5472.CAN-13-3311-T
10.1016/j.leukres.2011.03.029
10.1038/leu.2008.370
10.1124/mol.110.069633
10.1016/j.drup.2019.100647
10.1038/leu.2013.291
10.1016/j.jsbmb.2017.05.014
10.15171/apb.2017.041
10.5732/cjc.30.0381
10.1186/1476-4598-12-152
10.1016/j.leukres.2017.09.014
10.18632/oncotarget.24309
10.1172/JCI66553
10.1515/hsz-2016-0308
10.1080/15384101.2019.1632138
10.1038/s41416-020-0802-1
10.1186/1476-4598-11-37
10.1186/s13045-019-0734-5
10.1016/j.yexcr.2017.12.001
10.1016/j.exphem.2018.09.001
10.1371/journal.pone.0059390
10.1111/cas.12370
10.1074/jbc.M112.446831
10.1038/nature05983
10.1111/j.1582-4934.2010.01213.x
10.1007/s13277-015-3509-9
10.3109/10428194.2011.591004
10.1038/srep00314
10.1039/C6MD00394J
10.1038/cgt.2015.50
10.1016/j.canlet.2015.07.044
10.7554/eLife.47544
10.3892/ijo.2014.2390
10.1016/j.biopha.2019.109415
10.1182/blood-2007-03-081133
10.1186/1476-4598-9-176
10.1158/1078-0432.CCR-15-0489
10.3390/jcm9020593
10.1002/ijc.30669
10.1586/ehm.09.32
10.1038/s41467-020-14713-2
10.18632/oncotarget.19192
10.3324/haematol.2018.193086
10.18632/oncotarget.11032
10.1016/j.molmed.2015.08.002
10.1038/nm909
10.1073/pnas.1803377115
10.2353/jmoldx.2009.080095
10.1158/1535-7163.MCT-17-0802
10.1186/s13148-018-0587-8
10.1186/s13148-018-0492-1
10.1194/jlr.M091876
10.1038/srep44541
10.1002/cyto.b.20544
10.1182/blood-2013-06-511527
10.1016/j.drup.2019.100645
10.1182/blood-2010-03-275925
10.4103/0973-1482.143334
10.1016/j.bbrc.2012.07.098
10.1016/j.prp.2019.152603
10.1172/JCI64210
10.3109/10428194.2012.678004
10.1371/journal.pone.0082062
10.1182/blood-2012-07-444729
10.1016/j.gene.2014.03.049
10.1038/leu.2011.305
10.2174/1568009616666151113120705
10.1016/j.cell.2018.03.006
10.3390/molecules22010006
10.1186/1755-8166-6-27
10.1016/j.critrevonc.2014.08.006
10.1186/1476-4598-10-108
10.1007/978-1-4939-7435-1_6
10.18632/oncoscience.315
10.3389/fendo.2018.00402
10.1111/cas.12566
10.18632/oncotarget.17706
10.3109/10428194.2012.693178
10.1038/s41408-019-0272-y
10.1093/annonc/mdt412
10.2174/13894501113149990185
10.1016/j.blre.2014.09.005
10.1016/j.biopha.2017.07.035
10.1016/S1470-2045(17)30621-6
10.1038/ncb0309-228
10.1016/j.bbabio.2011.03.010
10.1158/1078-0432.CCR-09-0145
10.1007/978-1-4939-7046-9_1
10.2217/epi-2018-0123
10.1179/102453310X12647083620840
10.1016/j.mrrev.2016.11.003
10.1038/bcj.2011.25
10.1124/mol.110.066258
10.1093/carcin/bgz183
10.3892/ijo.2016.3830
10.1182/blood-2012-01-401794
10.1038/leu.2013.125
10.1038/bcj.2012.31
10.3390/ph13120438
10.1210/me.2010-0402
10.1182/blood-2016-10-697698
10.1016/j.drup.2013.05.001
10.1016/j.gpb.2012.06.004
10.3892/or.2016.5318
10.1016/j.exphem.2015.12.007
10.1038/leu.2016.325
10.1016/S0079-6123(10)82001-1
10.1038/onc.2010.634
10.2174/1389200221666200103111539
10.1016/j.bbagen.2015.12.011
10.1073/pnas.0808266105
10.1158/0008-5472.CAN-15-0457
10.1007/s13105-010-0050-6
10.1186/s13045-019-0714-9
10.1155/2018/5416923
10.3390/cancers11081087
10.1158/0008-5472.CAN-13-1768
10.1182/bloodadvances.2018029660
10.1002/ijc.31041
10.1002/jcb.26431
10.1073/pnas.242606799
10.1111/j.1365-2141.2008.07077.x
10.1371/journal.pone.0061858
10.1016/j.ejphar.2013.09.044
10.1007/s12032-009-9413-7
10.1016/j.leukres.2015.04.010
10.1186/1756-8722-4-37
10.3109/13880209.2012.665931
10.1016/j.leukres.2016.08.013
10.1111/j.1349-7006.2010.01489.x
10.1080/10245332.2015.1114766
10.1007/s12185-012-1256-x
10.18632/oncotarget.9021
10.1097/FPC.0b013e328350012b
10.1016/j.bbamcr.2013.11.022
10.1042/BST20140142
10.1038/leu.2011.273
10.1007/s10637-016-0407-y
10.1016/j.cell.2006.03.043
10.3109/10428194.2011.638069
10.3389/fphar.2018.01090
10.3892/or.2017.5464
10.1016/j.leukres.2014.12.002
10.1016/j.biopha.2017.08.084
10.1186/1476-4598-8-69
10.1016/j.ncrna.2020.02.001
10.3390/cells9051141
10.2174/1389201015666140519122524
10.3390/cancers12020407
10.1186/s12885-019-6151-x
10.1002/emmm.201100209
10.3892/ol.2017.6076
10.18632/oncotarget.16525
10.1111/bjh.15547
10.1182/blood-2009-08-237495
10.1016/j.cell.2009.04.021
10.1016/j.febslet.2010.12.027
10.1016/j.leukres.2011.08.023
10.1007/s12253-015-0035-4
10.1371/journal.pone.0029541
10.1158/1535-7163.MCT-09-0127
10.3390/cells9041044
10.1016/j.canlet.2016.01.043
10.1016/j.ejphar.2020.172976
10.3390/ijms21093084
10.1016/j.ymthe.2019.01.012
10.1182/blood-2008-08-172254
10.1261/rna.2442211
10.21037/tlcr.2017.12.01
10.1016/j.gene.2017.05.030
10.18632/oncotarget.3802
10.1186/1476-4598-9-115
10.1042/BSR20171383
10.3390/cancers12010200
10.3390/ijms21010132
10.1002/path.5222
10.3324/haematol.2015.134932
10.1016/j.blre.2013.04.002
10.1530/JOE-19-0180
10.1177/1758835918818347
10.1186/1479-5876-11-265
10.1038/s41419-017-0100-x
10.1016/j.canlet.2014.10.006
10.1186/s12935-015-0185-1
10.1016/j.leukres.2009.10.002
10.1002/jbt.22008
10.1007/s12032-012-0210-3
10.1159/000302889
10.1038/onc.2014.254
10.1182/blood-2008-12-191619
10.1007/s11899-019-00543-7
10.1016/j.cell.2013.11.027
10.3390/ijms19103139
10.1007/s00432-011-1137-3
10.1186/s13045-014-0083-3
10.1093/carcin/bgs179
10.1186/s12943-015-0460-8
10.1002/ijc.28500
10.3109/10428194.2011.576791
10.1186/s12967-016-0893-x
10.1016/j.cmet.2019.07.011
10.1007/s12672-011-0072-8
10.1111/cas.13965
10.1002/jcp.27486
10.1073/pnas.0806202105
10.3324/haematol.2011.046888
10.18632/oncotarget.11054
10.1016/j.fct.2016.06.010
10.1016/j.blre.2005.08.003
ContentType Journal Article
Copyright 2021 Elsevier Ltd
Copyright © 2021 Elsevier Ltd. All rights reserved.
Copyright_xml – notice: 2021 Elsevier Ltd
– notice: Copyright © 2021 Elsevier Ltd. All rights reserved.
DBID NPM
AAYXX
CITATION
7X8
DOI 10.1016/j.semcancer.2021.03.014
DatabaseName PubMed
CrossRef
MEDLINE - Academic
DatabaseTitle PubMed
CrossRef
MEDLINE - Academic
DatabaseTitleList
PubMed
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Anatomy & Physiology
EISSN 1096-3650
EndPage 302
ExternalDocumentID 10_1016_j_semcancer_2021_03_014
33757848
S1044579X2100064X
Genre Journal Article
Review
GroupedDBID ---
--K
--M
.1-
.FO
.~1
0R~
0SF
123
1B1
1P~
1RT
1~.
1~5
4.4
457
4G.
53G
5RE
5VS
7-5
71M
8P~
AACTN
AAEDT
AAEDW
AAIAV
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAQXK
AAXUO
ABFRF
ABGSF
ABJNI
ABMAC
ABUDA
ABXDB
ABYKQ
ACDAQ
ACGFO
ACGFS
ACRLP
ADBBV
ADEZE
ADFGL
ADMUD
ADUVX
AEBSH
AEFWE
AEHWI
AEKER
AENEX
AEVXI
AFCTW
AFKWA
AFRHN
AFTJW
AFXIZ
AGHFR
AGRDE
AGUBO
AGYEJ
AIEXJ
AIKHN
AITUG
AJBFU
AJOXV
AJUYK
ALMA_UNASSIGNED_HOLDINGS
AMFUW
AMRAJ
ASPBG
AVWKF
AXJTR
AZFZN
BKOJK
BLXMC
CAG
COF
CS3
DM4
DOVZS
EBS
EFBJH
EFLBG
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
G-Q
GBLVA
HVGLF
HX~
HZ~
IH2
IHE
J1W
KOM
LG5
M41
MO0
N9A
NCXOZ
O-L
O9-
OAUVE
OC~
OO-
OZT
P-8
P-9
P2P
PC.
Q38
R2-
RIG
RNS
ROL
RPZ
SDF
SDG
SDP
SES
SEW
SPCBC
SSU
SSZ
T5K
UDS
UNMZH
XPP
Z5R
ZMT
ZU3
~G-
AAXKI
ADVLN
AFJKZ
AKRWK
NPM
AAYXX
CITATION
7X8
ID FETCH-LOGICAL-c371t-4742644ce74c99ebd4f157862f0bbd8e112046cbfdca0a4e6b2f47481fab1b283
ISSN 1044-579X
IngestDate Fri Oct 25 06:32:37 EDT 2024
Thu Sep 26 16:33:13 EDT 2024
Wed Oct 16 00:41:11 EDT 2024
Fri Feb 23 02:40:57 EST 2024
IsPeerReviewed true
IsScholarly true
Keywords microRNAs
Cancer drug resistance
Hematological malignancies
Drug sensitivity
Language English
License Copyright © 2021 Elsevier Ltd. All rights reserved.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c371t-4742644ce74c99ebd4f157862f0bbd8e112046cbfdca0a4e6b2f47481fab1b283
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
ORCID 0000-0002-7811-9509
0000-0002-7801-4643
0000-0001-7657-7410
0000-0003-2030-6368
PMID 33757848
PQID 2504777404
PQPubID 23479
PageCount 20
ParticipantIDs proquest_miscellaneous_2504777404
crossref_primary_10_1016_j_semcancer_2021_03_014
pubmed_primary_33757848
elsevier_sciencedirect_doi_10_1016_j_semcancer_2021_03_014
PublicationCentury 2000
PublicationDate August 2022
2022-Aug
2022-08-00
20220801
PublicationDateYYYYMMDD 2022-08-01
PublicationDate_xml – month: 08
  year: 2022
  text: August 2022
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle Seminars in cancer biology
PublicationTitleAlternate Semin Cancer Biol
PublicationYear 2022
Publisher Elsevier Ltd
Publisher_xml – name: Elsevier Ltd
References Hussaarts, Veerman, Jansman, van Gelder, Mathijssen, van Leeuwen (bib0065) 2019; 11
Cui, Wang, Yao, Zhang, Xie, Cui (bib0405) 2019; 10
Li, Zhu, Gu, Hu, Dong, Yao (bib0745) 2010; 15
Iorio, Croce (bib0295) 2012; 4
Ghodousi, Rahgozar (bib0415) 2018; 119
Pichiorri, Suh, Ladetto, Kuehl, Palumbo, Drandi (bib0445) 2008; 105
Shen, Guo, Qi, Shi, Wu, Ni (bib1075) 2016; 22
Dalton (bib0830) 2008; 14
Zimmerman, Dollins, Crawford, Grant, Nana-Sinkam, Richards (bib1230) 2010; 78
Turrini, Haenisch, Laechelt, Diewock, Bruhn, Cascorbi (bib0585) 2012; 22
Hershkovitz-Rokah, Modai, Pasmanik-Chor, Toren, Shomron, Raanani (bib1200) 2015; 356
Ghafouri-Fard, Esmaeili, Taheri (bib0430) 2020; 875
Liu, Chen, Feng, Zhang, Pelicano, Wang (bib1110) 2014; 28
Manfe, Biskup, Rosbjerg, Kamstrup, Skov, Lerche (bib1250) 2012; 7
Bai, Cao, Deng, Zhou, Wang (bib0690) 2012; 138
Xie, Li, Vilborg, Lee, Shu, Yartseva (bib0395) 2013; 155
Groot, Lee (bib0905) 2020; 9
Min, Wang, Zhang, Chen, Li, Liu (bib0940) 2018; 362
Srutova, Curik, Burda, Savvulidi, Silvestri, Trotta (bib1300) 2018; 103
Zhou, Li, Liu, Shan, Li, Zhao (bib1145) 2017; 626
Graves, Zeng (bib0380) 2012; 10
Li, Lu, Sun, Mi, Zhang, Luo (bib0945) 2008; 105
Lopes-Rodrigues, Seca, Sousa, Sousa, Lima, Vasconcelos (bib0580) 2014; 135
Xavier, Caires, Barbosa, Bergantim, Guimaraes, Vasconcelos (bib0555) 2020; 9
Seca, Lima, Almeida, Sobrinho-Simoes, Bergantim, Guimaraes (bib0800) 2014; 15
Ramachandran, Muiwo, Ahmad, Pandey, Singh, Bakhshi (bib0325) 2017; 58
Murray, Rushworth, Zaitseva, Bowles, Macewan (bib0715) 2013; 12
Shah, Schwartz (bib0645) 2001; 7
Lwin, Lin, Choi, Zhang, Moscinski, Wright (bib0880) 2010; 116
Mosakhani, Mustjoki, Knuutila (bib1295) 2013; 6
Gu, Zhu, Li, Dong, Yao, Lin (bib1085) 2011; 28
Lawrie (bib0465) 2013; 27
Wang, Lim, Feng, Bao, Lee, Cai (bib0150) 2018; 17
Calin, Dumitru, Shimizu, Bichi, Zupo, Noch (bib0470) 2002; 99
Tang, Xu, Xu, Huang, Chen, Su (bib1080) 2018; 142
Vasconcelos (bib0005) 2016; 22
Otto, Candido, Pilarz, Sicinska, Bronson, Bowden (bib0260) 2017; 114
Li, Dalton (bib0805) 2006; 20
Chen, Jacamo, Konopleva, Garzon, Croce, Andreeff (bib0875) 2013; 123
Ferreira, Lie, Engelsen, Machado, Link, Lorens (bib0125) 2017; 8
Zhang, Rastgoo, Wu, Zhang, Pourabdollah, Zacksenhaus (bib0780) 2020; 480
Wu, Dai (bib0190) 2017; 387
Robey, Pluchino, Hall, Fojo, Bates, Gottesman (bib0100) 2018; 18
Li, Hui, Xu (bib0695) 2012; 44
Garofalo, Croce (bib1005) 2013; 16
Liu, Wang, Chen, Wu, Zhang, Huang (bib1290) 2012; 425
Tian, Zhao, Tai, Amin, Hu, Berger (bib0845) 2012; 120
Joshi, Chandrakala, Korgaonkar, Ghosh, Vundinti (bib0315) 2014; 542
Zhou, Zeng, Wang, Guo, Huang, Shen (bib0665) 2013; 11
Sun (bib0825) 2016; 380
de Souza, Cruz, Viola, Maia (bib0935) 2015; 106
Zhang, Luo, Feng, Zhang, Wu, Zheng (bib0170) 2011; 10
Kaur, Ruhela, Rani, Gupta, Sriram, Gogia (bib0500) 2020; 10
Ruby, Jan, Bartel (bib0390) 2007; 448
Ganapathy-Kanniappan, Geschwind (bib0895) 2013; 12
Tan, Dunton, Liu, Fox, Morad, Desai (bib0105) 2019; 60
Seca, Lima, Vasconcelos (bib0165) 2014
Xue, Zhuo, Shan (bib0240) 2017; 1617
Nishioka, Ikezoe, Yang, Nobumoto, Tsuda, Yokoyama (bib1195) 2014; 105
Li, Jiang, Liu, Wang, Zhao, Liu (bib0275) 2018; 115
Gulla, Di Martino, Gallo Cantafio, Morelli, Amodio, Botta (bib0605) 2016; 22
Sakthivel, Hariharan (bib0140) 2017; 93
Caliskan, Guler, Bozok Cetintas (bib0305) 2017; 95
Xu, Song, Huang, Zhang, Chen (bib0675) 2019; 35
Li, Hui, Xu, Shen, Chen, Long (bib0725) 2012; 50
Yamada, Noguchi, Kumazaki, Shinohara, Miki, Naoe (bib1265) 2014; 1843
Perez-Ramirez, Canadas-Garre, Molina, Robles, Faus-Dader, Calleja-Hernandez (bib0055) 2017; 771
Sousa, Matthiesen, Lima, Vasconcelos (bib0560) 2020; 12
Cuce, Gallo Cantafio, Siciliano, Riillo, Caracciolo, Scionti (bib0135) 2019; 12
Jaiswal, Luk, Gong, Mathys, Grau, Bebawy (bib0925) 2012; 11
Lawrie, Gal, Dunlop, Pushkaran, Liggins, Pulford (bib0975) 2008; 141
Chakraborty, Sharma, Sharma, Sarkar, Lee (bib1135) 2018; 9
Loffler, Brocke-Heidrich, Pfeifer, Stocsits, Hackermuller, Kretzschmar (bib0540) 2007; 110
Koo, Kwon (bib0270) 2018; 9
O’Brien, Hayder, Zayed, Peng (bib0335) 2018; 9
Yuan, Ma, Yang, Jiang, Wang, Zhu (bib0795) 2019; 18
Terrinoni, Calabrese, Basso, Aita, Caporali, Plebani (bib0960) 2019; 57
Kaddar, Chien, Bertrand, Pages, Rouault, Salles (bib0970) 2009; 33
Li, Zhou, Li, Yang, Ma, Peng (bib0760) 2019; 119
Salati, Salvestrini, Carretta, Genovese, Rontauroli, Zini (bib1220) 2017; 8
Huang, Yu, Li, Liu, Zhong (bib0950) 2012; 29
Ferracin, Zagatti, Rizzotto, Cavazzini, Veronese, Ciccone (bib1175) 2010; 9
Goler-Baron, Assaraf (bib0110) 2011; 6
Smith, Macleod (bib0765) 2019; 247
Sundahl, Clarisse, Bracke, Offner, Berghe, Beck (bib0620) 2016; 3
Zhang, Zhang, Shi, Yin (bib1010) 2018; 97
Lopes-Rodrigues, Di Luca, Mleczko, Meleady, Henry, Pesic (bib0200) 2017; 7
Zenz, Mohr, Eldering, Kater, Buhler, Kienle (bib1285) 2009; 113
Redis, Calin, Yang, You, Calin (bib0545) 2012; 136
Abdi, Rastgoo, Chen, Chen, Chang (bib0855) 2019; 19
Misiewicz-Krzeminska, Krzeminski, Corchete, Quwaider, Rojas, Herrero (bib0285) 2019; 5
Li, Zhong (bib1025) 2016; 21
Fonte, Apollonio, Scarfo, Ranghetti, Fazi, Ghia (bib1115) 2013; 19
Zeller, Dai, Steele, Siddiq, Walley, Wilhelm-Benartzi (bib0145) 2012; 31
Jagannathan, Vad, Vallabhapurapu, Vallabhapurapu, Anderson, Driscoll (bib1245) 2015; 29
Rao, Jiang, Ji, Huang, Iqbal, Lenz (bib0755) 2012; 26
Seto, Beatty, Lynch, Hermreck, Tetzlaff, Duvic (bib1040) 2018; 183
Gong, Luk, Jaiswal, George, Grau, Bebawy (bib0115) 2013; 721
Indran, Tufo, Pervaiz, Brenner (bib0120) 2011; 1807
Zhu, Zhu, Wu (bib0175) 2018; 1699
Szymczyk, Macheta, Podhorecka (bib0300) 2018; 10
Yu, Yang, Zhao, Zhu, Kang, Vernon (bib0770) 2012; 26
Tong, Cui, Wang, Zhou (bib0280) 2019; 47
Dzikiewicz-Krawczyk (bib0435) 2014; 7
Wang, Li, Ju, Wang, Wang, Zhong (bib0870) 2011; 52
Zhao, Yang, Hu, Ruan (bib0590) 2010; 34
Lwin, Zhao, Cheng, Zhang, Huang, Shah (bib0885) 2013; 123
Kaymaz, Gunel, Ceyhan, Cetintas, Ozel, Yandim (bib1205) 2015; 36
Al-Harbi, Choudhary, Ebron, Hill, Vivekanathan, Ting (bib1165) 2015; 14
Kosaka, Iguchi, Hagiwara, Yoshioka, Takeshita, Ochiya (bib0915) 2013; 288
Zhao, Li, Song, Zhou, Li, Miao (bib1210) 2016; 7
Li, Zhang, Li, Wang, Yan, Li (bib0450) 2016; 49
Lionetti, Biasiolo, Agnelli, Todoerti, Mosca, Fabris (bib0510) 2009; 114
Matsunaga, Takemoto, Sato, Takimoto, Tanaka, Fujimi (bib0815) 2003; 9
Wang, Li, Li, Chu, Shiang, Li (bib0210) 2015; 125
Liang, Tang, Ke, Chen, Luo, Zhang (bib0215) 2017; 172
Krisnamurti, Louisa, Anggraeni, Wanandi (bib0090) 2016; 2016
Yang, Ma, Wu, Qin, Zhao, Shi (bib1160) 2012; 53
Raimondo, Urzi, Conigliaro, Bosco, Parisi, Carlisi (bib0565) 2020; 12
Salerno, Scaglione, Coffman, Brown, Baccarini, Fernandes (bib0660) 2009; 8
Marques, Ranjbar, Laursen, Falgreen, Bilgrau, Bodker (bib0205) 2016; 44
Liang, Song (bib0860) 2020
Mansoori, Mohammadi, Davudian, Shirjang, Baradaran (bib0070) 2017; 7
Seca, Lima, Lopes-Rodrigues, Guimaraes, Almeida, Vasconcelos (bib0785) 2013; 14
Zhang, Pan, Xiang, Zhu, Wu, Chen (bib0320) 2016; 7
Liu, Chen, Huang, Wu, Li, Zhang (bib1235) 2012; 29
van Zandwijk, Pavlakis, Kao, Linton, Boyer, Clarke (bib1100) 2017; 18
Meng, Chen, Han, Tan, Wang, Wang (bib1035) 2018; 10
Sousa, Lima, Vasconcelos (bib0195) 2015; 21
Zhu, Zhu, Fang, Fan, Zou, Wang (bib0705) 2012; 33
Pepe, Balatti (bib0965) 2020; 9
Si, Shen, Zheng, Fan (bib0160) 2019; 11
Xu, Ohms, Li, Wang, Gong, Hu (bib0595) 2013; 8
Barger, Rahman, Jackson, Acunzo, Nana-Sinkam (bib0995) 2016; 98
Lu, Zhang, Ji, Li, Du, Wang (bib1020) 2014; 45
Xavier, Pesic, Vasconcelos (bib0010) 2016; 16
Temoche-Diaz, Shurtleff, Nottingham, Yao, Fadadu, Lambowitz (bib0910) 2019; 8
Hong, Kang, Borad, Sachdev, Ejadi, Lim (bib1090) 2020; 122
Huang, Shen, Zou, Wang, Tang, Zhang (bib0340) 2011; 67
Witten, Slack (bib1120) 2020; 41
Reid, Pel, Kirschner, Cheng, Mugridge, Weiss (bib1095) 2013; 24
Reddy (bib0375) 2015; 15
Chen, He, Arslan, Mo, Reinhold, Pommier (bib1140) 2011; 79
Tessel, Benham, Krett, Rosen, Gunaratne (bib0610) 2011; 2
Smith, Cidlowski (bib0625) 2010; 182
Jacamo, Chen, Wang, Ma, Zhang, Spaeth (bib0810) 2014; 123
Salerno, Yuan, Scaglione, Marti, Jankovic, Mazzella (bib0680) 2010; 78
Kim, Kim, Park (bib1260) 2012; 53
Dzikiewicz-Krawczyk (bib0485) 2015; 93
Guo, Zhao, Yang, Zhang, Chen (bib0245) 2014; 2014
He, Hu, Tang, Zheng, Sun, Sheng (bib0085) 2015; 11
Di Marco, Ramassone, Pagotto, Anastasiadou, Veronese, Visone (bib0425) 2018; 19
Li, Zhu, Gu, Dong, Yao, Lin (bib0740) 2010; 101
Zhu, Zhao, Lin, Zhang (bib0710) 2015; 22
Rinaldetti, Pfirrmann, Manz, Guilhot, Dietz, Panagiotidis (bib0095) 2018; 18
Li, Gao, Luo, Wang, Gao, Wang (bib0480) 2013; 121
Zhao, Chu, Hu, Lin, Wang, Jiang (bib0720) 2015; 75
Qin, Zhang, Deng, An, Qin, Li (bib0790) 2017; 31
Pinto, Bergantim, Caires, Seca, Guimaraes, Vasconcelos (bib0045) 2020; 12
Jones, Kamel-Reid, Bahler, Dong, Elenitoba-Johnson, Press (bib0075) 2009; 11
Viteri, Rosell (bib1060) 2018; 7
Mitra, Adams, Jiang, Greenawalt, Eischen (bib0370) 2020; 11
Umezu, Ohyashiki, Kuroda, Ohyashiki (bib0550) 2013; 32
Buhagiar, Borg, Ayers (bib0955) 2020; 5
Desantis, Saltarella, Lamanuzzi, Melaccio, Solimando, Mariggio (bib1070) 2020; 21
Jung, Lee, Lee, Kim, Yim, Kim (bib0985) 2017; 102
Hentati-Kallel, Le Jan, Bernard, Antonicelli, Trussardi-Regnier (bib1305) 2017; 50
Wu, Zhu, Shen, Huang, Xu (bib0850) 2019; 215
Tian, Zhan, Zhu, Li, Tang, Chen (bib0700) 2019; 43
Babiarz, Hsu, Melton, Thomas, Ullian, Blelloch (bib0385) 2011; 17
Saliminejad, Khorram Khorshid, Soleymani Fard, Ghaffari (bib0235) 2019; 234
Xia, Yang, Liu, Lou (bib0250) 2015; 14
Tagawa, Ikeda, Sawada (bib0475) 2013; 104
Scholl, Hassan, Zalcberg (bib0635) 2012; 36
Zhang, Li, Li, Li, Guo, Yao (bib0900) 2015; 13
Lavi, Gottesman, Levy (bib0030) 2012; 15
Vasconcelos, Caires, Abols, Xavier, Line (bib0020) 2019; 47
Abdi, Jian, Chang (bib0040) 2016; 7
Li, Hao, Feng, Zang, Qin, Yi (bib0980) 2015; 39
Xi, Li, Du, An, Fan, Lu (bib0600) 2017; 37
San Jose-Eneriz, Roman-Gomez, Jimenez-Velasco, Garate, Martin, Cordeu (bib0310) 2009; 8
Wan, Tian, Zhang, Peng, Sun, Zhang (bib0670) 2018; 119
Horiguchi, Kobune, Kikuchi, Yoshida, Murata, Murase (bib0575) 2016; 101
Kim, Jang, Song, Kim, Kim, Jang (bib0130) 2019;
Ferracin (10.1016/j.semcancer.2021.03.014_bib1175) 2010; 9
Hao (10.1016/j.semcancer.2021.03.014_bib0835) 2011; 52
Lavi (10.1016/j.semcancer.2021.03.014_bib0180) 2013; 73
Dzikiewicz-Krawczyk (10.1016/j.semcancer.2021.03.014_bib0435) 2014; 7
Iorio (10.1016/j.semcancer.2021.03.014_bib0295) 2012; 4
Lawrie (10.1016/j.semcancer.2021.03.014_bib0975) 2008; 141
Huang (10.1016/j.semcancer.2021.03.014_bib0950) 2012; 29
Li (10.1016/j.semcancer.2021.03.014_bib0275) 2018; 115
Harada (10.1016/j.semcancer.2021.03.014_bib1170) 2012; 53
Smith (10.1016/j.semcancer.2021.03.014_bib0625) 2010; 182
Moussay (10.1016/j.semcancer.2021.03.014_bib1280) 2010; 9
Graves (10.1016/j.semcancer.2021.03.014_bib0380) 2012; 10
Phi (10.1016/j.semcancer.2021.03.014_bib0185) 2018; 2018
Li (10.1016/j.semcancer.2021.03.014_bib0230) 2020; 33
Matsuyama (10.1016/j.semcancer.2021.03.014_bib0345) 2019; 21
Hodge (10.1016/j.semcancer.2021.03.014_bib0495) 2011; 1
Meng (10.1016/j.semcancer.2021.03.014_bib1035) 2018; 10
Han (10.1016/j.semcancer.2021.03.014_bib0350) 2006; 125
Liang (10.1016/j.semcancer.2021.03.014_bib0215) 2017; 172
Zhu (10.1016/j.semcancer.2021.03.014_bib0175) 2018; 1699
Kaddar (10.1016/j.semcancer.2021.03.014_bib0970) 2009; 33
Zhang (10.1016/j.semcancer.2021.03.014_bib0780) 2020; 480
Zimmerman (10.1016/j.semcancer.2021.03.014_bib1230) 2010; 78
Ghodousi (10.1016/j.semcancer.2021.03.014_bib0415) 2018; 119
Manfe (10.1016/j.semcancer.2021.03.014_bib1250) 2012; 7
Jung (10.1016/j.semcancer.2021.03.014_bib0985) 2017; 102
Chakraborty (10.1016/j.semcancer.2021.03.014_bib1135) 2018; 9
Li (10.1016/j.semcancer.2021.03.014_bib0725) 2012; 50
Zhou (10.1016/j.semcancer.2021.03.014_bib0665) 2013; 11
Mansoori (10.1016/j.semcancer.2021.03.014_bib0070) 2017; 7
Jones (10.1016/j.semcancer.2021.03.014_bib0075) 2009; 11
Munker (10.1016/j.semcancer.2021.03.014_bib0990) 2010; 123
Garofalo (10.1016/j.semcancer.2021.03.014_bib1005) 2013; 16
Xu (10.1016/j.semcancer.2021.03.014_bib0675) 2019; 35
Housman (10.1016/j.semcancer.2021.03.014_bib0015) 2014; 6
Wu (10.1016/j.semcancer.2021.03.014_bib0850) 2019; 215
Iqbal (10.1016/j.semcancer.2021.03.014_bib0460) 2015; 125
Krisnamurti (10.1016/j.semcancer.2021.03.014_bib0090) 2016; 2016
Wan (10.1016/j.semcancer.2021.03.014_bib0670) 2018; 119
Abdi (10.1016/j.semcancer.2021.03.014_bib0040) 2016; 7
Viteri (10.1016/j.semcancer.2021.03.014_bib1060) 2018; 7
Hussaarts (10.1016/j.semcancer.2021.03.014_bib0065) 2019; 11
Tong (10.1016/j.semcancer.2021.03.014_bib0280) 2019; 47
Kota (10.1016/j.semcancer.2021.03.014_bib1050) 2009; 137
Li (10.1016/j.semcancer.2021.03.014_bib0220) 2017; 37
Bai (10.1016/j.semcancer.2021.03.014_bib0730) 2011; 585
O’Brien (10.1016/j.semcancer.2021.03.014_bib0335) 2018; 9
Cui (10.1016/j.semcancer.2021.03.014_bib0405) 2019; 10
Xavier (10.1016/j.semcancer.2021.03.014_bib0555) 2020; 9
Pichiorri (10.1016/j.semcancer.2021.03.014_bib0445) 2008; 105
Liang (10.1016/j.semcancer.2021.03.014_bib0860) 2020
Mitra (10.1016/j.semcancer.2021.03.014_bib0370) 2020; 11
Marques (10.1016/j.semcancer.2021.03.014_bib0205) 2016; 44
Shen (10.1016/j.semcancer.2021.03.014_bib1075) 2016; 22
Ganapathy-Kanniappan (10.1016/j.semcancer.2021.03.014_bib0895) 2013; 12
Wallace (10.1016/j.semcancer.2021.03.014_bib0525) 2017; 130
Rainer (10.1016/j.semcancer.2021.03.014_bib1270) 2009; 23
Di Marco (10.1016/j.semcancer.2021.03.014_bib0425) 2018; 19
Kim (10.1016/j.semcancer.2021.03.014_bib1260) 2012; 53
Markovina (10.1016/j.semcancer.2021.03.014_bib0820) 2010; 9
Liu (10.1016/j.semcancer.2021.03.014_bib1290) 2012; 425
Jaiswal (10.1016/j.semcancer.2021.03.014_bib0925) 2012; 11
Seca (10.1016/j.semcancer.2021.03.014_bib0165) 2014
Lwin (10.1016/j.semcancer.2021.03.014_bib0880) 2010; 116
Yamada (10.1016/j.semcancer.2021.03.014_bib1265) 2014; 1843
Deng (10.1016/j.semcancer.2021.03.014_bib0890) 2018; 38
Horiguchi (10.1016/j.semcancer.2021.03.014_bib0575) 2016; 101
Chen (10.1016/j.semcancer.2021.03.014_bib0875) 2013; 123
Goler-Baron (10.1016/j.semcancer.2021.03.014_bib0110) 2011; 6
Matsunaga (10.1016/j.semcancer.2021.03.014_bib0815) 2003; 9
Hong (10.1016/j.semcancer.2021.03.014_bib1090) 2020; 122
Qin (10.1016/j.semcancer.2021.03.014_bib0790) 2017; 31
Zhao (10.1016/j.semcancer.2021.03.014_bib1210) 2016; 7
Rinaldetti (10.1016/j.semcancer.2021.03.014_bib0095) 2018; 18
Xia (10.1016/j.semcancer.2021.03.014_bib0250) 2015; 14
Calin (10.1016/j.semcancer.2021.03.014_bib0470) 2002; 99
Min (10.1016/j.semcancer.2021.03.014_bib0940) 2018; 362
Espadinha (10.1016/j.semcancer.2021.03.014_bib0505) 2017; 8
Cuce (10.1016/j.semcancer.2021.03.014_bib0135) 2019; 12
Mori (10.1016/j.semcancer.2021.03.014_bib0410) 2019; 30
Turrini (10.1016/j.semcancer.2021.03.014_bib0585) 2012; 22
Desantis (10.1016/j.semcancer.2021.03.014_bib1070) 2020; 21
Scholl (10.1016/j.semcancer.2021.03.014_bib0635) 2012; 36
Vasconcelos (10.1016/j.semcancer.2021.03.014_bib0005) 2016; 22
Ruby (10.1016/j.semcancer.2021.03.014_bib0390) 2007; 448
Lu (10.1016/j.semcancer.2021.03.014_bib1020) 2014; 45
Perez-Ramirez (10.1016/j.semcancer.2021.03.014_bib0055) 2017; 771
Huang (10.1016/j.semcancer.2021.03.014_bib0340) 2011; 67
Zhang (10.1016/j.semcancer.2021.03.014_bib0650) 2017; 398
San Jose-Eneriz (10.1016/j.semcancer.2021.03.014_bib0310) 2009; 8
Rao (10.1016/j.semcancer.2021.03.014_bib0755) 2012; 26
Kosaka (10.1016/j.semcancer.2021.03.014_bib0915) 2013; 288
Xiao (10.1016/j.semcancer.2021.03.014_bib0520) 2008; 9
Ghafouri-Fard (10.1016/j.semcancer.2021.03.014_bib0430) 2020; 875
Sousa (10.1016/j.semcancer.2021.03.014_bib0195) 2015; 21
Loffler (10.1016/j.semcancer.2021.03.014_bib0540) 2007; 110
Wu (10.1016/j.semcancer.2021.03.014_bib1310) 2018; 32
Saliminejad (10.1016/j.semcancer.2021.03.014_bib0235) 2019; 234
Molitoris (10.1016/j.semcancer.2021.03.014_bib0750) 2011; 25
Danielson (10.1016/j.semcancer.2021.03.014_bib0515) 2015; 39
Dzikiewicz-Krawczyk (10.1016/j.semcancer.2021.03.014_bib0485) 2015; 93
Mei (10.1016/j.semcancer.2021.03.014_bib1275) 2014; 105
Indran (10.1016/j.semcancer.2021.03.014_bib0120) 2011; 1807
Zhao (10.1016/j.semcancer.2021.03.014_bib0865) 2014; 74
Terrinoni (10.1016/j.semcancer.2021.03.014_bib0960) 2019; 57
Suzuki (10.1016/j.semcancer.2021.03.014_bib0490) 2015; 34
Winter (10.1016/j.semcancer.2021.03.014_bib0355) 2009; 11
Salerno (10.1016/j.semcancer.2021.03.014_bib0660) 2009; 8
Xie (10.1016/j.semcancer.2021.03.014_bib0395) 2013; 155
Kaymaz (10.1016/j.semcancer.2021.03.014_bib1205) 2015; 36
Gulyaeva (10.1016/j.semcancer.2021.03.014_bib0290) 2016; 14
Mosakhani (10.1016/j.semcancer.2021.03.014_bib1295) 2013; 6
Smith (10.1016/j.semcancer.2021.03.014_bib0765) 2019; 247
Bernardo (10.1016/j.semcancer.2021.03.014_bib1030) 2018; 9
Tessel (10.1016/j.semcancer.2021.03.014_bib0610) 2011; 2
Zhu (10.1016/j.semcancer.2021.03.014_bib0710) 2015; 22
Abdi (10.1016/j.semcancer.2021.03.014_bib0855) 2019; 19
Lopes-Rodrigues (10.1016/j.semcancer.2021.03.014_bib0580) 2014; 135
Assaraf (10.1016/j.semcancer.2021.03.014_bib0025) 2019; 46
Lawrie (10.1016/j.semcancer.2021.03.014_bib0465) 2013; 27
Wang (10.1016/j.semcancer.2021.03.014_bib0150) 2018; 17
He (10.1016/j.semcancer.2021.03.014_bib0085) 2015; 11
Pan (10.1016/j.semcancer.2021.03.014_bib1215) 2018; 68
Xiao (10.1016/j.semcancer.2021.03.014_bib1185) 2017; 13
Zhao (10.1016/j.semcancer.2021.03.014_bib0720) 2015; 75
Wu (10.1016/j.semcancer.2021.03.014_bib0190) 2017; 387
Yaghmaie (10.1016/j.semcancer.2021.03.014_bib0080) 2019; 14
Tang (10.1016/j.semcancer.2021.03.014_bib1080) 2018; 142
Lopotova (10.1016/j.semcancer.2021.03.014_bib0640) 2011; 35
Geskin (10.1016/j.semcancer.2021.03.014_bib1125) 2019; 17
Wang (10.1016/j.semcancer.2021.03.014_bib0400) 2018; 10
Chen (10.1016/j.semcancer.2021.03.014_bib0775) 2018; 291
Kim (10.1016/j.semcancer.2021.03.014_bib0050) 2009; 15
Gulla (10.1016/j.semcancer.2021.03.014_bib0605) 2016; 22
Al-Harbi (10.1016/j.semcancer.2021.03.014_bib1165) 2015; 14
Li (10.1016/j.semcancer.2021.03.014_bib0805) 2006; 20
Kotani (10.1016/j.semcancer.2021.03.014_bib0655) 2009; 114
Hao (10.1016/j.semcancer.2021.03.014_bib0840) 2011; 4
Raimondo (10.1016/j.semcancer.2021.03.014_bib0565) 2020; 12
Wang (10.1016/j.semcancer.2021.03.014_bib0870) 2011; 52
Beg (10.1016/j.semcancer.2021.03.014_bib1105) 2017; 35
Guo (10.1016/j.semcancer.2021.03.014_bib0245) 2014; 2014
Kim (10.1016/j.semcancer.2021.03.014_bib0130) 2019; 8
Yuan (10.1016/j.semcancer.2021.03.014_bib0795) 2019; 18
Si (10.1016/j.semcancer.2021.03.014_bib0160) 2019; 11
Kaur (10.1016/j.semcancer.2021.03.014_bib0500) 2020; 10
Song (10.1016/j.semcancer.2021.03.014_bib0535) 2011; 30
Babiarz (10.1016/j.semcancer.2021.03.014_bib0385) 2011; 17
Ferreira (10.1016/j.semcancer.2021.03.014_bib0125) 2017; 8
Jiang (10.1016/j.semcancer.2021.03.014_bib1225) 2019; 60
Shah (10.1016/j.semcancer.2021.03.014_bib0155) 2019; 20
Feng (10.1016/j.semcancer.2021.03.014_bib0225) 2011; 15
Tagawa (10.1016/j.semcancer.2021.03.014_bib0475) 2013; 104
Lopes-Rodrigues (10.1016/j.semcancer.2021.03.014_bib0200) 2017; 7
Joshi (10.1016/j.semcancer.2021.03.014_bib0315) 2014; 542
Du (10.1016/j.semcancer.2021.03.014_bib1150) 2015; 6
Gu (10.1016/j.semcancer.2021.03.014_bib1085) 2011; 28
Dalton (10.1016/j.semcancer.2021.03.014_bib0830) 2008; 14
Bai (10.1016/j.semcancer.2021.03.014_bib0690) 2012; 138
Huang (10.1016/j.semcancer.2021.03.014_bib0615) 2012; 53
Lionetti (10.1016/j.semcancer.2021.03.014_bib0510) 2009; 114
Xu (10.1016/j.semcancer.2021.03.014_bib0595) 2013; 8
Wang (10.1016/j.semcancer.2021.03.014_bib0210) 2015; 125
Salerno (10.1016/j.semcancer.2021.03.014_bib0680) 2010; 78
Rastgoo (10.1016/j.semcancer.2021.03.014_bib1065) 2018; 32
Hagiwara (10.1016/j.semcancer.2021.03.014_bib1055) 2012; 2
Caliskan (10.1016/j.semcancer.2021.03.014_bib0305) 2017; 95
Groot (10.1016/j.semcancer.2021.03.014_bib0905) 2020; 9
Abbas (10.1016/j.semcancer.2021.03.014_bib0060) 2015; 30
Li (10.1016/j.semcancer.2021.03.014_bib0740) 2010; 101
Robey (10.1016/j.semcancer.2021.03.014_bib0100) 2018; 18
Buhagiar (10.1016/j.semcancer.2021.03.014_bib0955) 2020; 5
Lv (10.1016/j.semcancer.2021.03.014_bib0630) 2012; 26
Koo (10.1016/j.semcancer.2021.03.014_bib0270) 2018; 9
Sun (10.1016/j.semcancer.2021.03.014_bib0825) 2016; 380
Li (10.1016/j.semcancer.2021.03.014_bib0760) 2019;
References_xml – volume: 11
  start-page: 968
  year: 2020
  ident: bib0370
  article-title: Pan-cancer analysis reveals cooperativity of both strands of microRNA that regulate tumorigenesis and patient survival
  publication-title: Nat. Commun.
  contributor:
    fullname: Eischen
– volume: 42
  start-page: 1135
  year: 2014
  end-page: 1140
  ident: bib0365
  article-title: Regulation of miRNA strand selection: follow the leader?
  publication-title: Biochem. Soc. Trans.
  contributor:
    fullname: Bushell
– volume: 1699
  start-page: 83
  year: 2018
  end-page: 89
  ident: bib0175
  article-title: MicroRNAs change the landscape of cancer resistance
  publication-title: Methods Mol. Biol.
  contributor:
    fullname: Wu
– volume: 106
  start-page: 60
  year: 2015
  end-page: 68
  ident: bib0935
  article-title: Microparticles induce multifactorial resistance through oncogenic pathways independently of cancer cell type
  publication-title: Cancer Sci.
  contributor:
    fullname: Maia
– volume: 8
  start-page: e61858
  year: 2013
  ident: bib1190
  article-title: Inhibition of BCR/ABL protein expression by miR-203 sensitizes for imatinib mesylate
  publication-title: PLoS One
  contributor:
    fullname: Huang
– volume: 50
  start-page: 1233
  year: 2012
  end-page: 1240
  ident: bib0725
  article-title: Triptolide modulates the sensitivity of K562/A02 cells to adriamycin by regulating miR-21 expression
  publication-title: Pharm Biol
  contributor:
    fullname: Long
– volume: 247
  start-page: 708
  year: 2019
  end-page: 718
  ident: bib0765
  article-title: Autophagy, cancer stem cells and drug resistance
  publication-title: J. Pathol.
  contributor:
    fullname: Macleod
– volume: 114
  start-page: 10660
  year: 2017
  end-page: 10665
  ident: bib0260
  article-title: Cell cycle-targeting microRNAs promote differentiation by enforcing cell-cycle exit
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
  contributor:
    fullname: Bowden
– volume: 35
  start-page: 180
  year: 2017
  end-page: 188
  ident: bib1105
  article-title: Phase I study of MRX34, a liposomal miR-34a mimic, administered twice weekly in patients with advanced solid tumors
  publication-title: Invest. New Drugs
  contributor:
    fullname: Stoudemire
– volume: 626
  start-page: 106
  year: 2017
  end-page: 118
  ident: bib1145
  article-title: Downregulation of miR-224 and let-7i contribute to cell survival and chemoresistance in chronic myeloid leukemia cells by regulating ST3GAL IV expression
  publication-title: Gene
  contributor:
    fullname: Zhao
– volume: 119
  start-page: 3843
  year: 2018
  end-page: 3852
  ident: bib0670
  article-title: MicroRNA-103 confers the resistance to long-treatment of adriamycin to human leukemia cells by regulation of COP1
  publication-title: J. Cell. Biochem.
  contributor:
    fullname: Zhang
– volume: 14
  start-page: 57
  year: 2015
  ident: bib0250
  article-title: miR-211 suppresses epithelial ovarian cancer proliferation and cell-cycle progression by targeting Cyclin D1 and CDK6
  publication-title: Mol. Cancer
  contributor:
    fullname: Lou
– volume: 123
  start-page: 4612
  year: 2013
  end-page: 4626
  ident: bib0885
  article-title: A microenvironment-mediated c-Myc/miR-548m/HDAC6 amplification loop in non-Hodgkin B cell lymphomas
  publication-title: J. Clin. Invest.
  contributor:
    fullname: Shah
– volume: 7
  start-page: 83
  year: 2014
  ident: bib0435
  article-title: MicroRNA-binding site polymorphisms in hematological malignancies
  publication-title: J. Hematol. Oncol.
  contributor:
    fullname: Dzikiewicz-Krawczyk
– volume: 29
  start-page: 2402
  year: 2012
  end-page: 2408
  ident: bib0950
  article-title: Circulating microRNA expression is associated with genetic subtype and survival of multiple myeloma
  publication-title: Med. Oncol.
  contributor:
    fullname: Zhong
– volume: 103
  start-page: 2016
  year: 2018
  end-page: 2025
  ident: bib1300
  article-title: BCR-ABL1 mediated miR-150 downregulation through MYC contributed to myeloid differentiation block and drug resistance in chronic myeloid leukemia
  publication-title: Haematologica
  contributor:
    fullname: Trotta
– volume: 14
  start-page: 395
  year: 2019
  end-page: 404
  ident: bib0080
  article-title: Molecular mechanisms of resistance to tyrosine kinase inhibitors
  publication-title: Curr. Hematol. Malig. Rep.
  contributor:
    fullname: Yeung
– volume: 398
  start-page: 929
  year: 2017
  end-page: 938
  ident: bib0650
  article-title: MicroRNAs are important regulators of drug resistance in colorectal cancer
  publication-title: Biol. Chem.
  contributor:
    fullname: Wang
– volume: 14
  start-page: PL04
  year: 2008
  end-page: 03
  ident: bib0830
  article-title: The influence of the tumor microenvironment on drug response and drug resistance
  publication-title: Clin. Cancer Res.
  contributor:
    fullname: Dalton
– volume: 11
  start-page: 35
  year: 2019
  end-page: 51
  ident: bib0420
  article-title: Exosome-derived miRNAs as predictive biomarkers for diffuse large B-cell lymphoma chemotherapy resistance
  publication-title: Epigenomics
  contributor:
    fullname: Xiao
– volume: 141
  start-page: 672
  year: 2008
  end-page: 675
  ident: bib0975
  article-title: Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma
  publication-title: Br. J. Haematol.
  contributor:
    fullname: Pulford
– volume: 35
  start-page: 974
  year: 2011
  end-page: 977
  ident: bib0640
  article-title: MicroRNA-451 in chronic myeloid leukemia: miR-451-BCR-ABL regulatory loop?
  publication-title: Leuk. Res.
  contributor:
    fullname: Moravcova
– volume: 10
  start-page: 4267
  year: 2018
  end-page: 4277
  ident: bib0300
  article-title: Abnormal microRNA expression in the course of hematological malignancies
  publication-title: Cancer Manag. Res.
  contributor:
    fullname: Podhorecka
– volume: 20
  start-page: 1114
  year: 2019
  end-page: 1131
  ident: bib0155
  article-title: Genetic and epigenetic modulation of drug resistance in cancer: challenges and opportunities
  publication-title: Curr. Drug Metab.
  contributor:
    fullname: Rawal
– volume: 6
  start-page: 14993
  year: 2015
  end-page: 15007
  ident: bib1150
  article-title: MicroRNA-451 regulates stemness of side population cells via PI3K/Akt/mTOR signaling pathway in multiple myeloma
  publication-title: Oncotarget
  contributor:
    fullname: Yan
– volume: 95
  start-page: 1000
  year: 2017
  end-page: 1012
  ident: bib0305
  article-title: Current updates on microRNAs as regulators of chemoresistance
  publication-title: Biomed. Pharmacother.
  contributor:
    fullname: Bozok Cetintas
– volume: 36
  start-page: 119
  year: 2012
  end-page: 121
  ident: bib0635
  article-title: miRNA-451: a putative predictor marker of Imatinib therapy response in chronic myeloid leukemia
  publication-title: Leuk. Res.
  contributor:
    fullname: Zalcberg
– volume: 9
  start-page: 77
  year: 2018
  ident: bib0270
  article-title: MicroRNA miR-4779 suppresses tumor growth by inducing apoptosis and cell cycle arrest through direct targeting of PAK2 and CCND3
  publication-title: Cell Death Dis.
  contributor:
    fullname: Kwon
– volume: 106
  start-page: 267
  year: 2018
  end-page: 274
  ident: bib1320
  article-title: Down-regulated miR-148b increases resistance to CHOP in diffuse large B-cell lymphoma cells by rescuing Ezrin
  publication-title: Biomed. Pharmacother.
  contributor:
    fullname: Su
– volume: 14
  start-page: 185
  year: 2015
  ident: bib1165
  article-title: miR-377-dependent BCL-xL regulation drives chemotherapeutic resistance in B-cell lymphoid malignancies
  publication-title: Mol. Cancer
  contributor:
    fullname: Ting
– volume: 43
  start-page: 1058
  year: 2019
  end-page: 1066
  ident: bib0700
  article-title: MicroRNA-497 inhibits multiple myeloma growth and increases susceptibility to bortezomib by targeting Bcl-2
  publication-title: Int. J. Mol. Med.
  contributor:
    fullname: Chen
– volume: 31
  start-page: 1123
  year: 2017
  end-page: 1135
  ident: bib0790
  article-title: Epigenetic silencing of miR-137 induces drug resistance and chromosomal instability by targeting AURKA in multiple myeloma
  publication-title: Leukemia
  contributor:
    fullname: Li
– volume: 96
  start-page: 1783
  year: 2011
  end-page: 1791
  ident: bib1180
  article-title: Integrative nucleophosmin mutation-associated microRNA and gene expression pattern analysis identifies novel microRNA - target gene interactions in acute myeloid leukemia
  publication-title: Haematologica
  contributor:
    fullname: Rucker
– volume: 31
  start-page: 4567
  year: 2012
  end-page: 4576
  ident: bib0145
  article-title: Candidate DNA methylation drivers of acquired cisplatin resistance in ovarian cancer identified by methylome and expression profiling
  publication-title: Oncogene
  contributor:
    fullname: Wilhelm-Benartzi
– volume: 101
  start-page: 437
  year: 2016
  end-page: 447
  ident: bib0575
  article-title: Extracellular vesicle miR-7977 is involved in hematopoietic dysfunction of mesenchymal stromal cells via poly(rC) binding protein 1 reduction in myeloid neoplasms
  publication-title: Haematologica
  contributor:
    fullname: Murase
– volume: 10
  start-page: 59
  year: 2018
  ident: bib0400
  article-title: Circulating microRNAs as potential cancer biomarkers: the advantage and disadvantage
  publication-title: Clin. Epigenetics
  contributor:
    fullname: Xue
– volume: 68
  start-page: 80
  year: 2018
  end-page: 88
  ident: bib1215
  article-title: miR-217 sensitizes chronic myelogenous leukemia cells to tyrosine kinase inhibitors by targeting pro-oncogenic anterior gradient 2
  publication-title: Exp. Hematol.
  contributor:
    fullname: Ikezoe
– volume: 75
  start-page: 4384
  year: 2015
  end-page: 4397
  ident: bib0720
  article-title: Targeting the miR-221-222/PUMA/BAK/BAX pathway abrogates dexamethasone resistance in multiple myeloma
  publication-title: Cancer Res.
  contributor:
    fullname: Jiang
– volume: 120
  start-page: 3958
  year: 2012
  end-page: 3967
  ident: bib0845
  article-title: Investigational agent MLN9708/2238 targets tumor-suppressor miR33b in MM cells
  publication-title: Blood
  contributor:
    fullname: Berger
– volume: 4
  start-page: 143
  year: 2012
  end-page: 159
  ident: bib0295
  article-title: MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review
  publication-title: EMBO Mol. Med.
  contributor:
    fullname: Croce
– volume: 8
  start-page: 2684
  year: 2009
  end-page: 2692
  ident: bib0660
  article-title: Correcting miR-15a/16 genetic defect in New Zealand Black mouse model of CLL enhances drug sensitivity
  publication-title: Mol. Cancer Ther.
  contributor:
    fullname: Fernandes
– volume: 119
  start-page: 109415
  year: 2019
  ident: bib0760
  article-title: Autophagy: a novel mechanism of chemoresistance in cancers
  publication-title: Biomed. Pharmacother.
  contributor:
    fullname: Peng
– volume: 7
  start-page: 30876
  year: 2016
  end-page: 30891
  ident: bib0320
  article-title: Potential role of exosome-associated microRNA panels and in vivo environment to predict drug resistance for patients with multiple myeloma
  publication-title: Oncotarget
  contributor:
    fullname: Chen
– volume: 7
  start-page: 60074
  year: 2016
  end-page: 60086
  ident: bib1210
  article-title: Upregulation of miR-181c inhibits chemoresistance by targeting ST8SIA4 in chronic myelocytic leukemia
  publication-title: Oncotarget
  contributor:
    fullname: Miao
– volume: 30
  start-page: 381
  year: 2011
  end-page: 391
  ident: bib0535
  article-title: Single-nucleotide polymorphisms among microRNA: big effects on cancer
  publication-title: Chin. J. Cancer
  contributor:
    fullname: Chen
– volume: 78
  start-page: 811
  year: 2010
  end-page: 817
  ident: bib1230
  article-title: Lyn kinase-dependent regulation of miR181 and myeloid cell leukemia-1 expression: implications for drug resistance in myelogenous leukemia
  publication-title: Mol. Pharmacol.
  contributor:
    fullname: Richards
– volume: 26
  start-page: 769
  year: 2012
  end-page: 777
  ident: bib0630
  article-title: An oncogenic role of miR-142-3p in human T-cell acute lymphoblastic leukemia (T-ALL) by targeting glucocorticoid receptor-alpha and cAMP/PKA pathways
  publication-title: Leukemia
  contributor:
    fullname: Zhang
– volume: 16
  start-page: 226
  year: 2016
  end-page: 237
  ident: bib0010
  article-title: Understanding cancer drug resistance by developing and studying resistant cell line models
  publication-title: Curr. Cancer Drug Targets
  contributor:
    fullname: Vasconcelos
– volume: 20
  start-page: 333
  year: 2006
  end-page: 342
  ident: bib0805
  article-title: Tumor microenvironment and drug resistance in hematologic malignancies
  publication-title: Blood Rev.
  contributor:
    fullname: Dalton
– volume: 50
  start-page: 717
  year: 2017
  end-page: 726
  ident: bib1305
  article-title: Histone deacetylases meet microRNA-associated MMP-9 expression regulation in glucocorticoid-sensitive and -resistant cell lines
  publication-title: Int. J. Oncol.
  contributor:
    fullname: Trussardi-Regnier
– volume: 7
  start-page: 339
  year: 2017
  end-page: 348
  ident: bib0070
  article-title: The different mechanisms of cancer drug resistance: a brief review
  publication-title: Adv. Pharm. Bull.
  contributor:
    fullname: Baradaran
– volume: 2016
  start-page: 6702424
  year: 2016
  ident: bib0090
  article-title: Drug efflux transporters are overexpressed in short-term tamoxifen-induced MCF7 breast cancer cells
  publication-title: Adv. Pharmacol. Sci.
  contributor:
    fullname: Wanandi
– volume: 52
  start-page: 1787
  year: 2011
  end-page: 1794
  ident: bib0835
  article-title: Bone marrow stromal cells protect myeloma cells from bortezomib induced apoptosis by suppressing microRNA-15a expression
  publication-title: Leuk. Lymphoma
  contributor:
    fullname: Xie
– volume: 53
  start-page: 1586
  year: 2012
  end-page: 1591
  ident: bib1260
  article-title: Epstein-Barr virus latent membrane protein-1 protects B-cell lymphoma from rituximab-induced apoptosis through miR-155-mediated Akt activation and up-regulation of Mcl-1
  publication-title: Leuk. Lymphoma
  contributor:
    fullname: Park
– volume: 12
  year: 2020
  ident: bib0565
  article-title: Extracellular vesicle microRNAs contribute to the osteogenic inhibition of mesenchymal stem cells in multiple myeloma
  publication-title: Cancers (Basel)
  contributor:
    fullname: Carlisi
– volume: 74
  start-page: 1801
  year: 2014
  end-page: 1813
  ident: bib0865
  article-title: miR-30-5p functions as a tumor suppressor and novel therapeutic tool by targeting the oncogenic Wnt/beta-catenin/BCL9 pathway
  publication-title: Cancer Res.
  contributor:
    fullname: Chen
– volume: 9
  start-page: 405
  year: 2008
  end-page: 414
  ident: bib0520
  article-title: Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytes
  publication-title: Nat. Immunol.
  contributor:
    fullname: Wang
– volume: 9
  year: 2020
  ident: bib0905
  article-title: Sorting mechanisms for MicroRNAs into extracellular vesicles and their associated diseases
  publication-title: Cells
  contributor:
    fullname: Lee
– volume: 78
  start-page: S98
  year: 2010
  end-page: S109
  ident: bib0680
  article-title: The New Zealand black mouse as a model for the development and progression of chronic lymphocytic leukemia
  publication-title: Cytometry B Clin. Cytom.
  contributor:
    fullname: Mazzella
– volume: 33
  start-page: 1217
  year: 2009
  end-page: 1223
  ident: bib0970
  article-title: Prognostic value of miR-16 expression in childhood acute lymphoblastic leukemia relationships to normal and malignant lymphocyte proliferation
  publication-title: Leuk. Res.
  contributor:
    fullname: Salles
– volume: 18
  start-page: 1660
  year: 2019
  end-page: 1669
  ident: bib0795
  article-title: miR-520g and miR-520h overcome bortezomib resistance in multiple myeloma via suppressing APE1
  publication-title: Cell Cycle
  contributor:
    fullname: Zhu
– volume: 8
  start-page: 49451
  year: 2017
  end-page: 49469
  ident: bib1220
  article-title: Deregulated expression of miR-29a-3p, miR-494-3p and miR-660-5p affects sensitivity to tyrosine kinase inhibitors in CML leukemic stem cells
  publication-title: Oncotarget
  contributor:
    fullname: Zini
– volume: 13
  start-page: 17
  year: 2015
  end-page: 24
  ident: bib0900
  article-title: Exosome and exosomal microRNA: trafficking, sorting, and function
  publication-title: Genomics Proteomics Bioinform.
  contributor:
    fullname: Yao
– volume: 9
  year: 2020
  ident: bib0555
  article-title: The role of extracellular vesicles in the hallmarks of cancer and drug resistance
  publication-title: Cells
  contributor:
    fullname: Vasconcelos
– volume: 380
  start-page: 205
  year: 2016
  end-page: 215
  ident: bib0825
  article-title: Tumor microenvironment and cancer therapy resistance
  publication-title: Cancer Lett.
  contributor:
    fullname: Sun
– volume: 27
  start-page: 559
  year: 2019
  end-page: 570
  ident: bib0330
  article-title: miR-221/222-mediated inhibition of autophagy promotes dexamethasone resistance in multiple myeloma
  publication-title: Mol. Ther.
  contributor:
    fullname: Chen
– volume: 135
  start-page: 253
  year: 2014
  end-page: 263
  ident: bib0580
  article-title: The network of P-glycoprotein and microRNAs interactions
  publication-title: Int. J. Cancer
  contributor:
    fullname: Vasconcelos
– volume: 15
  start-page: 90
  year: 2012
  end-page: 97
  ident: bib0030
  article-title: The dynamics of drug resistance: a mathematical perspective
  publication-title: Drug Resist. Updat.
  contributor:
    fullname: Levy
– volume: 542
  start-page: 109
  year: 2014
  end-page: 112
  ident: bib0315
  article-title: Down-regulation of miR-199b associated with imatinib drug resistance in 9q34.1 deleted BCR/ABL positive CML patients
  publication-title: Gene
  contributor:
    fullname: Vundinti
– volume: 24
  start-page: 3128
  year: 2013
  end-page: 3135
  ident: bib1095
  article-title: Restoring expression of miR-16: a novel approach to therapy for malignant pleural mesothelioma
  publication-title: Ann. Oncol.
  contributor:
    fullname: Weiss
– volume: 14
  start-page: 1135
  year: 2013
  end-page: 1143
  ident: bib0785
  article-title: Targeting miR-21 induces autophagy and chemosensitivity of leukemia cells
  publication-title: Curr. Drug Targets
  contributor:
    fullname: Vasconcelos
– volume: 3
  start-page: 188
  year: 2016
  end-page: 202
  ident: bib0620
  article-title: Selective glucocorticoid receptor-activating adjuvant therapy in cancer treatments
  publication-title: Oncoscience
  contributor:
    fullname: Beck
– volume: 8
  start-page: e82062
  year: 2013
  ident: bib0595
  article-title: Changes in the expression of miR-381 and miR-495 are inversely associated with the expression of the MDR1 gene and development of multi-drug resistance
  publication-title: PLoS One
  contributor:
    fullname: Hu
– volume: 9
  start-page: 115
  year: 2010
  ident: bib1280
  article-title: Determination of genes and microRNAs involved in the resistance to fludarabine in vivo in chronic lymphocytic leukemia
  publication-title: Mol. Cancer
  contributor:
    fullname: El Khoury
– volume: 122
  start-page: 1630
  year: 2020
  end-page: 1637
  ident: bib1090
  article-title: Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours
  publication-title: Br. J. Cancer
  contributor:
    fullname: Lim
– volume: 9
  start-page: 402
  year: 2018
  ident: bib0335
  article-title: Overview of MicroRNA biogenesis, mechanisms of actions, and circulation
  publication-title: Front. Endocrinol. (Lausanne)
  contributor:
    fullname: Peng
– volume: 11
  start-page: 265
  year: 2013
  ident: bib0665
  article-title: MiR-370 sensitizes chronic myeloid leukemia K562 cells to homoharringtonine by targeting Forkhead box M1
  publication-title: J. Transl. Med.
  contributor:
    fullname: Shen
– volume: 183
  start-page: 428
  year: 2018
  end-page: 444
  ident: bib1040
  article-title: Cobomarsen, an oligonucleotide inhibitor of miR-155, co-ordinately regulates multiple survival pathways to reduce cellular proliferation and survival in cutaneous T-cell lymphoma
  publication-title: Br. J. Haematol.
  contributor:
    fullname: Duvic
– volume: 37
  start-page: 961
  year: 2017
  end-page: 968
  ident: bib0600
  article-title: hsa-miR-631 resensitizes bortezomib-resistant multiple myeloma cell lines by inhibiting UbcH10
  publication-title: Oncol. Rep.
  contributor:
    fullname: Lu
– volume: 110
  start-page: 1140
  year: 2019
  end-page: 1147
  ident: bib1045
  article-title: Development of miRNA-based therapeutic approaches for cancer patients
  publication-title: Cancer Sci.
  contributor:
    fullname: Ochiya
– volume: 215
  start-page: 152603
  year: 2019
  ident: bib0850
  article-title: He S. miR-182 contributes to cell adhesion-mediated drug resistance in multiple myeloma via targeting PDCD4
  publication-title: Pathol. Res. Pract.
  contributor:
    fullname: Xu
– volume: 36
  start-page: 7915
  year: 2015
  end-page: 7927
  ident: bib1205
  article-title: Revealing genome-wide mRNA and microRNA expression patterns in leukemic cells highlighted “hsa-miR-2278” as a tumor suppressor for regain of chemotherapeutic imatinib response due to targeting STAT5A
  publication-title: Tumour Biol.
  contributor:
    fullname: Yandim
– volume: 425
  start-page: 368
  year: 2012
  end-page: 373
  ident: bib1290
  article-title: Myc induced miR-144/451 contributes to the acquired imatinib resistance in chronic myelogenous leukemia cell K562
  publication-title: Biochem. Biophys. Res. Commun.
  contributor:
    fullname: Huang
– volume: 9
  start-page: 123
  year: 2010
  ident: bib1175
  article-title: MicroRNAs involvement in fludarabine refractory chronic lymphocytic leukemia
  publication-title: Mol. Cancer
  contributor:
    fullname: Ciccone
– volume: 15
  start-page: 2164
  year: 2011
  end-page: 2175
  ident: bib0225
  article-title: Down-regulated miR-331-5p and miR-27a are associated with chemotherapy resistance and relapse in leukaemia
  publication-title: J. Cell. Mol. Med.
  contributor:
    fullname: Han
– volume: 44
  start-page: 269
  year: 2012
  end-page: 277
  ident: bib0695
  article-title: miR-181a sensitizes a multidrug-resistant leukemia cell line K562/A02 to daunorubicin by targeting BCL-2
  publication-title: Acta Biochim. Biophys. Sin. (Shanghai)
  contributor:
    fullname: Xu
– volume: 16
  start-page: 47
  year: 2013
  end-page: 59
  ident: bib1005
  article-title: MicroRNAs as therapeutic targets in chemoresistance
  publication-title: Drug Resist. Updat.
  contributor:
    fullname: Croce
– volume: 1843
  start-page: 590
  year: 2014
  end-page: 602
  ident: bib1265
  article-title: Epigenetic regulation of microRNA-128a expression contributes to the apoptosis-resistance of human T-cell leukaemia jurkat cells by modulating expression of fas-associated protein with death domain (FADD)
  publication-title: Biochim. Biophys. Acta
  contributor:
    fullname: Naoe
– volume: 14
  start-page: 143
  year: 2016
  ident: bib0290
  article-title: Regulatory mechanisms of microRNA expression
  publication-title: J. Transl. Med.
  contributor:
    fullname: Kushlinskiy
– volume: 21
  start-page: 263
  year: 2016
  end-page: 271
  ident: bib1025
  article-title: The diagnosis, prognosis, and therapeutic application of MicroRNAs in haematological malignancies
  publication-title: Hematology
  contributor:
    fullname: Zhong
– volume: 18
  start-page: 452
  year: 2018
  end-page: 464
  ident: bib0100
  article-title: Revisiting the role of ABC transporters in multidrug-resistant cancer
  publication-title: Nat. Rev. Cancer
  contributor:
    fullname: Gottesman
– volume: 585
  start-page: 402
  year: 2011
  end-page: 408
  ident: bib0730
  article-title: Involvement of miR-21 in resistance to daunorubicin by regulating PTEN expression in the leukaemia K562 cell line
  publication-title: FEBS Lett.
  contributor:
    fullname: Wang
– volume: 33
  start-page: 1294
  year: 2012
  end-page: 1301
  ident: bib0705
  article-title: miR-181a/b significantly enhances drug sensitivity in chronic lymphocytic leukemia cells via targeting multiple anti-apoptosis genes
  publication-title: Carcinogenesis
  contributor:
    fullname: Wang
– volume: 53
  start-page: 2041
  year: 2012
  end-page: 2050
  ident: bib1170
  article-title: Involvement of miR17 pathway in glucocorticoid-induced cell death in pediatric acute lymphoblastic leukemia
  publication-title: Leuk. Lymphoma
  contributor:
    fullname: Corcoran
– volume: 10
  start-page: 108
  year: 2011
  ident: bib0170
  article-title: Upregulation of microRNA-125b contributes to leukemogenesis and increases drug resistance in pediatric acute promyelocytic leukemia
  publication-title: Mol. Cancer
  contributor:
    fullname: Zheng
– volume: 8
  start-page: e59390
  year: 2013
  ident: bib1255
  article-title: cMyc/miR-125b-5p signalling determines sensitivity to bortezomib in preclinical model of cutaneous T-cell lymphomas
  publication-title: PLoS One
  contributor:
    fullname: Gasparini
– volume: 97
  start-page: 223
  year: 2013
  end-page: 231
  ident: bib0735
  article-title: MicroRNA-21 regulates the sensitivity of diffuse large B-cell lymphoma cells to the CHOP chemotherapy regimen
  publication-title: Int. J. Hematol.
  contributor:
    fullname: Xu
– volume: 19
  start-page: 975
  year: 2019
  ident: bib0855
  article-title: Ectopic expression of BIRC5-targeting miR-101-3p overcomes bone marrow stroma-mediated drug resistance in multiple myeloma cells
  publication-title: BMC Cancer
  contributor:
    fullname: Chang
– volume: 15
  start-page: 492
  year: 2014
  end-page: 502
  ident: bib0800
  article-title: Effect of miR-128 in DNA damage of HL-60 acute myeloid leukemia cells
  publication-title: Curr. Pharm. Biotechnol.
  contributor:
    fullname: Guimaraes
– volume: 115
  start-page: E10849
  year: 2018
  end-page: E10858
  ident: bib0275
  article-title: microRNA-378 promotes autophagy and inhibits apoptosis in skeletal muscle
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
  contributor:
    fullname: Liu
– volume: 9
  start-page: 1090
  year: 2018
  ident: bib1030
  article-title: Generation of MicroRNA-34 sponges and tough decoys for the heart: developments and challenges
  publication-title: Front. Pharmacol.
  contributor:
    fullname: McMullen
– volume: 136
  start-page: 169
  year: 2012
  end-page: 174
  ident: bib0545
  article-title: Cell-to-cell miRNA transfer: from body homeostasis to therapy
  publication-title: Pharmacol. Ther.
  contributor:
    fullname: Calin
– volume: 11
  start-page: 37
  year: 2012
  ident: bib0925
  article-title: Microparticle conferred microRNA profiles–implications in the transfer and dominance of cancer traits
  publication-title: Mol. Cancer
  contributor:
    fullname: Bebawy
– volume: 125
  start-page: 1302
  year: 2015
  end-page: 1313
  ident: bib0210
  article-title: MicroRNA-486 regulates normal erythropoiesis and enhances growth and modulates drug response in CML progenitors
  publication-title: Blood
  contributor:
    fullname: Li
– volume: 141
  start-page: 220
  year: 2017
  end-page: 230
  ident: bib1000
  article-title: The role of exosomes and miRNAs in drug-resistance of cancer cells
  publication-title: Int. J. Cancer
  contributor:
    fullname: Lee
– volume: 11
  start-page: 4
  year: 2009
  end-page: 11
  ident: bib0075
  article-title: Laboratory practice guidelines for detecting and reporting BCR-ABL drug resistance mutations in chronic myelogenous leukemia and acute lymphoblastic leukemia: a report of the Association for Molecular Pathology
  publication-title: J. Mol. Diagn.
  contributor:
    fullname: Press
– volume: 102
  start-page: e456
  year: 2017
  end-page: e459
  ident: bib0985
  article-title: Circulating microRNA expressions can predict the outcome of lenalidomide plus low-dose dexamethasone treatment in patients with refractory/relapsed multiple myeloma
  publication-title: Haematologica
  contributor:
    fullname: Kim
– volume: 3
  start-page: 1185
  year: 2019
  end-page: 1196
  ident: bib1155
  article-title: MicroRNA-155 controls vincristine sensitivity and predicts superior clinical outcome in diffuse large B-cell lymphoma
  publication-title: Blood Adv.
  contributor:
    fullname: Thomsen
– volume: 2
  start-page: 314
  year: 2012
  ident: bib1055
  article-title: Stilbene derivatives promote Ago2-dependent tumour-suppressive microRNA activity
  publication-title: Sci. Rep.
  contributor:
    fullname: Ochiya
– volume: 7
  start-page: S1
  year: 2018
  end-page: S4
  ident: bib1060
  article-title: An innovative mesothelioma treatment based on miR-16 mimic loaded EGFR targeted minicells (TargomiRs)
  publication-title: Transl. Lung Cancer Res.
  contributor:
    fullname: Rosell
– volume: 32
  start-page: 2471
  year: 2018
  end-page: 2482
  ident: bib1065
  article-title: Dysregulation of EZH2/miR-138 axis contributes to drug resistance in multiple myeloma by downregulating RBPMS
  publication-title: Leukemia
  contributor:
    fullname: Chang
– volume: 12
  year: 2020
  ident: bib0560
  article-title: Deep sequencing analysis reveals distinctive non-coding RNAs when comparing tumor multidrug-resistant cells and extracellular vesicles with drug-sensitive counterparts
  publication-title: Cancers (Basel)
  contributor:
    fullname: Vasconcelos
– volume: 875
  start-page: 172976
  year: 2020
  ident: bib0430
  article-title: Expression of non-coding RNAs in hematological malignancies
  publication-title: Eur. J. Pharmacol.
  contributor:
    fullname: Taheri
– volume: 62
  start-page: 70
  year: 2017
  end-page: 76
  ident: bib0930
  article-title: Transfer of multidrug resistance among acute myeloid leukemia cells via extracellular vesicles and their microRNA cargo
  publication-title: Leuk. Res.
  contributor:
    fullname: Dogne
– volume: 12
  start-page: 152
  year: 2013
  ident: bib0895
  article-title: Tumor glycolysis as a target for cancer therapy: progress and prospects
  publication-title: Mol. Cancer
  contributor:
    fullname: Geschwind
– volume: 38
  year: 2018
  ident: bib0890
  article-title: Overexpression of miR-202 resensitizes imatinib resistant chronic myeloid leukemia cells through targetting Hexokinase 2
  publication-title: Biosci. Rep.
  contributor:
    fullname: Zhang
– volume: 10
  start-page: 626
  year: 2019
  ident: bib0405
  article-title: Circulating MicroRNAs in cancer: potential and challenge
  publication-title: Front. Genet.
  contributor:
    fullname: Cui
– volume: 12
  start-page: 51
  year: 2019
  ident: bib0530
  article-title: Role of microRNAs, circRNAs and long noncoding RNAs in acute myeloid leukemia
  publication-title: J. Hematol. Oncol.
  contributor:
    fullname: Quan
– volume: 22
  start-page: 198
  year: 2012
  end-page: 205
  ident: bib0585
  article-title: MicroRNA profiling in K-562 cells under imatinib treatment: influence of miR-212 and miR-328 on ABCG2 expression
  publication-title: Pharmacogenet. Genomics
  contributor:
    fullname: Cascorbi
– volume: 2014
  start-page: 907420
  year: 2014
  ident: bib0245
  article-title: Integrative analysis of miRNA-mRNA and miRNA-miRNA interactions
  publication-title: Biomed Res. Int.
  contributor:
    fullname: Chen
– volume: 448
  start-page: 83
  year: 2007
  end-page: 86
  ident: bib0390
  article-title: Intronic microRNA precursors that bypass Drosha processing
  publication-title: Nature
  contributor:
    fullname: Bartel
– volume: 29
  start-page: 727
  year: 2015
  end-page: 738
  ident: bib1245
  article-title: MiR-29b replacement inhibits proteasomes and disrupts aggresome+autophagosome formation to enhance the antimyeloma benefit of bortezomib
  publication-title: Leukemia
  contributor:
    fullname: Driscoll
– volume: 125
  start-page: 887
  year: 2006
  end-page: 901
  ident: bib0350
  article-title: Molecular basis for the recognition of primary microRNAs by the Drosha-DGCR8 complex
  publication-title: Cell
  contributor:
    fullname: Rhee
– volume: 34
  start-page: 1078
  year: 2010
  end-page: 1082
  ident: bib0590
  article-title: miR-138 might reverse multidrug resistance of leukemia cells
  publication-title: Leuk. Res.
  contributor:
    fullname: Ruan
– volume: 12
  start-page: 32
  year: 2019
  ident: bib0135
  article-title: Trabectedin triggers direct and NK-mediated cytotoxicity in multiple myeloma
  publication-title: J. Hematol. Oncol.
  contributor:
    fullname: Scionti
– volume: 12
  start-page: 2144
  year: 2013
  end-page: 2153
  ident: bib0715
  article-title: Attenuation of dexamethasone-induced cell death in multiple myeloma is mediated by miR-125b expression
  publication-title: Cell Cycle
  contributor:
    fullname: Macewan
– volume: 17
  start-page: 21
  year: 2019
  end-page: 23
  ident: bib1125
  article-title: Highlights in cutaneous T-cell lymphoma from the 60th American Society of Hematology Annual Meeting: a dermatologist’s perspective
  publication-title: Clin. Adv. Hematol. Oncol.
  contributor:
    fullname: Geskin
– volume: 35
  start-page: 277
  year: 2019
  end-page: 283
  ident: bib0675
  article-title: MicroRNA-26a inhibits multiple myeloma cell growth by suppressing cyclin-dependent kinase 6 expression
  publication-title: Kaohsiung J. Med. Sci.
  contributor:
    fullname: Chen
– volume: 173
  start-page: 20
  year: 2018
  end-page: 51
  ident: bib0360
  article-title: Metazoan MicroRNAs
  publication-title: Cell
  contributor:
    fullname: Bartel
– volume: 387
  start-page: 61
  year: 2017
  end-page: 68
  ident: bib0190
  article-title: Tumor microenvironment and therapeutic response
  publication-title: Cancer Lett.
  contributor:
    fullname: Dai
– volume: 11
  start-page: 25
  year: 2019
  ident: bib0160
  article-title: The role and mechanisms of action of microRNAs in cancer drug resistance
  publication-title: Clin. Epigenetics
  contributor:
    fullname: Fan
– volume: 10
  start-page: 6
  year: 2020
  ident: bib0500
  article-title: RNA-Seq profiling of deregulated miRs in CLL and their impact on clinical outcome
  publication-title: Blood Cancer J.
  contributor:
    fullname: Gogia
– volume: 30
  start-page: 656
  year: 2019
  end-page: 673
  ident: bib0410
  article-title: Extracellular miRNAs: from biomarkers to mediators of physiology and disease
  publication-title: Cell Metab.
  contributor:
    fullname: Kahn
– volume: 119
  start-page: 6024
  year: 2018
  end-page: 6032
  ident: bib0415
  article-title: MicroRNA-326 and microRNA-200c: two novel biomarkers for diagnosis and prognosis of pediatric acute lymphoblastic leukemia
  publication-title: J. Cell. Biochem.
  contributor:
    fullname: Rahgozar
– volume: 101
  start-page: 948
  year: 2010
  end-page: 954
  ident: bib0740
  article-title: Anti-miR-21 oligonucleotide sensitizes leukemic K562 cells to arsenic trioxide by inducing apoptosis
  publication-title: Cancer Sci.
  contributor:
    fullname: Lin
– volume: 52
  start-page: 1991
  year: 2011
  end-page: 1998
  ident: bib0870
  article-title: Myeloma cell adhesion to bone marrow stromal cells confers drug resistance by microRNA-21 up-regulation
  publication-title: Leuk. Lymphoma
  contributor:
    fullname: Zhong
– volume: 2018
  start-page: 5416923
  year: 2018
  ident: bib0185
  article-title: Cancer stem cells (CSCs) in drug resistance and their therapeutic implications in cancer treatment
  publication-title: Stem Cells Int.
  contributor:
    fullname: Kim
– volume: 34
  start-page: 3085
  year: 2015
  end-page: 3094
  ident: bib0490
  article-title: MicroRNA regulons in tumor microenvironment
  publication-title: Oncogene
  contributor:
    fullname: Miyazono
– volume: 771
  start-page: 32
  year: 2017
  end-page: 58
  ident: bib0055
  article-title: Contribution of genetic factors to platinum-based chemotherapy sensitivity and prognosis of non-small cell lung cancer
  publication-title: Mutat. Res.
  contributor:
    fullname: Calleja-Hernandez
– volume: 113
  start-page: 3801
  year: 2009
  end-page: 1133808
  ident: bib1285
  article-title: miR-34a as part of the resistance network in chronic lymphocytic leukemia
  publication-title: Blood
  contributor:
    fullname: Kienle
– volume: 9
  year: 2020
  ident: bib0965
  article-title: Role of non-coding RNAs in the development of targeted therapy and immunotherapy approaches for chronic lymphocytic leukemia
  publication-title: J. Clin. Med.
  contributor:
    fullname: Balatti
– volume: 30
  start-page: 2587
  year: 2011
  end-page: 2594
  ident: bib1015
  article-title: Myc overexpression brings out unexpected antiapoptotic effects of miR-34a
  publication-title: Oncogene
  contributor:
    fullname: McMahon
– volume: 67
  start-page: 129
  year: 2011
  end-page: 139
  ident: bib0340
  article-title: Biological functions of microRNAs: a review
  publication-title: J. Physiol. Biochem.
  contributor:
    fullname: Zhang
– volume: 15
  start-page: 215
  year: 2010
  end-page: 221
  ident: bib0745
  article-title: Anti-miR-21 oligonucleotide enhances chemosensitivity of leukemic HL60 cells to arabinosylcytosine by inducing apoptosis
  publication-title: Hematology
  contributor:
    fullname: Yao
– volume: 126
  start-page: 1106
  year: 2015
  end-page: 1117
  ident: bib0570
  article-title: Exosomes released by chronic lymphocytic leukemia cells induce the transition of stromal cells into cancer-associated fibroblasts
  publication-title: Blood
  contributor:
    fullname: Ammerlaan
– volume: 7
  start-page: 44541
  year: 2017
  ident: bib0200
  article-title: Identification of the metabolic alterations associated with the multidrug resistant phenotype in cancer and their intercellular transfer mediated by extracellular vesicles
  publication-title: Sci. Rep.
  contributor:
    fullname: Pesic
– volume: 73
  start-page: 7168
  year: 2013
  end-page: 7175
  ident: bib0180
  article-title: The role of cell density and intratumoral heterogeneity in multidrug resistance
  publication-title: Cancer Res.
  contributor:
    fullname: Gottesman
– volume: 480
  start-page: 29
  year: 2020
  end-page: 38
  ident: bib0780
  article-title: MARCKS inhibition cooperates with autophagy antagonists to potentiate the effect of standard therapy against drug-resistant multiple myeloma
  publication-title: Cancer Lett.
  contributor:
    fullname: Zacksenhaus
– volume: 25
  start-page: 409
  year: 2011
  end-page: 420
  ident: bib0750
  article-title: Glucocorticoid-mediated repression of the oncogenic microRNA cluster miR-17∼92 contributes to the induction of Bim and initiation of apoptosis
  publication-title: Mol. Endocrinol.
  contributor:
    fullname: Distelhorst
– volume: 19
  year: 2018
  ident: bib0425
  article-title: MicroRNAs in autoimmunity and hematological malignancies
  publication-title: Int. J. Mol. Sci.
  contributor:
    fullname: Visone
– volume: 12
  year: 2020
  ident: bib0045
  article-title: Multiple myeloma: available therapies and causes of drug resistance
  publication-title: Cancers (Basel
  contributor:
    fullname: Vasconcelos
– start-page: 5
  year: 2020
  ident: bib0860
  article-title: The role of bone marrow stromal cells in blood diseases and clinical significance as a crucial part of the hematopoietic microenvironment
  publication-title: Ann. Blood
  contributor:
    fullname: Song
– volume: 8
  start-page: 69
  year: 2009
  ident: bib0310
  article-title: MicroRNA expression profiling in Imatinib-resistant Chronic Myeloid Leukemia patients without clinically significant ABL1-mutations
  publication-title: Mol. Cancer
  contributor:
    fullname: Cordeu
– volume: 11
  start-page: 18
  year: 2015
  end-page: 23
  ident: bib0085
  article-title: The overexpression of MRP4 is related to multidrug resistance in osteosarcoma cells
  publication-title: J. Cancer Res. Ther.
  contributor:
    fullname: Sheng
– volume: 142
  start-page: 109
  year: 2018
  end-page: 120
  ident: bib1080
  article-title: MicroRNA-324-5p regulates stemness, pathogenesis and sensitivity to bortezomib in multiple myeloma cells by targeting hedgehog signaling
  publication-title: Int. J. Cancer
  contributor:
    fullname: Su
– volume: 10
  year: 2018
  ident: bib1035
  article-title: Derepression of co-silenced tumor suppressor genes by nanoparticle-loaded circular ssDNA reduces tumor malignancy
  publication-title: Sci. Transl. Med.
  contributor:
    fullname: Wang
– volume: 6
  start-page: 1769
  year: 2014
  end-page: 1792
  ident: bib0015
  article-title: Drug resistance in cancer: an overview
  publication-title: Cancers (Basel)
  contributor:
    fullname: Snyder
– volume: 98
  start-page: 66
  year: 2016
  end-page: 72
  ident: bib0995
  article-title: Extracellular miRNAs as biomarkers in cancer
  publication-title: Food Chem. Toxicol.
  contributor:
    fullname: Nana-Sinkam
– volume: 17
  start-page: 1973
  year: 2018
  end-page: 1983
  ident: bib0150
  article-title: KDM6B counteracts EZH2-mediated suppression of IGFBP5 to confer resistance to PI3K/AKT inhibitor treatment in breast Cancer
  publication-title: Mol. Cancer Ther.
  contributor:
    fullname: Cai
– volume: 97
  start-page: 1189
  year: 2018
  end-page: 1194
  ident: bib1010
  article-title: MiR-182-5p regulates BCL2L12 and BCL2 expression in acute myeloid leukemia as a potential therapeutic target
  publication-title: Biomed. Pharmacother.
  contributor:
    fullname: Yin
– volume: 21
  year: 2020
  ident: bib1070
  article-title: MicroRNAs-based nano-strategies as new therapeutic approach in multiple myeloma to overcome disease progression and drug resistance
  publication-title: Int. J. Mol. Sci.
  contributor:
    fullname: Mariggio
– volume: 20
  start-page: 2278
  year: 2016
  end-page: 2284
  ident: bib0255
  article-title: MicroRNA-202 induces cell cycle arrest and apoptosis in lung cancer cells through targeting cyclin D1
  publication-title: Eur. Rev. Med. Pharmacol. Sci.
  contributor:
    fullname: Quan
– volume: 6
  start-page: 27
  year: 2013
  ident: bib1295
  article-title: Down-regulation of miR-181c in imatinib-resistant chronic myeloid leukemia
  publication-title: Mol. Cytogenet.
  contributor:
    fullname: Knuutila
– volume: 45
  start-page: 383
  year: 2014
  end-page: 392
  ident: bib1020
  article-title: miR-181b increases drug sensitivity in acute myeloid leukemia via targeting HMGB1 and Mcl-1
  publication-title: Int. J. Oncol.
  contributor:
    fullname: Wang
– volume: 130
  start-page: 1290
  year: 2017
  end-page: 1301
  ident: bib0525
  article-title: MicroRNAs and acute myeloid leukemia: therapeutic implications and emerging concepts
  publication-title: Blood
  contributor:
    fullname: O’Connell
– volume: 5
  start-page: 22
  year: 2020
  end-page: 26
  ident: bib0955
  article-title: Overview of current microRNA biomarker signatures as potential diagnostic tools for leukaemic conditions
  publication-title: Noncoding RNA Res.
  contributor:
    fullname: Ayers
– volume: 11
  start-page: 228
  year: 2009
  end-page: 234
  ident: bib0355
  article-title: Many roads to maturity: microRNA biogenesis pathways and their regulation
  publication-title: Nat. Cell Biol.
  contributor:
    fullname: Diederichs
– volume: 244
  start-page: 189
  year: 2020
  end-page: 200
  ident: bib0265
  article-title: microRNA-375 regulates glucose metabolism-related signaling for insulin secretion
  publication-title: J. Endocrinol.
  contributor:
    fullname: Hinault
– volume: 104
  start-page: 801
  year: 2013
  end-page: 809
  ident: bib0475
  article-title: Role of microRNA in the pathogenesis of malignant lymphoma
  publication-title: Cancer Sci.
  contributor:
    fullname: Sawada
– volume: 7
  start-page: 2168
  year: 2001
  end-page: 2181
  ident: bib0645
  article-title: Cell cycle-mediated drug resistance: an emerging concept in cancer therapy
  publication-title: Clin. Cancer Res.
  contributor:
    fullname: Schwartz
– volume: 105
  start-page: 12885
  year: 2008
  end-page: 12890
  ident: bib0445
  article-title: MicroRNAs regulate critical genes associated with multiple myeloma pathogenesis
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
  contributor:
    fullname: Drandi
– volume: 110
  start-page: 1330
  year: 2007
  end-page: 1333
  ident: bib0540
  article-title: Interleukin-6 dependent survival of multiple myeloma cells involves the Stat3-mediated induction of microRNA-21 through a highly conserved enhancer
  publication-title: Blood
  contributor:
    fullname: Kretzschmar
– volume: 9
  start-page: 10164
  year: 2018
  end-page: 10174
  ident: bib1135
  article-title: The novel strategies for next-generation cancer treatment: miRNA combined with chemotherapeutic agents for the treatment of cancer
  publication-title: Oncotarget
  contributor:
    fullname: Lee
– volume: 8
  start-page: 53
  year: 2017
  end-page: 66
  ident: bib0125
  article-title: Adaptive mechanisms of resistance to anti-neoplastic agents
  publication-title: Medchemcomm
  contributor:
    fullname: Lorens
– volume: 32
  start-page: 2747
  year: 2013
  end-page: 2755
  ident: bib0550
  article-title: Leukemia cell to endothelial cell communication via exosomal miRNAs
  publication-title: Oncogene
  contributor:
    fullname: Ohyashiki
– volume: 93
  start-page: 1238
  year: 2017
  end-page: 1245
  ident: bib0140
  article-title: Regulatory players of DNA damage repair mechanisms: role in cancer chemoresistance
  publication-title: Biomed. Pharmacother.
  contributor:
    fullname: Hariharan
– volume: 1860
  start-page: 618
  year: 2016
  end-page: 627
  ident: bib0920
  article-title: Multidrug resistant tumour cells shed more microvesicle-like EVs and less exosomes than their drug-sensitive counterpart cells
  publication-title: Biochim. Biophys. Acta
  contributor:
    fullname: Henry
– volume: 32
  year: 2018
  ident: bib1310
  article-title: LncRNA NEAT1 promotes dexamethasone resistance in multiple myeloma by targeting miR-193a/MCL1 pathway
  publication-title: J. Biochem. Mol. Toxicol.
  contributor:
    fullname: Wang
– volume: 121
  start-page: 499
  year: 2013
  end-page: 509
  ident: bib0480
  article-title: Epigenetic silencing of microRNA-193a contributes to leukemogenesis in t(8;21) acute myeloid leukemia by activating the PTEN/PI3K signal pathway
  publication-title: Blood
  contributor:
    fullname: Wang
– volume: 172
  start-page: 62
  year: 2017
  end-page: 68
  ident: bib0215
  article-title: MiR-124 contributes to glucocorticoid resistance in acute lymphoblastic leukemia by promoting proliferation, inhibiting apoptosis and targeting the glucocorticoid receptor
  publication-title: J. Steroid Biochem. Mol. Biol.
  contributor:
    fullname: Zhang
– volume: 57
  start-page: 932
  year: 2019
  end-page: 953
  ident: bib0960
  article-title: The circulating miRNAs as diagnostic and prognostic markers
  publication-title: Clin. Chem. Lab. Med.
  contributor:
    fullname: Plebani
– volume: 8
  start-page: 76174
  year: 2017
  end-page: 76188
  ident: bib0505
  article-title: A tyrosine kinase-STAT5-miR21-PDCD4 regulatory axis in chronic and acute myeloid leukemia cells
  publication-title: Oncotarget
  contributor:
    fullname: Mahon
– volume: 9
  start-page: 176
  year: 2010
  ident: bib0820
  article-title: Bone marrow stromal cells from multiple myeloma patients uniquely induce bortezomib resistant NF-kappaB activity in myeloma cells
  publication-title: Mol. Cancer
  contributor:
    fullname: Leith
– volume: 93
  start-page: 1
  year: 2015
  end-page: 17
  ident: bib0485
  article-title: MicroRNA polymorphisms as markers of risk, prognosis and treatment response in hematological malignancies
  publication-title: Crit. Rev. Oncol. Hematol.
  contributor:
    fullname: Dzikiewicz-Krawczyk
– volume: 22
  start-page: 573
  year: 2015
  end-page: 580
  ident: bib0710
  article-title: Functional studies of miR-130a on the inhibitory pathways of apoptosis in patients with chronic myeloid leukemia
  publication-title: Cancer Gene Ther.
  contributor:
    fullname: Zhang
– volume: 9
  start-page: 1158
  year: 2003
  end-page: 1165
  ident: bib0815
  article-title: Interaction between leukemic-cell VLA-4 and stromal fibronectin is a decisive factor for minimal residual disease of acute myelogenous leukemia
  publication-title: Nat. Med.
  contributor:
    fullname: Fujimi
– volume: 6
  start-page: e16007
  year: 2011
  ident: bib0110
  article-title: Structure and function of ABCG2-rich extracellular vesicles mediating multidrug resistance
  publication-title: PLoS One
  contributor:
    fullname: Assaraf
– start-page: 251
  year: 2014
  end-page: 293
  ident: bib0165
  article-title: MicroRNAs in cancer drug resistance and drug sensitivity
  publication-title: MicroRNAs: Key Regulators of Oncogenesis
  contributor:
    fullname: Vasconcelos
– volume: 138
  start-page: 595
  year: 2012
  end-page: 602
  ident: bib0690
  article-title: miR-181a sensitizes resistant leukaemia HL-60/Ara-C cells to Ara-C by inducing apoptosis
  publication-title: J. Cancer Res. Clin. Oncol.
  contributor:
    fullname: Wang
– volume: 288
  start-page: 10849
  year: 2013
  end-page: 10859
  ident: bib0915
  article-title: Neutral sphingomyelinase 2 (nSMase2)-dependent exosomal transfer of angiogenic microRNAs regulate cancer cell metastasis
  publication-title: J. Biol. Chem.
  contributor:
    fullname: Ochiya
– volume: 123
  start-page: 2691
  year: 2014
  end-page: 2702
  ident: bib0810
  article-title: Reciprocal leukemia-stroma VCAM-1/VLA-4-dependent activation of NF-kappaB mediates chemoresistance
  publication-title: Blood
  contributor:
    fullname: Spaeth
– volume: 28
  start-page: 118
  year: 2014
  end-page: 128
  ident: bib1110
  article-title: Loss of p53 and altered miR15-a/16-1short right arrowMCL-1 pathway in CLL: insights from TCL1-Tg:p53(-/-) mouse model and primary human leukemia cells
  publication-title: Leukemia
  contributor:
    fullname: Wang
– volume: 13
  start-page: 4986
  year: 2017
  end-page: 4994
  ident: bib1185
  article-title: MicroRNA 217 inhibits cell proliferation and enhances chemosensitivity to doxorubicin in acute myeloid leukemia by targeting KRAS
  publication-title: Oncol. Lett.
  contributor:
    fullname: Shang
– volume: 22
  start-page: 531
  year: 2016
  end-page: 539
  ident: bib1075
  article-title: Study on the association between miRNA-202 expression and drug sensitivity in multiple myeloma cells
  publication-title: Pathol. Oncol. Res.
  contributor:
    fullname: Ni
– volume: 21
  year: 2019
  ident: bib0345
  article-title: Systems and synthetic microRNA biology: from biogenesis to disease pathogenesis
  publication-title: Int. J. Mol. Sci.
  contributor:
    fullname: Suzuki
– volume: 23
  start-page: 746
  year: 2009
  end-page: 752
  ident: bib1270
  article-title: Glucocorticoid-regulated microRNAs and mirtrons in acute lymphoblastic leukemia
  publication-title: Leukemia
  contributor:
    fullname: Mansha
– volume: 79
  start-page: 735
  year: 2011
  end-page: 741
  ident: bib1140
  article-title: Novel regulation of nuclear factor-YB by miR-485-3p affects the expression of DNA topoisomerase IIalpha and drug responsiveness
  publication-title: Mol. Pharmacol.
  contributor:
    fullname: Pommier
– volume: 21
  start-page: 595
  year: 2015
  end-page: 608
  ident: bib0195
  article-title: Intercellular transfer of cancer drug resistance traits by extracellular vesicles
  publication-title: Trends Mol. Med.
  contributor:
    fullname: Vasconcelos
– volume: 8
  start-page: 33078
  year: 2017
  end-page: 33085
  ident: bib0455
  article-title: Classification of pediatric acute myeloid leukemia based on miRNA expression profiles
  publication-title: Oncotarget
  contributor:
    fullname: Jongen-Lavrencic
– volume: 53
  start-page: 2465
  year: 2012
  end-page: 2473
  ident: bib1160
  article-title: Aberrant microRNA-182 expression is associated with glucocorticoid resistance in lymphoblastic malignancies
  publication-title: Leuk. Lymphoma
  contributor:
    fullname: Shi
– volume: 39
  start-page: 335
  year: 2015
  end-page: 341
  ident: bib0515
  article-title: Limited miR-17-92 overexpression drives hematologic malignancies
  publication-title: Leuk. Res.
  contributor:
    fullname: Guijarro
– volume: 7
  start-page: e29541
  year: 2012
  ident: bib1250
  article-title: miR-122 regulates p53/Akt signalling and the chemotherapy-induced apoptosis in cutaneous T-cell lymphoma
  publication-title: PLoS One
  contributor:
    fullname: Lerche
– volume: 234
  start-page: 5451
  year: 2019
  end-page: 5465
  ident: bib0235
  article-title: An overview of microRNAs: biology, functions, therapeutics, and analysis methods
  publication-title: J. Cell. Physiol.
  contributor:
    fullname: Ghaffari
– volume: 10
  start-page: 239
  year: 2012
  end-page: 245
  ident: bib0380
  article-title: Biogenesis of mammalian microRNAs: a global view
  publication-title: Genomics Proteomics Bioinform.
  contributor:
    fullname: Zeng
– volume: 46
  start-page: 100645
  year: 2019
  ident: bib0025
  article-title: The multi-factorial nature of clinical multidrug resistance in cancer
  publication-title: Drug Resist. Updat.
  contributor:
    fullname: Machuqueiro
– volume: 7
  start-page: 60723
  year: 2016
  end-page: 60735
  ident: bib0040
  article-title: Role of micro-RNAs in drug resistance of multiple myeloma
  publication-title: Oncotarget
  contributor:
    fullname: Chang
– volume: 18
  start-page: 266
  year: 2018
  end-page: 271
  ident: bib0095
  article-title: Effect of ABCG2, OCT1, and ABCB1 (MDR1) gene expression on treatment-free remission in a EURO-SKI subtrial
  publication-title: Clin. Lymphoma Myeloma Leuk.
  contributor:
    fullname: Panagiotidis
– volume: 13
  year: 2020
  ident: bib1130
  article-title: The therapeutic potential of MicroRNAs in cancer: illusion or opportunity?
  publication-title: Pharmaceuticals (Basel)
  contributor:
    fullname: Iorio
– volume: 27
  start-page: 143
  year: 2013
  end-page: 154
  ident: bib0465
  article-title: MicroRNAs in hematological malignancies
  publication-title: Blood Rev.
  contributor:
    fullname: Lawrie
– volume: 356
  start-page: 597
  year: 2015
  end-page: 356605
  ident: bib1200
  article-title: MiR-30e induces apoptosis and sensitizes K562 cells to imatinib treatment via regulation of the BCR-ABL protein
  publication-title: Cancer Lett.
  contributor:
    fullname: Raanani
– volume: 29
  start-page: 33
  year: 2015
  end-page: 44
  ident: bib0035
  article-title: Drug resistance-related microRNAs in hematological malignancies: translating basic evidence into therapeutic strategies
  publication-title: Blood Rev.
  contributor:
    fullname: Ju
– volume: 4
  start-page: 37
  year: 2011
  ident: bib0840
  article-title: Suppressing miRNA-15a/-16 expression by interleukin-6 enhances drug-resistance in myeloma cells
  publication-title: J. Hematol. Oncol.
  contributor:
    fullname: Zou
– volume: 155
  start-page: 1568
  year: 2013
  end-page: 1580
  ident: bib0395
  article-title: Mammalian 5’-capped microRNA precursors that generate a single microRNA
  publication-title: Cell
  contributor:
    fullname: Yartseva
– volume: 8
  year: 2019
  ident: bib0130
  article-title: Redox-mediated mechanism of chemoresistance in cancer cells
  publication-title: Antioxidants (Basel)
  contributor:
    fullname: Jang
– volume: 125
  start-page: 1137
  year: 2015
  end-page: 1145
  ident: bib0460
  article-title: Global microRNA expression profiling uncovers molecular markers for classification and prognosis in aggressive B-cell lymphoma
  publication-title: Blood
  contributor:
    fullname: Liu
– volume: 17
  start-page: 1489
  year: 2011
  end-page: 1501
  ident: bib0385
  article-title: A role for noncanonical microRNAs in the mammalian brain revealed by phenotypic differences in Dgcr8 versus Dicer1 knockouts and small RNA sequencing
  publication-title: RNA
  contributor:
    fullname: Blelloch
– volume: 182
  start-page: 1
  year: 2010
  end-page: 30
  ident: bib0625
  article-title: Glucocorticoid-induced apoptosis of healthy and malignant lymphocytes
  publication-title: Prog. Brain Res.
  contributor:
    fullname: Cidlowski
– volume: 99
  start-page: 15524
  year: 2002
  end-page: 15529
  ident: bib0470
  article-title: Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
  contributor:
    fullname: Noch
– volume: 15
  start-page: 4750
  year: 2009
  end-page: 4758
  ident: bib0050
  article-title: Clinical relevance of a pharmacogenetic approach using multiple candidate genes to predict response and resistance to imatinib therapy in chronic myeloid leukemia
  publication-title: Clin. Cancer Res.
  contributor:
    fullname: Siminovitch
– volume: 39
  start-page: 793
  year: 2015
  end-page: 799
  ident: bib0980
  article-title: Downregulated miR-33b is a novel predictor associated with disease progression and poor prognosis in multiple myeloma
  publication-title: Leuk. Res.
  contributor:
    fullname: Yi
– volume: 105
  start-page: 463
  year: 2014
  end-page: 472
  ident: bib1275
  article-title: Effect of microRNA-210 on prognosis and response to chemotherapeutic drugs in pediatric acute lymphoblastic leukemia
  publication-title: Cancer Sci.
  contributor:
    fullname: Zhao
– volume: 37
  start-page: 2193
  year: 2017
  end-page: 2200
  ident: bib0220
  article-title: Jia L. miR-9 regulates the multidrug resistance of chronic myelogenous leukemia by targeting ABCB1
  publication-title: Oncol. Rep.
  contributor:
    fullname: Zhou
– volume: 2
  start-page: 415
  year: 2009
  end-page: 423
  ident: bib0440
  article-title: Role of microRNAs in hematological malignancies
  publication-title: Expert Rev. Hematol.
  contributor:
    fullname: Bozzoni
– volume: 30
  start-page: 57
  year: 2015
  end-page: 63
  ident: bib0060
  article-title: Effect of rifampin on the pharmacokinetics of bosutinib, a dual Src/Abl tyrosine kinase inhibitor, when administered concomitantly to healthy subjects
  publication-title: Drug Metab. Pers. Ther.
  contributor:
    fullname: Sonnichsen
– volume: 53
  start-page: 1188
  year: 2012
  end-page: 1195
  ident: bib0615
  article-title: Triptolide enhances the sensitivity of multiple myeloma cells to dexamethasone via microRNAs
  publication-title: Leuk. Lymphoma
  contributor:
    fullname: Jin
– volume: 29
  start-page: 243
  year: 2012
  end-page: 247
  ident: bib1235
  article-title: miR-153 sensitized the K562 cells to As2O3-induced apoptosis
  publication-title: Med. Oncol.
  contributor:
    fullname: Zhang
– volume: 2
  start-page: e83
  year: 2012
  ident: bib1240
  article-title: Bortezomib action in multiple myeloma: microRNA-mediated synergy (and miR-27a/CDK5 driven sensitivity)?
  publication-title: Blood Cancer J.
  contributor:
    fullname: Tramonti
– volume: 15
  start-page: 38
  year: 2015
  ident: bib0375
  article-title: MicroRNA (miRNA) in cancer
  publication-title: Cancer Cell Int.
  contributor:
    fullname: Reddy
– volume: 11
  year: 2019
  ident: bib0685
  article-title: Novel apoptosis-inducing agents for the treatment of cancer, a new arsenal in the toolbox
  publication-title: Cancers (Basel)
  contributor:
    fullname: Takebe
– volume: 26
  start-page: 1752
  year: 2012
  end-page: 1760
  ident: bib0770
  article-title: Targeting microRNA-30a-mediated autophagy enhances imatinib activity against human chronic myeloid leukemia cells
  publication-title: Leukemia
  contributor:
    fullname: Vernon
– volume: 291
  start-page: 144
  year: 2018
  end-page: 151
  ident: bib0775
  article-title: microRNA-199a/b-5p enhance imatinib efficacy via repressing WNT2 signaling-mediated protective autophagy in imatinib-resistant chronic myeloid leukemia cells
  publication-title: Chem. Biol. Interact.
  contributor:
    fullname: Lee
– volume: 123
  start-page: 2395
  year: 2013
  end-page: 2407
  ident: bib0875
  article-title: CXCR4 downregulation of let-7a drives chemoresistance in acute myeloid leukemia
  publication-title: J. Clin. Invest.
  contributor:
    fullname: Andreeff
– volume: 1
  start-page: e24
  year: 2011
  ident: bib0495
  article-title: MicroRNA expression in tumor cells from Waldenstrom’s macroglobulinemia reflects both their normal and malignant cell counterparts
  publication-title: Blood Cancer J.
  contributor:
    fullname: Fonseca
– volume: 47
  start-page: 100647
  year: 2019
  ident: bib0020
  article-title: Extracellular vesicles as a novel source of biomarkers in liquid biopsies for monitoring cancer progression and drug resistance
  publication-title: Drug Resist. Updat.
  contributor:
    fullname: Line
– volume: 49
  start-page: 73
  year: 2016
  end-page: 79
  ident: bib0450
  article-title: MiR-15a/16 regulates the growth of myeloma cells, angiogenesis and antitumor immunity by inhibiting Bcl-2, VEGF-A and IL-17 expression in multiple myeloma
  publication-title: Leuk. Res.
  contributor:
    fullname: Li
– volume: 105
  start-page: 15535
  year: 2008
  end-page: 15540
  ident: bib0945
  article-title: Distinct microRNA expression profiles in acute myeloid leukemia with common translocations
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
  contributor:
    fullname: Luo
– volume: 28
  start-page: 880
  year: 2014
  end-page: 887
  ident: bib1315
  article-title: MicroRNA187 overexpression is related to tumor progression and determines sensitivity to bortezomib in peripheral T-cell lymphoma
  publication-title: Leukemia
  contributor:
    fullname: Romero
– volume: 11
  year: 2019
  ident: bib0065
  article-title: Clinically relevant drug interactions with multikinase inhibitors: a review
  publication-title: Ther. Adv. Med. Oncol.
  contributor:
    fullname: van Leeuwen
– volume: 123
  start-page: 201
  year: 2010
  end-page: 204
  ident: bib0990
  article-title: MicroRNA profiles of drug-resistant myeloma cell lines
  publication-title: Acta Haematol.
  contributor:
    fullname: Heerema
– volume: 44
  start-page: 238
  year: 2016
  end-page: 246
  ident: bib0205
  article-title: High miR-34a expression improves response to doxorubicin in diffuse large B-cell lymphoma
  publication-title: Exp. Hematol.
  contributor:
    fullname: Bodker
– volume: 2
  start-page: 182
  year: 2011
  end-page: 189
  ident: bib0610
  article-title: Role for microRNAs in regulating glucocorticoid response and resistance in multiple myeloma
  publication-title: Horm. Cancer
  contributor:
    fullname: Gunaratne
– volume: 47
  start-page: D253
  year: 2019
  end-page: D258
  ident: bib0280
  article-title: TransmiR v2.0: an updated transcription factor-microRNA regulation database
  publication-title: Nucleic Acids Res.
  contributor:
    fullname: Zhou
– volume: 721
  start-page: 116
  year: 2013
  end-page: 125
  ident: bib0115
  article-title: Microparticle drug sequestration provides a parallel pathway in the acquisition of cancer drug resistance
  publication-title: Eur. J. Pharmacol.
  contributor:
    fullname: Bebawy
– volume: 105
  start-page: 297
  year: 2014
  end-page: 307
  ident: bib1195
  article-title: Downregulation of miR-217 correlates with resistance of Ph(+) leukemia cells to ABL tyrosine kinase inhibitors
  publication-title: Cancer Sci.
  contributor:
    fullname: Yokoyama
– volume: 22
  year: 2016
  ident: bib0005
  article-title: Special issue: new approaches to counteract drug resistance in cancer
  publication-title: Molecules
  contributor:
    fullname: Vasconcelos
– volume: 5
  year: 2019
  ident: bib0285
  article-title: Factors regulating microRNA expression and function in multiple myeloma
  publication-title: Noncoding RNA
  contributor:
    fullname: Herrero
– volume: 26
  start-page: 1064
  year: 2012
  end-page: 1072
  ident: bib0755
  article-title: The miRNA-17 approximately 92 cluster mediates chemoresistance and enhances tumor growth in mantle cell lymphoma via PI3K/AKT pathway activation
  publication-title: Leukemia
  contributor:
    fullname: Lenz
– volume: 362
  start-page: 386
  year: 2018
  end-page: 393
  ident: bib0940
  article-title: Exosomes derived from imatinib-resistant chronic myeloid leukemia cells mediate a horizontal transfer of drug-resistant trait by delivering miR-365
  publication-title: Exp. Cell Res.
  contributor:
    fullname: Liu
– volume: 28
  start-page: 211
  year: 2011
  end-page: 218
  ident: bib1085
  article-title: miRNA-21 regulates arsenic-induced anti-leukemia activity in myelogenous cell lines
  publication-title: Med. Oncol.
  contributor:
    fullname: Lin
– volume: 22
  start-page: 1222
  year: 2016
  end-page: 1233
  ident: bib0605
  article-title: A 13 mer LNA-i-miR-221 inhibitor restores drug sensitivity in melphalan-refractory multiple myeloma cells
  publication-title: Clin. Cancer Res.
  contributor:
    fullname: Botta
– volume: 137
  start-page: 1005
  year: 2009
  end-page: 1017
  ident: bib1050
  article-title: Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model
  publication-title: Cell
  contributor:
    fullname: Hwang
– volume: 58
  start-page: 1981
  year: 2017
  end-page: 1984
  ident: bib0325
  article-title: miR-505-5p and miR-193b-3p: potential biomarkers of imatinib response in patients with chronic myeloid leukemia
  publication-title: Leuk. Lymphoma
  contributor:
    fullname: Bakhshi
– volume: 8
  year: 2019
  ident: bib0910
  article-title: Distinct mechanisms of microRNA sorting into cancer cell-derived extracellular vesicle subtypes
  publication-title: Elife
  contributor:
    fullname: Lambowitz
– volume: 1807
  start-page: 735
  year: 2011
  end-page: 745
  ident: bib0120
  article-title: Recent advances in apoptosis, mitochondria and drug resistance in cancer cells
  publication-title: Biochim. Biophys. Acta
  contributor:
    fullname: Brenner
– volume: 114
  start-page: e20
  year: 2009
  end-page: e26
  ident: bib0510
  article-title: Identification of microRNA expression patterns and definition of a microRNA/mRNA regulatory network in distinct molecular groups of multiple myeloma
  publication-title: Blood
  contributor:
    fullname: Fabris
– volume: 116
  start-page: 5228
  year: 2010
  end-page: 5236
  ident: bib0880
  article-title: Follicular dendritic cell-dependent drug resistance of non-Hodgkin lymphoma involves cell adhesion-mediated Bim down-regulation through induction of microRNA-181a
  publication-title: Blood
  contributor:
    fullname: Wright
– volume: 18
  start-page: 1386
  year: 2017
  end-page: 1396
  ident: bib1100
  article-title: Safety and activity of microRNA-loaded minicells in patients with recurrent malignant pleural mesothelioma: a first-in-man, phase 1, open-label, dose-escalation study
  publication-title: Lancet Oncol.
  contributor:
    fullname: Clarke
– volume: 114
  start-page: 4169
  year: 2009
  end-page: 4178
  ident: bib0655
  article-title: miR-128b is a potent glucocorticoid sensitizer in MLL-AF4 acute lymphocytic leukemia cells and exerts cooperative effects with miR-221
  publication-title: Blood
  contributor:
    fullname: den Boer
– volume: 60
  start-page: 1078
  year: 2019
  end-page: 1086
  ident: bib0105
  article-title: Acid ceramidase promotes drug resistance in acute myeloid leukemia through NF-kappaB-dependent P-glycoprotein upregulation
  publication-title: J. Lipid Res.
  contributor:
    fullname: Desai
– volume: 33
  start-page: 610
  year: 2020
  end-page: 618
  ident: bib0230
  article-title: MicroRNA-153-3p enhances the sensitivity of chronic myeloid leukemia cells to imatinib by inhibiting B-cell lymphoma-2-mediated autophagy
  publication-title: Hum. Cell
  contributor:
    fullname: Qu
– volume: 1617
  start-page: 1
  year: 2017
  end-page: 25
  ident: bib0240
  article-title: MicroRNAs, long noncoding RNAs, and their functions in human disease
  publication-title: Methods Mol. Biol.
  contributor:
    fullname: Shan
– volume: 41
  start-page: 2
  year: 2020
  end-page: 7
  ident: bib1120
  article-title: miR-155 as a novel clinical target for hematological malignancies
  publication-title: Carcinogenesis
  contributor:
    fullname: Slack
– volume: 60
  start-page: 1709
  year: 2019
  end-page: 1720
  ident: bib1225
  article-title: MicroRNA-221 sensitizes chronic myeloid leukemia cells to imatinib by targeting STAT5
  publication-title: Leuk. Lymphoma
  contributor:
    fullname: Xu
– volume: 19
  start-page: 367
  year: 2013
  end-page: 379
  ident: bib1115
  article-title: In vitro sensitivity of CLL cells to fludarabine may be modulated by the stimulation of Toll-like receptors
  publication-title: Clin. Cancer Res.
  contributor:
    fullname: Ghia
– volume: 19
  start-page: 367
  issue: 2
  year: 2013
  ident: 10.1016/j.semcancer.2021.03.014_bib1115
  article-title: In vitro sensitivity of CLL cells to fludarabine may be modulated by the stimulation of Toll-like receptors
  publication-title: Clin. Cancer Res.
  doi: 10.1158/1078-0432.CCR-12-1922
  contributor:
    fullname: Fonte
– volume: 32
  start-page: 2471
  issue: 11
  year: 2018
  ident: 10.1016/j.semcancer.2021.03.014_bib1065
  article-title: Dysregulation of EZH2/miR-138 axis contributes to drug resistance in multiple myeloma by downregulating RBPMS
  publication-title: Leukemia
  doi: 10.1038/s41375-018-0140-y
  contributor:
    fullname: Rastgoo
– volume: 33
  start-page: 1217
  issue: 9
  year: 2009
  ident: 10.1016/j.semcancer.2021.03.014_bib0970
  article-title: Prognostic value of miR-16 expression in childhood acute lymphoblastic leukemia relationships to normal and malignant lymphocyte proliferation
  publication-title: Leuk. Res.
  doi: 10.1016/j.leukres.2008.12.015
  contributor:
    fullname: Kaddar
– volume: 43
  start-page: 1058
  issue: 2
  year: 2019
  ident: 10.1016/j.semcancer.2021.03.014_bib0700
  article-title: MicroRNA-497 inhibits multiple myeloma growth and increases susceptibility to bortezomib by targeting Bcl-2
  publication-title: Int. J. Mol. Med.
  contributor:
    fullname: Tian
– volume: 126
  start-page: 1106
  issue: 9
  year: 2015
  ident: 10.1016/j.semcancer.2021.03.014_bib0570
  article-title: Exosomes released by chronic lymphocytic leukemia cells induce the transition of stromal cells into cancer-associated fibroblasts
  publication-title: Blood
  doi: 10.1182/blood-2014-12-618025
  contributor:
    fullname: Paggetti
– volume: 29
  start-page: 243
  issue: 1
  year: 2012
  ident: 10.1016/j.semcancer.2021.03.014_bib1235
  article-title: miR-153 sensitized the K562 cells to As2O3-induced apoptosis
  publication-title: Med. Oncol.
  doi: 10.1007/s12032-010-9807-6
  contributor:
    fullname: Liu
– volume: 58
  start-page: 1981
  issue: 8
  year: 2017
  ident: 10.1016/j.semcancer.2021.03.014_bib0325
  article-title: miR-505-5p and miR-193b-3p: potential biomarkers of imatinib response in patients with chronic myeloid leukemia
  publication-title: Leuk. Lymphoma
  doi: 10.1080/10428194.2016.1272681
  contributor:
    fullname: Ramachandran
– volume: 106
  start-page: 267
  year: 2018
  ident: 10.1016/j.semcancer.2021.03.014_bib1320
  article-title: Down-regulated miR-148b increases resistance to CHOP in diffuse large B-cell lymphoma cells by rescuing Ezrin
  publication-title: Biomed. Pharmacother.
  doi: 10.1016/j.biopha.2018.06.093
  contributor:
    fullname: Sun
– volume: 10
  start-page: 626
  year: 2019
  ident: 10.1016/j.semcancer.2021.03.014_bib0405
  article-title: Circulating MicroRNAs in cancer: potential and challenge
  publication-title: Front. Genet.
  doi: 10.3389/fgene.2019.00626
  contributor:
    fullname: Cui
– volume: 13
  start-page: 17
  issue: 1
  year: 2015
  ident: 10.1016/j.semcancer.2021.03.014_bib0900
  article-title: Exosome and exosomal microRNA: trafficking, sorting, and function
  publication-title: Genomics Proteomics Bioinform.
  doi: 10.1016/j.gpb.2015.02.001
  contributor:
    fullname: Zhang
– volume: 44
  start-page: 269
  issue: 3
  year: 2012
  ident: 10.1016/j.semcancer.2021.03.014_bib0695
  article-title: miR-181a sensitizes a multidrug-resistant leukemia cell line K562/A02 to daunorubicin by targeting BCL-2
  publication-title: Acta Biochim. Biophys. Sin. (Shanghai)
  doi: 10.1093/abbs/gmr128
  contributor:
    fullname: Li
– volume: 29
  start-page: 727
  issue: 3
  year: 2015
  ident: 10.1016/j.semcancer.2021.03.014_bib1245
  article-title: MiR-29b replacement inhibits proteasomes and disrupts aggresome+autophagosome formation to enhance the antimyeloma benefit of bortezomib
  publication-title: Leukemia
  doi: 10.1038/leu.2014.279
  contributor:
    fullname: Jagannathan
– volume: 15
  start-page: 90
  issue: 1–2
  year: 2012
  ident: 10.1016/j.semcancer.2021.03.014_bib0030
  article-title: The dynamics of drug resistance: a mathematical perspective
  publication-title: Drug Resist. Updat.
  doi: 10.1016/j.drup.2012.01.003
  contributor:
    fullname: Lavi
– volume: 32
  start-page: 2747
  issue: 22
  year: 2013
  ident: 10.1016/j.semcancer.2021.03.014_bib0550
  article-title: Leukemia cell to endothelial cell communication via exosomal miRNAs
  publication-title: Oncogene
  doi: 10.1038/onc.2012.295
  contributor:
    fullname: Umezu
– volume: 33
  start-page: 610
  issue: 3
  year: 2020
  ident: 10.1016/j.semcancer.2021.03.014_bib0230
  article-title: MicroRNA-153-3p enhances the sensitivity of chronic myeloid leukemia cells to imatinib by inhibiting B-cell lymphoma-2-mediated autophagy
  publication-title: Hum. Cell
  doi: 10.1007/s13577-020-00367-1
  contributor:
    fullname: Li
– volume: 12
  issue: 2
  year: 2020
  ident: 10.1016/j.semcancer.2021.03.014_bib0565
  article-title: Extracellular vesicle microRNAs contribute to the osteogenic inhibition of mesenchymal stem cells in multiple myeloma
  publication-title: Cancers (Basel)
  doi: 10.3390/cancers12020449
  contributor:
    fullname: Raimondo
– volume: 57
  start-page: 932
  issue: 7
  year: 2019
  ident: 10.1016/j.semcancer.2021.03.014_bib0960
  article-title: The circulating miRNAs as diagnostic and prognostic markers
  publication-title: Clin. Chem. Lab. Med.
  doi: 10.1515/cclm-2018-0838
  contributor:
    fullname: Terrinoni
– volume: 31
  start-page: 4567
  issue: 42
  year: 2012
  ident: 10.1016/j.semcancer.2021.03.014_bib0145
  article-title: Candidate DNA methylation drivers of acquired cisplatin resistance in ovarian cancer identified by methylome and expression profiling
  publication-title: Oncogene
  doi: 10.1038/onc.2011.611
  contributor:
    fullname: Zeller
– volume: 119
  start-page: 6024
  issue: 7
  year: 2018
  ident: 10.1016/j.semcancer.2021.03.014_bib0415
  article-title: MicroRNA-326 and microRNA-200c: two novel biomarkers for diagnosis and prognosis of pediatric acute lymphoblastic leukemia
  publication-title: J. Cell. Biochem.
  doi: 10.1002/jcb.26800
  contributor:
    fullname: Ghodousi
– volume: 18
  start-page: 266
  issue: 4
  year: 2018
  ident: 10.1016/j.semcancer.2021.03.014_bib0095
  article-title: Effect of ABCG2, OCT1, and ABCB1 (MDR1) gene expression on treatment-free remission in a EURO-SKI subtrial
  publication-title: Clin. Lymphoma Myeloma Leuk.
  doi: 10.1016/j.clml.2018.02.004
  contributor:
    fullname: Rinaldetti
– volume: 9
  start-page: 123
  year: 2010
  ident: 10.1016/j.semcancer.2021.03.014_bib1175
  article-title: MicroRNAs involvement in fludarabine refractory chronic lymphocytic leukemia
  publication-title: Mol. Cancer
  doi: 10.1186/1476-4598-9-123
  contributor:
    fullname: Ferracin
– volume: 125
  start-page: 1302
  issue: 8
  year: 2015
  ident: 10.1016/j.semcancer.2021.03.014_bib0210
  article-title: MicroRNA-486 regulates normal erythropoiesis and enhances growth and modulates drug response in CML progenitors
  publication-title: Blood
  doi: 10.1182/blood-2014-06-581926
  contributor:
    fullname: Wang
– volume: 102
  start-page: e456
  issue: 11
  year: 2017
  ident: 10.1016/j.semcancer.2021.03.014_bib0985
  article-title: Circulating microRNA expressions can predict the outcome of lenalidomide plus low-dose dexamethasone treatment in patients with refractory/relapsed multiple myeloma
  publication-title: Haematologica
  doi: 10.3324/haematol.2017.168070
  contributor:
    fullname: Jung
– volume: 53
  start-page: 1586
  issue: 8
  year: 2012
  ident: 10.1016/j.semcancer.2021.03.014_bib1260
  article-title: Epstein-Barr virus latent membrane protein-1 protects B-cell lymphoma from rituximab-induced apoptosis through miR-155-mediated Akt activation and up-regulation of Mcl-1
  publication-title: Leuk. Lymphoma
  doi: 10.3109/10428194.2012.659736
  contributor:
    fullname: Kim
– volume: 105
  start-page: 297
  issue: 3
  year: 2014
  ident: 10.1016/j.semcancer.2021.03.014_bib1195
  article-title: Downregulation of miR-217 correlates with resistance of Ph(+) leukemia cells to ABL tyrosine kinase inhibitors
  publication-title: Cancer Sci.
  doi: 10.1111/cas.12339
  contributor:
    fullname: Nishioka
– volume: 60
  start-page: 1709
  issue: 7
  year: 2019
  ident: 10.1016/j.semcancer.2021.03.014_bib1225
  article-title: MicroRNA-221 sensitizes chronic myeloid leukemia cells to imatinib by targeting STAT5
  publication-title: Leuk. Lymphoma
  doi: 10.1080/10428194.2018.1543875
  contributor:
    fullname: Jiang
– volume: 125
  start-page: 1137
  issue: 7
  year: 2015
  ident: 10.1016/j.semcancer.2021.03.014_bib0460
  article-title: Global microRNA expression profiling uncovers molecular markers for classification and prognosis in aggressive B-cell lymphoma
  publication-title: Blood
  doi: 10.1182/blood-2014-04-566778
  contributor:
    fullname: Iqbal
– volume: 291
  start-page: 144
  year: 2018
  ident: 10.1016/j.semcancer.2021.03.014_bib0775
  article-title: microRNA-199a/b-5p enhance imatinib efficacy via repressing WNT2 signaling-mediated protective autophagy in imatinib-resistant chronic myeloid leukemia cells
  publication-title: Chem. Biol. Interact.
  doi: 10.1016/j.cbi.2018.06.006
  contributor:
    fullname: Chen
– volume: 10
  start-page: 4267
  year: 2018
  ident: 10.1016/j.semcancer.2021.03.014_bib0300
  article-title: Abnormal microRNA expression in the course of hematological malignancies
  publication-title: Cancer Manag. Res.
  doi: 10.2147/CMAR.S174476
  contributor:
    fullname: Szymczyk
– volume: 97
  start-page: 1189
  year: 2018
  ident: 10.1016/j.semcancer.2021.03.014_bib1010
  article-title: MiR-182-5p regulates BCL2L12 and BCL2 expression in acute myeloid leukemia as a potential therapeutic target
  publication-title: Biomed. Pharmacother.
  doi: 10.1016/j.biopha.2017.11.002
  contributor:
    fullname: Zhang
– volume: 480
  start-page: 29
  year: 2020
  ident: 10.1016/j.semcancer.2021.03.014_bib0780
  article-title: MARCKS inhibition cooperates with autophagy antagonists to potentiate the effect of standard therapy against drug-resistant multiple myeloma
  publication-title: Cancer Lett.
  doi: 10.1016/j.canlet.2020.03.020
  contributor:
    fullname: Zhang
– volume: 47
  start-page: D253
  issue: D1
  year: 2019
  ident: 10.1016/j.semcancer.2021.03.014_bib0280
  article-title: TransmiR v2.0: an updated transcription factor-microRNA regulation database
  publication-title: Nucleic Acids Res.
  doi: 10.1093/nar/gky1023
  contributor:
    fullname: Tong
– volume: 12
  start-page: 2144
  issue: 13
  year: 2013
  ident: 10.1016/j.semcancer.2021.03.014_bib0715
  article-title: Attenuation of dexamethasone-induced cell death in multiple myeloma is mediated by miR-125b expression
  publication-title: Cell Cycle
  doi: 10.4161/cc.25251
  contributor:
    fullname: Murray
– volume: 26
  start-page: 1752
  issue: 8
  year: 2012
  ident: 10.1016/j.semcancer.2021.03.014_bib0770
  article-title: Targeting microRNA-30a-mediated autophagy enhances imatinib activity against human chronic myeloid leukemia cells
  publication-title: Leukemia
  doi: 10.1038/leu.2012.65
  contributor:
    fullname: Yu
– volume: 10
  issue: 442
  year: 2018
  ident: 10.1016/j.semcancer.2021.03.014_bib1035
  article-title: Derepression of co-silenced tumor suppressor genes by nanoparticle-loaded circular ssDNA reduces tumor malignancy
  publication-title: Sci. Transl. Med.
  doi: 10.1126/scitranslmed.aao6321
  contributor:
    fullname: Meng
– volume: 14
  start-page: 57
  year: 2015
  ident: 10.1016/j.semcancer.2021.03.014_bib0250
  article-title: miR-211 suppresses epithelial ovarian cancer proliferation and cell-cycle progression by targeting Cyclin D1 and CDK6
  publication-title: Mol. Cancer
  doi: 10.1186/s12943-015-0322-4
  contributor:
    fullname: Xia
– volume: 18
  start-page: 452
  issue: 7
  year: 2018
  ident: 10.1016/j.semcancer.2021.03.014_bib0100
  article-title: Revisiting the role of ABC transporters in multidrug-resistant cancer
  publication-title: Nat. Rev. Cancer
  doi: 10.1038/s41568-018-0005-8
  contributor:
    fullname: Robey
– volume: 9
  start-page: 405
  issue: 4
  year: 2008
  ident: 10.1016/j.semcancer.2021.03.014_bib0520
  article-title: Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytes
  publication-title: Nat. Immunol.
  doi: 10.1038/ni1575
  contributor:
    fullname: Xiao
– volume: 35
  start-page: 277
  issue: 5
  year: 2019
  ident: 10.1016/j.semcancer.2021.03.014_bib0675
  article-title: MicroRNA-26a inhibits multiple myeloma cell growth by suppressing cyclin-dependent kinase 6 expression
  publication-title: Kaohsiung J. Med. Sci.
  doi: 10.1002/kjm2.12057
  contributor:
    fullname: Xu
– volume: 136
  start-page: 169
  issue: 2
  year: 2012
  ident: 10.1016/j.semcancer.2021.03.014_bib0545
  article-title: Cell-to-cell miRNA transfer: from body homeostasis to therapy
  publication-title: Pharmacol. Ther.
  doi: 10.1016/j.pharmthera.2012.08.003
  contributor:
    fullname: Redis
– volume: 114
  start-page: 10660
  issue: 40
  year: 2017
  ident: 10.1016/j.semcancer.2021.03.014_bib0260
  article-title: Cell cycle-targeting microRNAs promote differentiation by enforcing cell-cycle exit
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
  doi: 10.1073/pnas.1702914114
  contributor:
    fullname: Otto
– volume: 6
  start-page: 1769
  issue: 3
  year: 2014
  ident: 10.1016/j.semcancer.2021.03.014_bib0015
  article-title: Drug resistance in cancer: an overview
  publication-title: Cancers (Basel)
  doi: 10.3390/cancers6031769
  contributor:
    fullname: Housman
– volume: 6
  start-page: e16007
  issue: 1
  year: 2011
  ident: 10.1016/j.semcancer.2021.03.014_bib0110
  article-title: Structure and function of ABCG2-rich extracellular vesicles mediating multidrug resistance
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0016007
  contributor:
    fullname: Goler-Baron
– volume: 104
  start-page: 801
  issue: 7
  year: 2013
  ident: 10.1016/j.semcancer.2021.03.014_bib0475
  article-title: Role of microRNA in the pathogenesis of malignant lymphoma
  publication-title: Cancer Sci.
  doi: 10.1111/cas.12160
  contributor:
    fullname: Tagawa
– volume: 30
  start-page: 57
  issue: 1
  year: 2015
  ident: 10.1016/j.semcancer.2021.03.014_bib0060
  article-title: Effect of rifampin on the pharmacokinetics of bosutinib, a dual Src/Abl tyrosine kinase inhibitor, when administered concomitantly to healthy subjects
  publication-title: Drug Metab. Pers. Ther.
  doi: 10.1515/dmdi-2014-0026
  contributor:
    fullname: Abbas
– volume: 74
  start-page: 1801
  issue: 6
  year: 2014
  ident: 10.1016/j.semcancer.2021.03.014_bib0865
  article-title: miR-30-5p functions as a tumor suppressor and novel therapeutic tool by targeting the oncogenic Wnt/beta-catenin/BCL9 pathway
  publication-title: Cancer Res.
  doi: 10.1158/0008-5472.CAN-13-3311-T
  contributor:
    fullname: Zhao
– volume: 35
  start-page: 974
  issue: 7
  year: 2011
  ident: 10.1016/j.semcancer.2021.03.014_bib0640
  article-title: MicroRNA-451 in chronic myeloid leukemia: miR-451-BCR-ABL regulatory loop?
  publication-title: Leuk. Res.
  doi: 10.1016/j.leukres.2011.03.029
  contributor:
    fullname: Lopotova
– volume: 23
  start-page: 746
  issue: 4
  year: 2009
  ident: 10.1016/j.semcancer.2021.03.014_bib1270
  article-title: Glucocorticoid-regulated microRNAs and mirtrons in acute lymphoblastic leukemia
  publication-title: Leukemia
  doi: 10.1038/leu.2008.370
  contributor:
    fullname: Rainer
– volume: 79
  start-page: 735
  issue: 4
  year: 2011
  ident: 10.1016/j.semcancer.2021.03.014_bib1140
  article-title: Novel regulation of nuclear factor-YB by miR-485-3p affects the expression of DNA topoisomerase IIalpha and drug responsiveness
  publication-title: Mol. Pharmacol.
  doi: 10.1124/mol.110.069633
  contributor:
    fullname: Chen
– volume: 47
  start-page: 100647
  year: 2019
  ident: 10.1016/j.semcancer.2021.03.014_bib0020
  article-title: Extracellular vesicles as a novel source of biomarkers in liquid biopsies for monitoring cancer progression and drug resistance
  publication-title: Drug Resist. Updat.
  doi: 10.1016/j.drup.2019.100647
  contributor:
    fullname: Vasconcelos
– volume: 28
  start-page: 880
  issue: 4
  year: 2014
  ident: 10.1016/j.semcancer.2021.03.014_bib1315
  article-title: MicroRNA187 overexpression is related to tumor progression and determines sensitivity to bortezomib in peripheral T-cell lymphoma
  publication-title: Leukemia
  doi: 10.1038/leu.2013.291
  contributor:
    fullname: Yan
– volume: 172
  start-page: 62
  year: 2017
  ident: 10.1016/j.semcancer.2021.03.014_bib0215
  article-title: MiR-124 contributes to glucocorticoid resistance in acute lymphoblastic leukemia by promoting proliferation, inhibiting apoptosis and targeting the glucocorticoid receptor
  publication-title: J. Steroid Biochem. Mol. Biol.
  doi: 10.1016/j.jsbmb.2017.05.014
  contributor:
    fullname: Liang
– volume: 7
  start-page: 339
  issue: 3
  year: 2017
  ident: 10.1016/j.semcancer.2021.03.014_bib0070
  article-title: The different mechanisms of cancer drug resistance: a brief review
  publication-title: Adv. Pharm. Bull.
  doi: 10.15171/apb.2017.041
  contributor:
    fullname: Mansoori
– volume: 30
  start-page: 381
  issue: 6
  year: 2011
  ident: 10.1016/j.semcancer.2021.03.014_bib0535
  article-title: Single-nucleotide polymorphisms among microRNA: big effects on cancer
  publication-title: Chin. J. Cancer
  doi: 10.5732/cjc.30.0381
  contributor:
    fullname: Song
– volume: 12
  start-page: 152
  year: 2013
  ident: 10.1016/j.semcancer.2021.03.014_bib0895
  article-title: Tumor glycolysis as a target for cancer therapy: progress and prospects
  publication-title: Mol. Cancer
  doi: 10.1186/1476-4598-12-152
  contributor:
    fullname: Ganapathy-Kanniappan
– volume: 62
  start-page: 70
  year: 2017
  ident: 10.1016/j.semcancer.2021.03.014_bib0930
  article-title: Transfer of multidrug resistance among acute myeloid leukemia cells via extracellular vesicles and their microRNA cargo
  publication-title: Leuk. Res.
  doi: 10.1016/j.leukres.2017.09.014
  contributor:
    fullname: Bouvy
– volume: 9
  start-page: 10164
  issue: 11
  year: 2018
  ident: 10.1016/j.semcancer.2021.03.014_bib1135
  article-title: The novel strategies for next-generation cancer treatment: miRNA combined with chemotherapeutic agents for the treatment of cancer
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.24309
  contributor:
    fullname: Chakraborty
– volume: 123
  start-page: 2395
  issue: 6
  year: 2013
  ident: 10.1016/j.semcancer.2021.03.014_bib0875
  article-title: CXCR4 downregulation of let-7a drives chemoresistance in acute myeloid leukemia
  publication-title: J. Clin. Invest.
  doi: 10.1172/JCI66553
  contributor:
    fullname: Chen
– volume: 398
  start-page: 929
  issue: 8
  year: 2017
  ident: 10.1016/j.semcancer.2021.03.014_bib0650
  article-title: MicroRNAs are important regulators of drug resistance in colorectal cancer
  publication-title: Biol. Chem.
  doi: 10.1515/hsz-2016-0308
  contributor:
    fullname: Zhang
– volume: 18
  start-page: 1660
  issue: 14
  year: 2019
  ident: 10.1016/j.semcancer.2021.03.014_bib0795
  article-title: miR-520g and miR-520h overcome bortezomib resistance in multiple myeloma via suppressing APE1
  publication-title: Cell Cycle
  doi: 10.1080/15384101.2019.1632138
  contributor:
    fullname: Yuan
– volume: 122
  start-page: 1630
  issue: 11
  year: 2020
  ident: 10.1016/j.semcancer.2021.03.014_bib1090
  article-title: Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours
  publication-title: Br. J. Cancer
  doi: 10.1038/s41416-020-0802-1
  contributor:
    fullname: Hong
– volume: 11
  start-page: 37
  year: 2012
  ident: 10.1016/j.semcancer.2021.03.014_bib0925
  article-title: Microparticle conferred microRNA profiles–implications in the transfer and dominance of cancer traits
  publication-title: Mol. Cancer
  doi: 10.1186/1476-4598-11-37
  contributor:
    fullname: Jaiswal
– volume: 12
  start-page: 51
  issue: 1
  year: 2019
  ident: 10.1016/j.semcancer.2021.03.014_bib0530
  article-title: Role of microRNAs, circRNAs and long noncoding RNAs in acute myeloid leukemia
  publication-title: J. Hematol. Oncol.
  doi: 10.1186/s13045-019-0734-5
  contributor:
    fullname: Liu
– volume: 362
  start-page: 386
  issue: 2
  year: 2018
  ident: 10.1016/j.semcancer.2021.03.014_bib0940
  article-title: Exosomes derived from imatinib-resistant chronic myeloid leukemia cells mediate a horizontal transfer of drug-resistant trait by delivering miR-365
  publication-title: Exp. Cell Res.
  doi: 10.1016/j.yexcr.2017.12.001
  contributor:
    fullname: Min
– volume: 68
  start-page: 80
  year: 2018
  ident: 10.1016/j.semcancer.2021.03.014_bib1215
  article-title: miR-217 sensitizes chronic myelogenous leukemia cells to tyrosine kinase inhibitors by targeting pro-oncogenic anterior gradient 2
  publication-title: Exp. Hematol.
  doi: 10.1016/j.exphem.2018.09.001
  contributor:
    fullname: Pan
– start-page: 5
  year: 2020
  ident: 10.1016/j.semcancer.2021.03.014_bib0860
  article-title: The role of bone marrow stromal cells in blood diseases and clinical significance as a crucial part of the hematopoietic microenvironment
  publication-title: Ann. Blood
  contributor:
    fullname: Liang
– volume: 8
  start-page: e59390
  issue: 3
  year: 2013
  ident: 10.1016/j.semcancer.2021.03.014_bib1255
  article-title: cMyc/miR-125b-5p signalling determines sensitivity to bortezomib in preclinical model of cutaneous T-cell lymphomas
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0059390
  contributor:
    fullname: Manfe
– volume: 105
  start-page: 463
  issue: 4
  year: 2014
  ident: 10.1016/j.semcancer.2021.03.014_bib1275
  article-title: Effect of microRNA-210 on prognosis and response to chemotherapeutic drugs in pediatric acute lymphoblastic leukemia
  publication-title: Cancer Sci.
  doi: 10.1111/cas.12370
  contributor:
    fullname: Mei
– volume: 288
  start-page: 10849
  issue: 15
  year: 2013
  ident: 10.1016/j.semcancer.2021.03.014_bib0915
  article-title: Neutral sphingomyelinase 2 (nSMase2)-dependent exosomal transfer of angiogenic microRNAs regulate cancer cell metastasis
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M112.446831
  contributor:
    fullname: Kosaka
– volume: 448
  start-page: 83
  issue: 7149
  year: 2007
  ident: 10.1016/j.semcancer.2021.03.014_bib0390
  article-title: Intronic microRNA precursors that bypass Drosha processing
  publication-title: Nature
  doi: 10.1038/nature05983
  contributor:
    fullname: Ruby
– volume: 15
  start-page: 2164
  issue: 10
  year: 2011
  ident: 10.1016/j.semcancer.2021.03.014_bib0225
  article-title: Down-regulated miR-331-5p and miR-27a are associated with chemotherapy resistance and relapse in leukaemia
  publication-title: J. Cell. Mol. Med.
  doi: 10.1111/j.1582-4934.2010.01213.x
  contributor:
    fullname: Feng
– volume: 36
  start-page: 7915
  issue: 10
  year: 2015
  ident: 10.1016/j.semcancer.2021.03.014_bib1205
  article-title: Revealing genome-wide mRNA and microRNA expression patterns in leukemic cells highlighted “hsa-miR-2278” as a tumor suppressor for regain of chemotherapeutic imatinib response due to targeting STAT5A
  publication-title: Tumour Biol.
  doi: 10.1007/s13277-015-3509-9
  contributor:
    fullname: Kaymaz
– volume: 52
  start-page: 1991
  issue: 10
  year: 2011
  ident: 10.1016/j.semcancer.2021.03.014_bib0870
  article-title: Myeloma cell adhesion to bone marrow stromal cells confers drug resistance by microRNA-21 up-regulation
  publication-title: Leuk. Lymphoma
  doi: 10.3109/10428194.2011.591004
  contributor:
    fullname: Wang
– volume: 2
  start-page: 314
  year: 2012
  ident: 10.1016/j.semcancer.2021.03.014_bib1055
  article-title: Stilbene derivatives promote Ago2-dependent tumour-suppressive microRNA activity
  publication-title: Sci. Rep.
  doi: 10.1038/srep00314
  contributor:
    fullname: Hagiwara
– volume: 8
  start-page: 53
  issue: 1
  year: 2017
  ident: 10.1016/j.semcancer.2021.03.014_bib0125
  article-title: Adaptive mechanisms of resistance to anti-neoplastic agents
  publication-title: Medchemcomm
  doi: 10.1039/C6MD00394J
  contributor:
    fullname: Ferreira
– volume: 22
  start-page: 573
  issue: 12
  year: 2015
  ident: 10.1016/j.semcancer.2021.03.014_bib0710
  article-title: Functional studies of miR-130a on the inhibitory pathways of apoptosis in patients with chronic myeloid leukemia
  publication-title: Cancer Gene Ther.
  doi: 10.1038/cgt.2015.50
  contributor:
    fullname: Zhu
– volume: 380
  start-page: 205
  issue: 1
  year: 2016
  ident: 10.1016/j.semcancer.2021.03.014_bib0825
  article-title: Tumor microenvironment and cancer therapy resistance
  publication-title: Cancer Lett.
  doi: 10.1016/j.canlet.2015.07.044
  contributor:
    fullname: Sun
– volume: 8
  issue: 10
  year: 2019
  ident: 10.1016/j.semcancer.2021.03.014_bib0130
  article-title: Redox-mediated mechanism of chemoresistance in cancer cells
  publication-title: Antioxidants (Basel)
  contributor:
    fullname: Kim
– volume: 8
  year: 2019
  ident: 10.1016/j.semcancer.2021.03.014_bib0910
  article-title: Distinct mechanisms of microRNA sorting into cancer cell-derived extracellular vesicle subtypes
  publication-title: Elife
  doi: 10.7554/eLife.47544
  contributor:
    fullname: Temoche-Diaz
– volume: 45
  start-page: 383
  issue: 1
  year: 2014
  ident: 10.1016/j.semcancer.2021.03.014_bib1020
  article-title: miR-181b increases drug sensitivity in acute myeloid leukemia via targeting HMGB1 and Mcl-1
  publication-title: Int. J. Oncol.
  doi: 10.3892/ijo.2014.2390
  contributor:
    fullname: Lu
– volume: 119
  start-page: 109415
  year: 2019
  ident: 10.1016/j.semcancer.2021.03.014_bib0760
  article-title: Autophagy: a novel mechanism of chemoresistance in cancers
  publication-title: Biomed. Pharmacother.
  doi: 10.1016/j.biopha.2019.109415
  contributor:
    fullname: Li
– volume: 110
  start-page: 1330
  issue: 4
  year: 2007
  ident: 10.1016/j.semcancer.2021.03.014_bib0540
  article-title: Interleukin-6 dependent survival of multiple myeloma cells involves the Stat3-mediated induction of microRNA-21 through a highly conserved enhancer
  publication-title: Blood
  doi: 10.1182/blood-2007-03-081133
  contributor:
    fullname: Loffler
– volume: 9
  start-page: 176
  year: 2010
  ident: 10.1016/j.semcancer.2021.03.014_bib0820
  article-title: Bone marrow stromal cells from multiple myeloma patients uniquely induce bortezomib resistant NF-kappaB activity in myeloma cells
  publication-title: Mol. Cancer
  doi: 10.1186/1476-4598-9-176
  contributor:
    fullname: Markovina
– volume: 22
  start-page: 1222
  issue: 5
  year: 2016
  ident: 10.1016/j.semcancer.2021.03.014_bib0605
  article-title: A 13 mer LNA-i-miR-221 inhibitor restores drug sensitivity in melphalan-refractory multiple myeloma cells
  publication-title: Clin. Cancer Res.
  doi: 10.1158/1078-0432.CCR-15-0489
  contributor:
    fullname: Gulla
– volume: 9
  issue: 2
  year: 2020
  ident: 10.1016/j.semcancer.2021.03.014_bib0965
  article-title: Role of non-coding RNAs in the development of targeted therapy and immunotherapy approaches for chronic lymphocytic leukemia
  publication-title: J. Clin. Med.
  doi: 10.3390/jcm9020593
  contributor:
    fullname: Pepe
– volume: 141
  start-page: 220
  issue: 2
  year: 2017
  ident: 10.1016/j.semcancer.2021.03.014_bib1000
  article-title: The role of exosomes and miRNAs in drug-resistance of cancer cells
  publication-title: Int. J. Cancer
  doi: 10.1002/ijc.30669
  contributor:
    fullname: Bach
– volume: 2
  start-page: 415
  issue: 4
  year: 2009
  ident: 10.1016/j.semcancer.2021.03.014_bib0440
  article-title: Role of microRNAs in hematological malignancies
  publication-title: Expert Rev. Hematol.
  doi: 10.1586/ehm.09.32
  contributor:
    fullname: Fatica
– volume: 11
  start-page: 968
  issue: 1
  year: 2020
  ident: 10.1016/j.semcancer.2021.03.014_bib0370
  article-title: Pan-cancer analysis reveals cooperativity of both strands of microRNA that regulate tumorigenesis and patient survival
  publication-title: Nat. Commun.
  doi: 10.1038/s41467-020-14713-2
  contributor:
    fullname: Mitra
– volume: 8
  start-page: 76174
  issue: 44
  year: 2017
  ident: 10.1016/j.semcancer.2021.03.014_bib0505
  article-title: A tyrosine kinase-STAT5-miR21-PDCD4 regulatory axis in chronic and acute myeloid leukemia cells
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.19192
  contributor:
    fullname: Espadinha
– volume: 103
  start-page: 2016
  issue: 12
  year: 2018
  ident: 10.1016/j.semcancer.2021.03.014_bib1300
  article-title: BCR-ABL1 mediated miR-150 downregulation through MYC contributed to myeloid differentiation block and drug resistance in chronic myeloid leukemia
  publication-title: Haematologica
  doi: 10.3324/haematol.2018.193086
  contributor:
    fullname: Srutova
– volume: 7
  start-page: 60723
  issue: 37
  year: 2016
  ident: 10.1016/j.semcancer.2021.03.014_bib0040
  article-title: Role of micro-RNAs in drug resistance of multiple myeloma
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.11032
  contributor:
    fullname: Abdi
– volume: 21
  start-page: 595
  issue: 10
  year: 2015
  ident: 10.1016/j.semcancer.2021.03.014_bib0195
  article-title: Intercellular transfer of cancer drug resistance traits by extracellular vesicles
  publication-title: Trends Mol. Med.
  doi: 10.1016/j.molmed.2015.08.002
  contributor:
    fullname: Sousa
– volume: 9
  start-page: 1158
  issue: 9
  year: 2003
  ident: 10.1016/j.semcancer.2021.03.014_bib0815
  article-title: Interaction between leukemic-cell VLA-4 and stromal fibronectin is a decisive factor for minimal residual disease of acute myelogenous leukemia
  publication-title: Nat. Med.
  doi: 10.1038/nm909
  contributor:
    fullname: Matsunaga
– volume: 115
  start-page: E10849
  issue: 46
  year: 2018
  ident: 10.1016/j.semcancer.2021.03.014_bib0275
  article-title: microRNA-378 promotes autophagy and inhibits apoptosis in skeletal muscle
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
  doi: 10.1073/pnas.1803377115
  contributor:
    fullname: Li
– volume: 7
  start-page: 2168
  issue: 8
  year: 2001
  ident: 10.1016/j.semcancer.2021.03.014_bib0645
  article-title: Cell cycle-mediated drug resistance: an emerging concept in cancer therapy
  publication-title: Clin. Cancer Res.
  contributor:
    fullname: Shah
– volume: 11
  start-page: 4
  issue: 1
  year: 2009
  ident: 10.1016/j.semcancer.2021.03.014_bib0075
  article-title: Laboratory practice guidelines for detecting and reporting BCR-ABL drug resistance mutations in chronic myelogenous leukemia and acute lymphoblastic leukemia: a report of the Association for Molecular Pathology
  publication-title: J. Mol. Diagn.
  doi: 10.2353/jmoldx.2009.080095
  contributor:
    fullname: Jones
– volume: 17
  start-page: 1973
  issue: 9
  year: 2018
  ident: 10.1016/j.semcancer.2021.03.014_bib0150
  article-title: KDM6B counteracts EZH2-mediated suppression of IGFBP5 to confer resistance to PI3K/AKT inhibitor treatment in breast Cancer
  publication-title: Mol. Cancer Ther.
  doi: 10.1158/1535-7163.MCT-17-0802
  contributor:
    fullname: Wang
– volume: 11
  start-page: 25
  issue: 1
  year: 2019
  ident: 10.1016/j.semcancer.2021.03.014_bib0160
  article-title: The role and mechanisms of action of microRNAs in cancer drug resistance
  publication-title: Clin. Epigenetics
  doi: 10.1186/s13148-018-0587-8
  contributor:
    fullname: Si
– volume: 10
  start-page: 59
  year: 2018
  ident: 10.1016/j.semcancer.2021.03.014_bib0400
  article-title: Circulating microRNAs as potential cancer biomarkers: the advantage and disadvantage
  publication-title: Clin. Epigenetics
  doi: 10.1186/s13148-018-0492-1
  contributor:
    fullname: Wang
– volume: 60
  start-page: 1078
  issue: 6
  year: 2019
  ident: 10.1016/j.semcancer.2021.03.014_bib0105
  article-title: Acid ceramidase promotes drug resistance in acute myeloid leukemia through NF-kappaB-dependent P-glycoprotein upregulation
  publication-title: J. Lipid Res.
  doi: 10.1194/jlr.M091876
  contributor:
    fullname: Tan
– volume: 7
  start-page: 44541
  year: 2017
  ident: 10.1016/j.semcancer.2021.03.014_bib0200
  article-title: Identification of the metabolic alterations associated with the multidrug resistant phenotype in cancer and their intercellular transfer mediated by extracellular vesicles
  publication-title: Sci. Rep.
  doi: 10.1038/srep44541
  contributor:
    fullname: Lopes-Rodrigues
– volume: 78
  start-page: S98
  issue: Suppl. 1
  year: 2010
  ident: 10.1016/j.semcancer.2021.03.014_bib0680
  article-title: The New Zealand black mouse as a model for the development and progression of chronic lymphocytic leukemia
  publication-title: Cytometry B Clin. Cytom.
  doi: 10.1002/cyto.b.20544
  contributor:
    fullname: Salerno
– volume: 123
  start-page: 2691
  issue: 17
  year: 2014
  ident: 10.1016/j.semcancer.2021.03.014_bib0810
  article-title: Reciprocal leukemia-stroma VCAM-1/VLA-4-dependent activation of NF-kappaB mediates chemoresistance
  publication-title: Blood
  doi: 10.1182/blood-2013-06-511527
  contributor:
    fullname: Jacamo
– volume: 46
  start-page: 100645
  year: 2019
  ident: 10.1016/j.semcancer.2021.03.014_bib0025
  article-title: The multi-factorial nature of clinical multidrug resistance in cancer
  publication-title: Drug Resist. Updat.
  doi: 10.1016/j.drup.2019.100645
  contributor:
    fullname: Assaraf
– volume: 116
  start-page: 5228
  issue: 24
  year: 2010
  ident: 10.1016/j.semcancer.2021.03.014_bib0880
  article-title: Follicular dendritic cell-dependent drug resistance of non-Hodgkin lymphoma involves cell adhesion-mediated Bim down-regulation through induction of microRNA-181a
  publication-title: Blood
  doi: 10.1182/blood-2010-03-275925
  contributor:
    fullname: Lwin
– volume: 11
  start-page: 18
  issue: 1
  year: 2015
  ident: 10.1016/j.semcancer.2021.03.014_bib0085
  article-title: The overexpression of MRP4 is related to multidrug resistance in osteosarcoma cells
  publication-title: J. Cancer Res. Ther.
  doi: 10.4103/0973-1482.143334
  contributor:
    fullname: He
– volume: 425
  start-page: 368
  issue: 2
  year: 2012
  ident: 10.1016/j.semcancer.2021.03.014_bib1290
  article-title: Myc induced miR-144/451 contributes to the acquired imatinib resistance in chronic myelogenous leukemia cell K562
  publication-title: Biochem. Biophys. Res. Commun.
  doi: 10.1016/j.bbrc.2012.07.098
  contributor:
    fullname: Liu
– volume: 215
  start-page: 152603
  issue: 11
  year: 2019
  ident: 10.1016/j.semcancer.2021.03.014_bib0850
  article-title: He S. miR-182 contributes to cell adhesion-mediated drug resistance in multiple myeloma via targeting PDCD4
  publication-title: Pathol. Res. Pract.
  doi: 10.1016/j.prp.2019.152603
  contributor:
    fullname: Wu
– volume: 123
  start-page: 4612
  issue: 11
  year: 2013
  ident: 10.1016/j.semcancer.2021.03.014_bib0885
  article-title: A microenvironment-mediated c-Myc/miR-548m/HDAC6 amplification loop in non-Hodgkin B cell lymphomas
  publication-title: J. Clin. Invest.
  doi: 10.1172/JCI64210
  contributor:
    fullname: Lwin
– volume: 53
  start-page: 2041
  issue: 10
  year: 2012
  ident: 10.1016/j.semcancer.2021.03.014_bib1170
  article-title: Involvement of miR17 pathway in glucocorticoid-induced cell death in pediatric acute lymphoblastic leukemia
  publication-title: Leuk. Lymphoma
  doi: 10.3109/10428194.2012.678004
  contributor:
    fullname: Harada
– volume: 8
  start-page: e82062
  issue: 11
  year: 2013
  ident: 10.1016/j.semcancer.2021.03.014_bib0595
  article-title: Changes in the expression of miR-381 and miR-495 are inversely associated with the expression of the MDR1 gene and development of multi-drug resistance
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0082062
  contributor:
    fullname: Xu
– volume: 14
  start-page: PL04
  issue: 15 Supplement
  year: 2008
  ident: 10.1016/j.semcancer.2021.03.014_bib0830
  article-title: The influence of the tumor microenvironment on drug response and drug resistance
  publication-title: Clin. Cancer Res.
  contributor:
    fullname: Dalton
– volume: 121
  start-page: 499
  issue: 3
  year: 2013
  ident: 10.1016/j.semcancer.2021.03.014_bib0480
  article-title: Epigenetic silencing of microRNA-193a contributes to leukemogenesis in t(8;21) acute myeloid leukemia by activating the PTEN/PI3K signal pathway
  publication-title: Blood
  doi: 10.1182/blood-2012-07-444729
  contributor:
    fullname: Li
– volume: 542
  start-page: 109
  issue: 2
  year: 2014
  ident: 10.1016/j.semcancer.2021.03.014_bib0315
  article-title: Down-regulation of miR-199b associated with imatinib drug resistance in 9q34.1 deleted BCR/ABL positive CML patients
  publication-title: Gene
  doi: 10.1016/j.gene.2014.03.049
  contributor:
    fullname: Joshi
– volume: 26
  start-page: 1064
  issue: 5
  year: 2012
  ident: 10.1016/j.semcancer.2021.03.014_bib0755
  article-title: The miRNA-17 approximately 92 cluster mediates chemoresistance and enhances tumor growth in mantle cell lymphoma via PI3K/AKT pathway activation
  publication-title: Leukemia
  doi: 10.1038/leu.2011.305
  contributor:
    fullname: Rao
– volume: 16
  start-page: 226
  issue: 3
  year: 2016
  ident: 10.1016/j.semcancer.2021.03.014_bib0010
  article-title: Understanding cancer drug resistance by developing and studying resistant cell line models
  publication-title: Curr. Cancer Drug Targets
  doi: 10.2174/1568009616666151113120705
  contributor:
    fullname: Xavier
– volume: 173
  start-page: 20
  issue: 1
  year: 2018
  ident: 10.1016/j.semcancer.2021.03.014_bib0360
  article-title: Metazoan MicroRNAs
  publication-title: Cell
  doi: 10.1016/j.cell.2018.03.006
  contributor:
    fullname: Bartel
– volume: 22
  issue: 1
  year: 2016
  ident: 10.1016/j.semcancer.2021.03.014_bib0005
  article-title: Special issue: new approaches to counteract drug resistance in cancer
  publication-title: Molecules
  doi: 10.3390/molecules22010006
  contributor:
    fullname: Vasconcelos
– volume: 6
  start-page: 27
  issue: 1
  year: 2013
  ident: 10.1016/j.semcancer.2021.03.014_bib1295
  article-title: Down-regulation of miR-181c in imatinib-resistant chronic myeloid leukemia
  publication-title: Mol. Cytogenet.
  doi: 10.1186/1755-8166-6-27
  contributor:
    fullname: Mosakhani
– volume: 93
  start-page: 1
  issue: 1
  year: 2015
  ident: 10.1016/j.semcancer.2021.03.014_bib0485
  article-title: MicroRNA polymorphisms as markers of risk, prognosis and treatment response in hematological malignancies
  publication-title: Crit. Rev. Oncol. Hematol.
  doi: 10.1016/j.critrevonc.2014.08.006
  contributor:
    fullname: Dzikiewicz-Krawczyk
– volume: 10
  start-page: 108
  year: 2011
  ident: 10.1016/j.semcancer.2021.03.014_bib0170
  article-title: Upregulation of microRNA-125b contributes to leukemogenesis and increases drug resistance in pediatric acute promyelocytic leukemia
  publication-title: Mol. Cancer
  doi: 10.1186/1476-4598-10-108
  contributor:
    fullname: Zhang
– volume: 1699
  start-page: 83
  year: 2018
  ident: 10.1016/j.semcancer.2021.03.014_bib0175
  article-title: MicroRNAs change the landscape of cancer resistance
  publication-title: Methods Mol. Biol.
  doi: 10.1007/978-1-4939-7435-1_6
  contributor:
    fullname: Zhu
– volume: 3
  start-page: 188
  issue: 7–8
  year: 2016
  ident: 10.1016/j.semcancer.2021.03.014_bib0620
  article-title: Selective glucocorticoid receptor-activating adjuvant therapy in cancer treatments
  publication-title: Oncoscience
  doi: 10.18632/oncoscience.315
  contributor:
    fullname: Sundahl
– volume: 9
  start-page: 402
  year: 2018
  ident: 10.1016/j.semcancer.2021.03.014_bib0335
  article-title: Overview of MicroRNA biogenesis, mechanisms of actions, and circulation
  publication-title: Front. Endocrinol. (Lausanne)
  doi: 10.3389/fendo.2018.00402
  contributor:
    fullname: O’Brien
– volume: 106
  start-page: 60
  issue: 1
  year: 2015
  ident: 10.1016/j.semcancer.2021.03.014_bib0935
  article-title: Microparticles induce multifactorial resistance through oncogenic pathways independently of cancer cell type
  publication-title: Cancer Sci.
  doi: 10.1111/cas.12566
  contributor:
    fullname: de Souza
– volume: 8
  start-page: 49451
  issue: 30
  year: 2017
  ident: 10.1016/j.semcancer.2021.03.014_bib1220
  article-title: Deregulated expression of miR-29a-3p, miR-494-3p and miR-660-5p affects sensitivity to tyrosine kinase inhibitors in CML leukemic stem cells
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.17706
  contributor:
    fullname: Salati
– volume: 53
  start-page: 2465
  issue: 12
  year: 2012
  ident: 10.1016/j.semcancer.2021.03.014_bib1160
  article-title: Aberrant microRNA-182 expression is associated with glucocorticoid resistance in lymphoblastic malignancies
  publication-title: Leuk. Lymphoma
  doi: 10.3109/10428194.2012.693178
  contributor:
    fullname: Yang
– volume: 10
  start-page: 6
  issue: 1
  year: 2020
  ident: 10.1016/j.semcancer.2021.03.014_bib0500
  article-title: RNA-Seq profiling of deregulated miRs in CLL and their impact on clinical outcome
  publication-title: Blood Cancer J.
  doi: 10.1038/s41408-019-0272-y
  contributor:
    fullname: Kaur
– volume: 24
  start-page: 3128
  issue: 12
  year: 2013
  ident: 10.1016/j.semcancer.2021.03.014_bib1095
  article-title: Restoring expression of miR-16: a novel approach to therapy for malignant pleural mesothelioma
  publication-title: Ann. Oncol.
  doi: 10.1093/annonc/mdt412
  contributor:
    fullname: Reid
– volume: 14
  start-page: 1135
  issue: 10
  year: 2013
  ident: 10.1016/j.semcancer.2021.03.014_bib0785
  article-title: Targeting miR-21 induces autophagy and chemosensitivity of leukemia cells
  publication-title: Curr. Drug Targets
  doi: 10.2174/13894501113149990185
  contributor:
    fullname: Seca
– volume: 29
  start-page: 33
  issue: 1
  year: 2015
  ident: 10.1016/j.semcancer.2021.03.014_bib0035
  article-title: Drug resistance-related microRNAs in hematological malignancies: translating basic evidence into therapeutic strategies
  publication-title: Blood Rev.
  doi: 10.1016/j.blre.2014.09.005
  contributor:
    fullname: Xie
– volume: 93
  start-page: 1238
  year: 2017
  ident: 10.1016/j.semcancer.2021.03.014_bib0140
  article-title: Regulatory players of DNA damage repair mechanisms: role in cancer chemoresistance
  publication-title: Biomed. Pharmacother.
  doi: 10.1016/j.biopha.2017.07.035
  contributor:
    fullname: Sakthivel
– volume: 18
  start-page: 1386
  issue: 10
  year: 2017
  ident: 10.1016/j.semcancer.2021.03.014_bib1100
  article-title: Safety and activity of microRNA-loaded minicells in patients with recurrent malignant pleural mesothelioma: a first-in-man, phase 1, open-label, dose-escalation study
  publication-title: Lancet Oncol.
  doi: 10.1016/S1470-2045(17)30621-6
  contributor:
    fullname: van Zandwijk
– volume: 11
  start-page: 228
  issue: 3
  year: 2009
  ident: 10.1016/j.semcancer.2021.03.014_bib0355
  article-title: Many roads to maturity: microRNA biogenesis pathways and their regulation
  publication-title: Nat. Cell Biol.
  doi: 10.1038/ncb0309-228
  contributor:
    fullname: Winter
– volume: 1807
  start-page: 735
  issue: 6
  year: 2011
  ident: 10.1016/j.semcancer.2021.03.014_bib0120
  article-title: Recent advances in apoptosis, mitochondria and drug resistance in cancer cells
  publication-title: Biochim. Biophys. Acta
  doi: 10.1016/j.bbabio.2011.03.010
  contributor:
    fullname: Indran
– volume: 15
  start-page: 4750
  issue: 14
  year: 2009
  ident: 10.1016/j.semcancer.2021.03.014_bib0050
  article-title: Clinical relevance of a pharmacogenetic approach using multiple candidate genes to predict response and resistance to imatinib therapy in chronic myeloid leukemia
  publication-title: Clin. Cancer Res.
  doi: 10.1158/1078-0432.CCR-09-0145
  contributor:
    fullname: Kim
– volume: 1617
  start-page: 1
  year: 2017
  ident: 10.1016/j.semcancer.2021.03.014_bib0240
  article-title: MicroRNAs, long noncoding RNAs, and their functions in human disease
  publication-title: Methods Mol. Biol.
  doi: 10.1007/978-1-4939-7046-9_1
  contributor:
    fullname: Xue
– volume: 11
  start-page: 35
  issue: 1
  year: 2019
  ident: 10.1016/j.semcancer.2021.03.014_bib0420
  article-title: Exosome-derived miRNAs as predictive biomarkers for diffuse large B-cell lymphoma chemotherapy resistance
  publication-title: Epigenomics
  doi: 10.2217/epi-2018-0123
  contributor:
    fullname: Feng
– volume: 15
  start-page: 215
  issue: 4
  year: 2010
  ident: 10.1016/j.semcancer.2021.03.014_bib0745
  article-title: Anti-miR-21 oligonucleotide enhances chemosensitivity of leukemic HL60 cells to arabinosylcytosine by inducing apoptosis
  publication-title: Hematology
  doi: 10.1179/102453310X12647083620840
  contributor:
    fullname: Li
– volume: 17
  start-page: 21
  issue: Suppl. 3 (2)
  year: 2019
  ident: 10.1016/j.semcancer.2021.03.014_bib1125
  article-title: Highlights in cutaneous T-cell lymphoma from the 60th American Society of Hematology Annual Meeting: a dermatologist’s perspective
  publication-title: Clin. Adv. Hematol. Oncol.
  contributor:
    fullname: Geskin
– volume: 771
  start-page: 32
  year: 2017
  ident: 10.1016/j.semcancer.2021.03.014_bib0055
  article-title: Contribution of genetic factors to platinum-based chemotherapy sensitivity and prognosis of non-small cell lung cancer
  publication-title: Mutat. Res.
  doi: 10.1016/j.mrrev.2016.11.003
  contributor:
    fullname: Perez-Ramirez
– volume: 1
  start-page: e24
  issue: 6
  year: 2011
  ident: 10.1016/j.semcancer.2021.03.014_bib0495
  article-title: MicroRNA expression in tumor cells from Waldenstrom’s macroglobulinemia reflects both their normal and malignant cell counterparts
  publication-title: Blood Cancer J.
  doi: 10.1038/bcj.2011.25
  contributor:
    fullname: Hodge
– volume: 78
  start-page: 811
  issue: 5
  year: 2010
  ident: 10.1016/j.semcancer.2021.03.014_bib1230
  article-title: Lyn kinase-dependent regulation of miR181 and myeloid cell leukemia-1 expression: implications for drug resistance in myelogenous leukemia
  publication-title: Mol. Pharmacol.
  doi: 10.1124/mol.110.066258
  contributor:
    fullname: Zimmerman
– volume: 41
  start-page: 2
  issue: 1
  year: 2020
  ident: 10.1016/j.semcancer.2021.03.014_bib1120
  article-title: miR-155 as a novel clinical target for hematological malignancies
  publication-title: Carcinogenesis
  doi: 10.1093/carcin/bgz183
  contributor:
    fullname: Witten
– volume: 50
  start-page: 717
  issue: 2
  year: 2017
  ident: 10.1016/j.semcancer.2021.03.014_bib1305
  article-title: Histone deacetylases meet microRNA-associated MMP-9 expression regulation in glucocorticoid-sensitive and -resistant cell lines
  publication-title: Int. J. Oncol.
  doi: 10.3892/ijo.2016.3830
  contributor:
    fullname: Hentati-Kallel
– volume: 120
  start-page: 3958
  issue: 19
  year: 2012
  ident: 10.1016/j.semcancer.2021.03.014_bib0845
  article-title: Investigational agent MLN9708/2238 targets tumor-suppressor miR33b in MM cells
  publication-title: Blood
  doi: 10.1182/blood-2012-01-401794
  contributor:
    fullname: Tian
– volume: 28
  start-page: 118
  issue: 1
  year: 2014
  ident: 10.1016/j.semcancer.2021.03.014_bib1110
  article-title: Loss of p53 and altered miR15-a/16-1short right arrowMCL-1 pathway in CLL: insights from TCL1-Tg:p53(-/-) mouse model and primary human leukemia cells
  publication-title: Leukemia
  doi: 10.1038/leu.2013.125
  contributor:
    fullname: Liu
– volume: 2
  start-page: e83
  year: 2012
  ident: 10.1016/j.semcancer.2021.03.014_bib1240
  article-title: Bortezomib action in multiple myeloma: microRNA-mediated synergy (and miR-27a/CDK5 driven sensitivity)?
  publication-title: Blood Cancer J.
  doi: 10.1038/bcj.2012.31
  contributor:
    fullname: Ballabio
– volume: 13
  issue: 12
  year: 2020
  ident: 10.1016/j.semcancer.2021.03.014_bib1130
  article-title: The therapeutic potential of MicroRNAs in cancer: illusion or opportunity?
  publication-title: Pharmaceuticals (Basel)
  doi: 10.3390/ph13120438
  contributor:
    fullname: Fortunato
– volume: 25
  start-page: 409
  issue: 3
  year: 2011
  ident: 10.1016/j.semcancer.2021.03.014_bib0750
  article-title: Glucocorticoid-mediated repression of the oncogenic microRNA cluster miR-17∼92 contributes to the induction of Bim and initiation of apoptosis
  publication-title: Mol. Endocrinol.
  doi: 10.1210/me.2010-0402
  contributor:
    fullname: Molitoris
– volume: 130
  start-page: 1290
  issue: 11
  year: 2017
  ident: 10.1016/j.semcancer.2021.03.014_bib0525
  article-title: MicroRNAs and acute myeloid leukemia: therapeutic implications and emerging concepts
  publication-title: Blood
  doi: 10.1182/blood-2016-10-697698
  contributor:
    fullname: Wallace
– volume: 16
  start-page: 47
  issue: 3-5
  year: 2013
  ident: 10.1016/j.semcancer.2021.03.014_bib1005
  article-title: MicroRNAs as therapeutic targets in chemoresistance
  publication-title: Drug Resist. Updat.
  doi: 10.1016/j.drup.2013.05.001
  contributor:
    fullname: Garofalo
– volume: 10
  start-page: 239
  issue: 5
  year: 2012
  ident: 10.1016/j.semcancer.2021.03.014_bib0380
  article-title: Biogenesis of mammalian microRNAs: a global view
  publication-title: Genomics Proteomics Bioinform.
  doi: 10.1016/j.gpb.2012.06.004
  contributor:
    fullname: Graves
– volume: 37
  start-page: 961
  issue: 2
  year: 2017
  ident: 10.1016/j.semcancer.2021.03.014_bib0600
  article-title: hsa-miR-631 resensitizes bortezomib-resistant multiple myeloma cell lines by inhibiting UbcH10
  publication-title: Oncol. Rep.
  doi: 10.3892/or.2016.5318
  contributor:
    fullname: Xi
– volume: 44
  start-page: 238
  issue: 4
  year: 2016
  ident: 10.1016/j.semcancer.2021.03.014_bib0205
  article-title: High miR-34a expression improves response to doxorubicin in diffuse large B-cell lymphoma
  publication-title: Exp. Hematol.
  doi: 10.1016/j.exphem.2015.12.007
  contributor:
    fullname: Marques
– volume: 31
  start-page: 1123
  issue: 5
  year: 2017
  ident: 10.1016/j.semcancer.2021.03.014_bib0790
  article-title: Epigenetic silencing of miR-137 induces drug resistance and chromosomal instability by targeting AURKA in multiple myeloma
  publication-title: Leukemia
  doi: 10.1038/leu.2016.325
  contributor:
    fullname: Qin
– volume: 182
  start-page: 1
  year: 2010
  ident: 10.1016/j.semcancer.2021.03.014_bib0625
  article-title: Glucocorticoid-induced apoptosis of healthy and malignant lymphocytes
  publication-title: Prog. Brain Res.
  doi: 10.1016/S0079-6123(10)82001-1
  contributor:
    fullname: Smith
– volume: 30
  start-page: 2587
  issue: 22
  year: 2011
  ident: 10.1016/j.semcancer.2021.03.014_bib1015
  article-title: Myc overexpression brings out unexpected antiapoptotic effects of miR-34a
  publication-title: Oncogene
  doi: 10.1038/onc.2010.634
  contributor:
    fullname: Sotillo
– volume: 20
  start-page: 1114
  issue: 14
  year: 2019
  ident: 10.1016/j.semcancer.2021.03.014_bib0155
  article-title: Genetic and epigenetic modulation of drug resistance in cancer: challenges and opportunities
  publication-title: Curr. Drug Metab.
  doi: 10.2174/1389200221666200103111539
  contributor:
    fullname: Shah
– volume: 1860
  start-page: 618
  issue: 3
  year: 2016
  ident: 10.1016/j.semcancer.2021.03.014_bib0920
  article-title: Multidrug resistant tumour cells shed more microvesicle-like EVs and less exosomes than their drug-sensitive counterpart cells
  publication-title: Biochim. Biophys. Acta
  doi: 10.1016/j.bbagen.2015.12.011
  contributor:
    fullname: Lopes-Rodrigues
– volume: 2014
  start-page: 907420
  year: 2014
  ident: 10.1016/j.semcancer.2021.03.014_bib0245
  article-title: Integrative analysis of miRNA-mRNA and miRNA-miRNA interactions
  publication-title: Biomed Res. Int.
  contributor:
    fullname: Guo
– volume: 105
  start-page: 15535
  issue: 40
  year: 2008
  ident: 10.1016/j.semcancer.2021.03.014_bib0945
  article-title: Distinct microRNA expression profiles in acute myeloid leukemia with common translocations
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
  doi: 10.1073/pnas.0808266105
  contributor:
    fullname: Li
– volume: 75
  start-page: 4384
  issue: 20
  year: 2015
  ident: 10.1016/j.semcancer.2021.03.014_bib0720
  article-title: Targeting the miR-221-222/PUMA/BAK/BAX pathway abrogates dexamethasone resistance in multiple myeloma
  publication-title: Cancer Res.
  doi: 10.1158/0008-5472.CAN-15-0457
  contributor:
    fullname: Zhao
– volume: 67
  start-page: 129
  issue: 1
  year: 2011
  ident: 10.1016/j.semcancer.2021.03.014_bib0340
  article-title: Biological functions of microRNAs: a review
  publication-title: J. Physiol. Biochem.
  doi: 10.1007/s13105-010-0050-6
  contributor:
    fullname: Huang
– volume: 12
  start-page: 32
  issue: 1
  year: 2019
  ident: 10.1016/j.semcancer.2021.03.014_bib0135
  article-title: Trabectedin triggers direct and NK-mediated cytotoxicity in multiple myeloma
  publication-title: J. Hematol. Oncol.
  doi: 10.1186/s13045-019-0714-9
  contributor:
    fullname: Cuce
– volume: 2018
  start-page: 5416923
  year: 2018
  ident: 10.1016/j.semcancer.2021.03.014_bib0185
  article-title: Cancer stem cells (CSCs) in drug resistance and their therapeutic implications in cancer treatment
  publication-title: Stem Cells Int.
  doi: 10.1155/2018/5416923
  contributor:
    fullname: Phi
– volume: 11
  issue: 8
  year: 2019
  ident: 10.1016/j.semcancer.2021.03.014_bib0685
  article-title: Novel apoptosis-inducing agents for the treatment of cancer, a new arsenal in the toolbox
  publication-title: Cancers (Basel)
  doi: 10.3390/cancers11081087
  contributor:
    fullname: Lim
– volume: 73
  start-page: 7168
  issue: 24
  year: 2013
  ident: 10.1016/j.semcancer.2021.03.014_bib0180
  article-title: The role of cell density and intratumoral heterogeneity in multidrug resistance
  publication-title: Cancer Res.
  doi: 10.1158/0008-5472.CAN-13-1768
  contributor:
    fullname: Lavi
– volume: 3
  start-page: 1185
  issue: 7
  year: 2019
  ident: 10.1016/j.semcancer.2021.03.014_bib1155
  article-title: MicroRNA-155 controls vincristine sensitivity and predicts superior clinical outcome in diffuse large B-cell lymphoma
  publication-title: Blood Adv.
  doi: 10.1182/bloodadvances.2018029660
  contributor:
    fullname: Due
– volume: 142
  start-page: 109
  issue: 1
  year: 2018
  ident: 10.1016/j.semcancer.2021.03.014_bib1080
  article-title: MicroRNA-324-5p regulates stemness, pathogenesis and sensitivity to bortezomib in multiple myeloma cells by targeting hedgehog signaling
  publication-title: Int. J. Cancer
  doi: 10.1002/ijc.31041
  contributor:
    fullname: Tang
– volume: 119
  start-page: 3843
  issue: 5
  year: 2018
  ident: 10.1016/j.semcancer.2021.03.014_bib0670
  article-title: MicroRNA-103 confers the resistance to long-treatment of adriamycin to human leukemia cells by regulation of COP1
  publication-title: J. Cell. Biochem.
  doi: 10.1002/jcb.26431
  contributor:
    fullname: Wan
– volume: 99
  start-page: 15524
  issue: 24
  year: 2002
  ident: 10.1016/j.semcancer.2021.03.014_bib0470
  article-title: Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
  doi: 10.1073/pnas.242606799
  contributor:
    fullname: Calin
– volume: 141
  start-page: 672
  issue: 5
  year: 2008
  ident: 10.1016/j.semcancer.2021.03.014_bib0975
  article-title: Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma
  publication-title: Br. J. Haematol.
  doi: 10.1111/j.1365-2141.2008.07077.x
  contributor:
    fullname: Lawrie
– volume: 8
  start-page: e61858
  issue: 4
  year: 2013
  ident: 10.1016/j.semcancer.2021.03.014_bib1190
  article-title: Inhibition of BCR/ABL protein expression by miR-203 sensitizes for imatinib mesylate
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0061858
  contributor:
    fullname: Li
– volume: 721
  start-page: 116
  issue: 1–3
  year: 2013
  ident: 10.1016/j.semcancer.2021.03.014_bib0115
  article-title: Microparticle drug sequestration provides a parallel pathway in the acquisition of cancer drug resistance
  publication-title: Eur. J. Pharmacol.
  doi: 10.1016/j.ejphar.2013.09.044
  contributor:
    fullname: Gong
– volume: 28
  start-page: 211
  issue: 1
  year: 2011
  ident: 10.1016/j.semcancer.2021.03.014_bib1085
  article-title: miRNA-21 regulates arsenic-induced anti-leukemia activity in myelogenous cell lines
  publication-title: Med. Oncol.
  doi: 10.1007/s12032-009-9413-7
  contributor:
    fullname: Gu
– volume: 39
  start-page: 793
  issue: 7
  year: 2015
  ident: 10.1016/j.semcancer.2021.03.014_bib0980
  article-title: Downregulated miR-33b is a novel predictor associated with disease progression and poor prognosis in multiple myeloma
  publication-title: Leuk. Res.
  doi: 10.1016/j.leukres.2015.04.010
  contributor:
    fullname: Li
– volume: 4
  start-page: 37
  year: 2011
  ident: 10.1016/j.semcancer.2021.03.014_bib0840
  article-title: Suppressing miRNA-15a/-16 expression by interleukin-6 enhances drug-resistance in myeloma cells
  publication-title: J. Hematol. Oncol.
  doi: 10.1186/1756-8722-4-37
  contributor:
    fullname: Hao
– start-page: 251
  year: 2014
  ident: 10.1016/j.semcancer.2021.03.014_bib0165
  article-title: MicroRNAs in cancer drug resistance and drug sensitivity
  contributor:
    fullname: Seca
– volume: 50
  start-page: 1233
  issue: 10
  year: 2012
  ident: 10.1016/j.semcancer.2021.03.014_bib0725
  article-title: Triptolide modulates the sensitivity of K562/A02 cells to adriamycin by regulating miR-21 expression
  publication-title: Pharm Biol
  doi: 10.3109/13880209.2012.665931
  contributor:
    fullname: Li
– volume: 5
  issue: 1
  year: 2019
  ident: 10.1016/j.semcancer.2021.03.014_bib0285
  article-title: Factors regulating microRNA expression and function in multiple myeloma
  publication-title: Noncoding RNA
  contributor:
    fullname: Misiewicz-Krzeminska
– volume: 49
  start-page: 73
  year: 2016
  ident: 10.1016/j.semcancer.2021.03.014_bib0450
  article-title: MiR-15a/16 regulates the growth of myeloma cells, angiogenesis and antitumor immunity by inhibiting Bcl-2, VEGF-A and IL-17 expression in multiple myeloma
  publication-title: Leuk. Res.
  doi: 10.1016/j.leukres.2016.08.013
  contributor:
    fullname: Li
– volume: 101
  start-page: 948
  issue: 4
  year: 2010
  ident: 10.1016/j.semcancer.2021.03.014_bib0740
  article-title: Anti-miR-21 oligonucleotide sensitizes leukemic K562 cells to arsenic trioxide by inducing apoptosis
  publication-title: Cancer Sci.
  doi: 10.1111/j.1349-7006.2010.01489.x
  contributor:
    fullname: Li
– volume: 21
  start-page: 263
  issue: 5
  year: 2016
  ident: 10.1016/j.semcancer.2021.03.014_bib1025
  article-title: The diagnosis, prognosis, and therapeutic application of MicroRNAs in haematological malignancies
  publication-title: Hematology
  doi: 10.1080/10245332.2015.1114766
  contributor:
    fullname: Li
– volume: 97
  start-page: 223
  issue: 2
  year: 2013
  ident: 10.1016/j.semcancer.2021.03.014_bib0735
  article-title: MicroRNA-21 regulates the sensitivity of diffuse large B-cell lymphoma cells to the CHOP chemotherapy regimen
  publication-title: Int. J. Hematol.
  doi: 10.1007/s12185-012-1256-x
  contributor:
    fullname: Bai
– volume: 7
  start-page: 30876
  issue: 21
  year: 2016
  ident: 10.1016/j.semcancer.2021.03.014_bib0320
  article-title: Potential role of exosome-associated microRNA panels and in vivo environment to predict drug resistance for patients with multiple myeloma
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.9021
  contributor:
    fullname: Zhang
– volume: 22
  start-page: 198
  issue: 3
  year: 2012
  ident: 10.1016/j.semcancer.2021.03.014_bib0585
  article-title: MicroRNA profiling in K-562 cells under imatinib treatment: influence of miR-212 and miR-328 on ABCG2 expression
  publication-title: Pharmacogenet. Genomics
  doi: 10.1097/FPC.0b013e328350012b
  contributor:
    fullname: Turrini
– volume: 1843
  start-page: 590
  issue: 3
  year: 2014
  ident: 10.1016/j.semcancer.2021.03.014_bib1265
  article-title: Epigenetic regulation of microRNA-128a expression contributes to the apoptosis-resistance of human T-cell leukaemia jurkat cells by modulating expression of fas-associated protein with death domain (FADD)
  publication-title: Biochim. Biophys. Acta
  doi: 10.1016/j.bbamcr.2013.11.022
  contributor:
    fullname: Yamada
– volume: 2016
  start-page: 6702424
  year: 2016
  ident: 10.1016/j.semcancer.2021.03.014_bib0090
  article-title: Drug efflux transporters are overexpressed in short-term tamoxifen-induced MCF7 breast cancer cells
  publication-title: Adv. Pharmacol. Sci.
  contributor:
    fullname: Krisnamurti
– volume: 42
  start-page: 1135
  issue: 4
  year: 2014
  ident: 10.1016/j.semcancer.2021.03.014_bib0365
  article-title: Regulation of miRNA strand selection: follow the leader?
  publication-title: Biochem. Soc. Trans.
  doi: 10.1042/BST20140142
  contributor:
    fullname: Meijer
– volume: 26
  start-page: 769
  issue: 4
  year: 2012
  ident: 10.1016/j.semcancer.2021.03.014_bib0630
  article-title: An oncogenic role of miR-142-3p in human T-cell acute lymphoblastic leukemia (T-ALL) by targeting glucocorticoid receptor-alpha and cAMP/PKA pathways
  publication-title: Leukemia
  doi: 10.1038/leu.2011.273
  contributor:
    fullname: Lv
– volume: 35
  start-page: 180
  issue: 2
  year: 2017
  ident: 10.1016/j.semcancer.2021.03.014_bib1105
  article-title: Phase I study of MRX34, a liposomal miR-34a mimic, administered twice weekly in patients with advanced solid tumors
  publication-title: Invest. New Drugs
  doi: 10.1007/s10637-016-0407-y
  contributor:
    fullname: Beg
– volume: 125
  start-page: 887
  issue: 5
  year: 2006
  ident: 10.1016/j.semcancer.2021.03.014_bib0350
  article-title: Molecular basis for the recognition of primary microRNAs by the Drosha-DGCR8 complex
  publication-title: Cell
  doi: 10.1016/j.cell.2006.03.043
  contributor:
    fullname: Han
– volume: 53
  start-page: 1188
  issue: 6
  year: 2012
  ident: 10.1016/j.semcancer.2021.03.014_bib0615
  article-title: Triptolide enhances the sensitivity of multiple myeloma cells to dexamethasone via microRNAs
  publication-title: Leuk. Lymphoma
  doi: 10.3109/10428194.2011.638069
  contributor:
    fullname: Huang
– volume: 9
  start-page: 1090
  year: 2018
  ident: 10.1016/j.semcancer.2021.03.014_bib1030
  article-title: Generation of MicroRNA-34 sponges and tough decoys for the heart: developments and challenges
  publication-title: Front. Pharmacol.
  doi: 10.3389/fphar.2018.01090
  contributor:
    fullname: Bernardo
– volume: 37
  start-page: 2193
  issue: 4
  year: 2017
  ident: 10.1016/j.semcancer.2021.03.014_bib0220
  article-title: Jia L. miR-9 regulates the multidrug resistance of chronic myelogenous leukemia by targeting ABCB1
  publication-title: Oncol. Rep.
  doi: 10.3892/or.2017.5464
  contributor:
    fullname: Li
– volume: 39
  start-page: 335
  issue: 3
  year: 2015
  ident: 10.1016/j.semcancer.2021.03.014_bib0515
  article-title: Limited miR-17-92 overexpression drives hematologic malignancies
  publication-title: Leuk. Res.
  doi: 10.1016/j.leukres.2014.12.002
  contributor:
    fullname: Danielson
– volume: 95
  start-page: 1000
  year: 2017
  ident: 10.1016/j.semcancer.2021.03.014_bib0305
  article-title: Current updates on microRNAs as regulators of chemoresistance
  publication-title: Biomed. Pharmacother.
  doi: 10.1016/j.biopha.2017.08.084
  contributor:
    fullname: Caliskan
– volume: 8
  start-page: 69
  year: 2009
  ident: 10.1016/j.semcancer.2021.03.014_bib0310
  article-title: MicroRNA expression profiling in Imatinib-resistant Chronic Myeloid Leukemia patients without clinically significant ABL1-mutations
  publication-title: Mol. Cancer
  doi: 10.1186/1476-4598-8-69
  contributor:
    fullname: San Jose-Eneriz
– volume: 5
  start-page: 22
  issue: 1
  year: 2020
  ident: 10.1016/j.semcancer.2021.03.014_bib0955
  article-title: Overview of current microRNA biomarker signatures as potential diagnostic tools for leukaemic conditions
  publication-title: Noncoding RNA Res.
  doi: 10.1016/j.ncrna.2020.02.001
  contributor:
    fullname: Buhagiar
– volume: 9
  issue: 5
  year: 2020
  ident: 10.1016/j.semcancer.2021.03.014_bib0555
  article-title: The role of extracellular vesicles in the hallmarks of cancer and drug resistance
  publication-title: Cells
  doi: 10.3390/cells9051141
  contributor:
    fullname: Xavier
– volume: 15
  start-page: 492
  issue: 5
  year: 2014
  ident: 10.1016/j.semcancer.2021.03.014_bib0800
  article-title: Effect of miR-128 in DNA damage of HL-60 acute myeloid leukemia cells
  publication-title: Curr. Pharm. Biotechnol.
  doi: 10.2174/1389201015666140519122524
  contributor:
    fullname: Seca
– volume: 12
  issue: 2
  year: 2020
  ident: 10.1016/j.semcancer.2021.03.014_bib0045
  article-title: Multiple myeloma: available therapies and causes of drug resistance
  publication-title: Cancers (Basel
  doi: 10.3390/cancers12020407
  contributor:
    fullname: Pinto
– volume: 19
  start-page: 975
  issue: 1
  year: 2019
  ident: 10.1016/j.semcancer.2021.03.014_bib0855
  article-title: Ectopic expression of BIRC5-targeting miR-101-3p overcomes bone marrow stroma-mediated drug resistance in multiple myeloma cells
  publication-title: BMC Cancer
  doi: 10.1186/s12885-019-6151-x
  contributor:
    fullname: Abdi
– volume: 4
  start-page: 143
  issue: 3
  year: 2012
  ident: 10.1016/j.semcancer.2021.03.014_bib0295
  article-title: MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review
  publication-title: EMBO Mol. Med.
  doi: 10.1002/emmm.201100209
  contributor:
    fullname: Iorio
– volume: 13
  start-page: 4986
  issue: 6
  year: 2017
  ident: 10.1016/j.semcancer.2021.03.014_bib1185
  article-title: MicroRNA 217 inhibits cell proliferation and enhances chemosensitivity to doxorubicin in acute myeloid leukemia by targeting KRAS
  publication-title: Oncol. Lett.
  doi: 10.3892/ol.2017.6076
  contributor:
    fullname: Xiao
– volume: 8
  start-page: 33078
  issue: 20
  year: 2017
  ident: 10.1016/j.semcancer.2021.03.014_bib0455
  article-title: Classification of pediatric acute myeloid leukemia based on miRNA expression profiles
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.16525
  contributor:
    fullname: Obulkasim
– volume: 183
  start-page: 428
  issue: 3
  year: 2018
  ident: 10.1016/j.semcancer.2021.03.014_bib1040
  article-title: Cobomarsen, an oligonucleotide inhibitor of miR-155, co-ordinately regulates multiple survival pathways to reduce cellular proliferation and survival in cutaneous T-cell lymphoma
  publication-title: Br. J. Haematol.
  doi: 10.1111/bjh.15547
  contributor:
    fullname: Seto
– volume: 114
  start-page: e20
  issue: 25
  year: 2009
  ident: 10.1016/j.semcancer.2021.03.014_bib0510
  article-title: Identification of microRNA expression patterns and definition of a microRNA/mRNA regulatory network in distinct molecular groups of multiple myeloma
  publication-title: Blood
  doi: 10.1182/blood-2009-08-237495
  contributor:
    fullname: Lionetti
– volume: 137
  start-page: 1005
  issue: 6
  year: 2009
  ident: 10.1016/j.semcancer.2021.03.014_bib1050
  article-title: Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model
  publication-title: Cell
  doi: 10.1016/j.cell.2009.04.021
  contributor:
    fullname: Kota
– volume: 585
  start-page: 402
  issue: 2
  year: 2011
  ident: 10.1016/j.semcancer.2021.03.014_bib0730
  article-title: Involvement of miR-21 in resistance to daunorubicin by regulating PTEN expression in the leukaemia K562 cell line
  publication-title: FEBS Lett.
  doi: 10.1016/j.febslet.2010.12.027
  contributor:
    fullname: Bai
– volume: 36
  start-page: 119
  issue: 1
  year: 2012
  ident: 10.1016/j.semcancer.2021.03.014_bib0635
  article-title: miRNA-451: a putative predictor marker of Imatinib therapy response in chronic myeloid leukemia
  publication-title: Leuk. Res.
  doi: 10.1016/j.leukres.2011.08.023
  contributor:
    fullname: Scholl
– volume: 22
  start-page: 531
  issue: 3
  year: 2016
  ident: 10.1016/j.semcancer.2021.03.014_bib1075
  article-title: Study on the association between miRNA-202 expression and drug sensitivity in multiple myeloma cells
  publication-title: Pathol. Oncol. Res.
  doi: 10.1007/s12253-015-0035-4
  contributor:
    fullname: Shen
– volume: 7
  start-page: e29541
  issue: 1
  year: 2012
  ident: 10.1016/j.semcancer.2021.03.014_bib1250
  article-title: miR-122 regulates p53/Akt signalling and the chemotherapy-induced apoptosis in cutaneous T-cell lymphoma
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0029541
  contributor:
    fullname: Manfe
– volume: 8
  start-page: 2684
  issue: 9
  year: 2009
  ident: 10.1016/j.semcancer.2021.03.014_bib0660
  article-title: Correcting miR-15a/16 genetic defect in New Zealand Black mouse model of CLL enhances drug sensitivity
  publication-title: Mol. Cancer Ther.
  doi: 10.1158/1535-7163.MCT-09-0127
  contributor:
    fullname: Salerno
– volume: 9
  issue: 4
  year: 2020
  ident: 10.1016/j.semcancer.2021.03.014_bib0905
  article-title: Sorting mechanisms for MicroRNAs into extracellular vesicles and their associated diseases
  publication-title: Cells
  doi: 10.3390/cells9041044
  contributor:
    fullname: Groot
– volume: 387
  start-page: 61
  year: 2017
  ident: 10.1016/j.semcancer.2021.03.014_bib0190
  article-title: Tumor microenvironment and therapeutic response
  publication-title: Cancer Lett.
  doi: 10.1016/j.canlet.2016.01.043
  contributor:
    fullname: Wu
– volume: 875
  start-page: 172976
  year: 2020
  ident: 10.1016/j.semcancer.2021.03.014_bib0430
  article-title: Expression of non-coding RNAs in hematological malignancies
  publication-title: Eur. J. Pharmacol.
  doi: 10.1016/j.ejphar.2020.172976
  contributor:
    fullname: Ghafouri-Fard
– volume: 21
  issue: 9
  year: 2020
  ident: 10.1016/j.semcancer.2021.03.014_bib1070
  article-title: MicroRNAs-based nano-strategies as new therapeutic approach in multiple myeloma to overcome disease progression and drug resistance
  publication-title: Int. J. Mol. Sci.
  doi: 10.3390/ijms21093084
  contributor:
    fullname: Desantis
– volume: 27
  start-page: 559
  issue: 3
  year: 2019
  ident: 10.1016/j.semcancer.2021.03.014_bib0330
  article-title: miR-221/222-mediated inhibition of autophagy promotes dexamethasone resistance in multiple myeloma
  publication-title: Mol. Ther.
  doi: 10.1016/j.ymthe.2019.01.012
  contributor:
    fullname: Xu
– volume: 113
  start-page: 3801
  issue: 16
  year: 2009
  ident: 10.1016/j.semcancer.2021.03.014_bib1285
  article-title: miR-34a as part of the resistance network in chronic lymphocytic leukemia
  publication-title: Blood
  doi: 10.1182/blood-2008-08-172254
  contributor:
    fullname: Zenz
– volume: 17
  start-page: 1489
  issue: 8
  year: 2011
  ident: 10.1016/j.semcancer.2021.03.014_bib0385
  article-title: A role for noncanonical microRNAs in the mammalian brain revealed by phenotypic differences in Dgcr8 versus Dicer1 knockouts and small RNA sequencing
  publication-title: RNA
  doi: 10.1261/rna.2442211
  contributor:
    fullname: Babiarz
– volume: 7
  start-page: S1
  issue: Suppl. 1
  year: 2018
  ident: 10.1016/j.semcancer.2021.03.014_bib1060
  article-title: An innovative mesothelioma treatment based on miR-16 mimic loaded EGFR targeted minicells (TargomiRs)
  publication-title: Transl. Lung Cancer Res.
  doi: 10.21037/tlcr.2017.12.01
  contributor:
    fullname: Viteri
– volume: 626
  start-page: 106
  year: 2017
  ident: 10.1016/j.semcancer.2021.03.014_bib1145
  article-title: Downregulation of miR-224 and let-7i contribute to cell survival and chemoresistance in chronic myeloid leukemia cells by regulating ST3GAL IV expression
  publication-title: Gene
  doi: 10.1016/j.gene.2017.05.030
  contributor:
    fullname: Zhou
– volume: 6
  start-page: 14993
  issue: 17
  year: 2015
  ident: 10.1016/j.semcancer.2021.03.014_bib1150
  article-title: MicroRNA-451 regulates stemness of side population cells via PI3K/Akt/mTOR signaling pathway in multiple myeloma
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.3802
  contributor:
    fullname: Du
– volume: 9
  start-page: 115
  year: 2010
  ident: 10.1016/j.semcancer.2021.03.014_bib1280
  article-title: Determination of genes and microRNAs involved in the resistance to fludarabine in vivo in chronic lymphocytic leukemia
  publication-title: Mol. Cancer
  doi: 10.1186/1476-4598-9-115
  contributor:
    fullname: Moussay
– volume: 38
  issue: 3
  year: 2018
  ident: 10.1016/j.semcancer.2021.03.014_bib0890
  article-title: Overexpression of miR-202 resensitizes imatinib resistant chronic myeloid leukemia cells through targetting Hexokinase 2
  publication-title: Biosci. Rep.
  doi: 10.1042/BSR20171383
  contributor:
    fullname: Deng
– volume: 12
  issue: 1
  year: 2020
  ident: 10.1016/j.semcancer.2021.03.014_bib0560
  article-title: Deep sequencing analysis reveals distinctive non-coding RNAs when comparing tumor multidrug-resistant cells and extracellular vesicles with drug-sensitive counterparts
  publication-title: Cancers (Basel)
  doi: 10.3390/cancers12010200
  contributor:
    fullname: Sousa
– volume: 21
  issue: 1
  year: 2019
  ident: 10.1016/j.semcancer.2021.03.014_bib0345
  article-title: Systems and synthetic microRNA biology: from biogenesis to disease pathogenesis
  publication-title: Int. J. Mol. Sci.
  doi: 10.3390/ijms21010132
  contributor:
    fullname: Matsuyama
– volume: 247
  start-page: 708
  issue: 5
  year: 2019
  ident: 10.1016/j.semcancer.2021.03.014_bib0765
  article-title: Autophagy, cancer stem cells and drug resistance
  publication-title: J. Pathol.
  doi: 10.1002/path.5222
  contributor:
    fullname: Smith
– volume: 101
  start-page: 437
  issue: 4
  year: 2016
  ident: 10.1016/j.semcancer.2021.03.014_bib0575
  article-title: Extracellular vesicle miR-7977 is involved in hematopoietic dysfunction of mesenchymal stromal cells via poly(rC) binding protein 1 reduction in myeloid neoplasms
  publication-title: Haematologica
  doi: 10.3324/haematol.2015.134932
  contributor:
    fullname: Horiguchi
– volume: 27
  start-page: 143
  issue: 3
  year: 2013
  ident: 10.1016/j.semcancer.2021.03.014_bib0465
  article-title: MicroRNAs in hematological malignancies
  publication-title: Blood Rev.
  doi: 10.1016/j.blre.2013.04.002
  contributor:
    fullname: Lawrie
– volume: 244
  start-page: 189
  issue: 1
  year: 2020
  ident: 10.1016/j.semcancer.2021.03.014_bib0265
  article-title: microRNA-375 regulates glucose metabolism-related signaling for insulin secretion
  publication-title: J. Endocrinol.
  doi: 10.1530/JOE-19-0180
  contributor:
    fullname: Dumortier
– volume: 11
  year: 2019
  ident: 10.1016/j.semcancer.2021.03.014_bib0065
  article-title: Clinically relevant drug interactions with multikinase inhibitors: a review
  publication-title: Ther. Adv. Med. Oncol.
  doi: 10.1177/1758835918818347
  contributor:
    fullname: Hussaarts
– volume: 11
  start-page: 265
  year: 2013
  ident: 10.1016/j.semcancer.2021.03.014_bib0665
  article-title: MiR-370 sensitizes chronic myeloid leukemia K562 cells to homoharringtonine by targeting Forkhead box M1
  publication-title: J. Transl. Med.
  doi: 10.1186/1479-5876-11-265
  contributor:
    fullname: Zhou
– volume: 9
  start-page: 77
  issue: 2
  year: 2018
  ident: 10.1016/j.semcancer.2021.03.014_bib0270
  article-title: MicroRNA miR-4779 suppresses tumor growth by inducing apoptosis and cell cycle arrest through direct targeting of PAK2 and CCND3
  publication-title: Cell Death Dis.
  doi: 10.1038/s41419-017-0100-x
  contributor:
    fullname: Koo
– volume: 356
  start-page: 597
  issue: 2 Pt B
  year: 2015
  ident: 10.1016/j.semcancer.2021.03.014_bib1200
  article-title: MiR-30e induces apoptosis and sensitizes K562 cells to imatinib treatment via regulation of the BCR-ABL protein
  publication-title: Cancer Lett.
  doi: 10.1016/j.canlet.2014.10.006
  contributor:
    fullname: Hershkovitz-Rokah
– volume: 15
  start-page: 38
  year: 2015
  ident: 10.1016/j.semcancer.2021.03.014_bib0375
  article-title: MicroRNA (miRNA) in cancer
  publication-title: Cancer Cell Int.
  doi: 10.1186/s12935-015-0185-1
  contributor:
    fullname: Reddy
– volume: 34
  start-page: 1078
  issue: 8
  year: 2010
  ident: 10.1016/j.semcancer.2021.03.014_bib0590
  article-title: miR-138 might reverse multidrug resistance of leukemia cells
  publication-title: Leuk. Res.
  doi: 10.1016/j.leukres.2009.10.002
  contributor:
    fullname: Zhao
– volume: 32
  issue: 1
  year: 2018
  ident: 10.1016/j.semcancer.2021.03.014_bib1310
  article-title: LncRNA NEAT1 promotes dexamethasone resistance in multiple myeloma by targeting miR-193a/MCL1 pathway
  publication-title: J. Biochem. Mol. Toxicol.
  doi: 10.1002/jbt.22008
  contributor:
    fullname: Wu
– volume: 29
  start-page: 2402
  issue: 4
  year: 2012
  ident: 10.1016/j.semcancer.2021.03.014_bib0950
  article-title: Circulating microRNA expression is associated with genetic subtype and survival of multiple myeloma
  publication-title: Med. Oncol.
  doi: 10.1007/s12032-012-0210-3
  contributor:
    fullname: Huang
– volume: 123
  start-page: 201
  issue: 4
  year: 2010
  ident: 10.1016/j.semcancer.2021.03.014_bib0990
  article-title: MicroRNA profiles of drug-resistant myeloma cell lines
  publication-title: Acta Haematol.
  doi: 10.1159/000302889
  contributor:
    fullname: Munker
– volume: 34
  start-page: 3085
  issue: 24
  year: 2015
  ident: 10.1016/j.semcancer.2021.03.014_bib0490
  article-title: MicroRNA regulons in tumor microenvironment
  publication-title: Oncogene
  doi: 10.1038/onc.2014.254
  contributor:
    fullname: Suzuki
– volume: 114
  start-page: 4169
  issue: 19
  year: 2009
  ident: 10.1016/j.semcancer.2021.03.014_bib0655
  article-title: miR-128b is a potent glucocorticoid sensitizer in MLL-AF4 acute lymphocytic leukemia cells and exerts cooperative effects with miR-221
  publication-title: Blood
  doi: 10.1182/blood-2008-12-191619
  contributor:
    fullname: Kotani
– volume: 14
  start-page: 395
  issue: 5
  year: 2019
  ident: 10.1016/j.semcancer.2021.03.014_bib0080
  article-title: Molecular mechanisms of resistance to tyrosine kinase inhibitors
  publication-title: Curr. Hematol. Malig. Rep.
  doi: 10.1007/s11899-019-00543-7
  contributor:
    fullname: Yaghmaie
– volume: 155
  start-page: 1568
  issue: 7
  year: 2013
  ident: 10.1016/j.semcancer.2021.03.014_bib0395
  article-title: Mammalian 5’-capped microRNA precursors that generate a single microRNA
  publication-title: Cell
  doi: 10.1016/j.cell.2013.11.027
  contributor:
    fullname: Xie
– volume: 19
  issue: 10
  year: 2018
  ident: 10.1016/j.semcancer.2021.03.014_bib0425
  article-title: MicroRNAs in autoimmunity and hematological malignancies
  publication-title: Int. J. Mol. Sci.
  doi: 10.3390/ijms19103139
  contributor:
    fullname: Di Marco
– volume: 138
  start-page: 595
  issue: 4
  year: 2012
  ident: 10.1016/j.semcancer.2021.03.014_bib0690
  article-title: miR-181a sensitizes resistant leukaemia HL-60/Ara-C cells to Ara-C by inducing apoptosis
  publication-title: J. Cancer Res. Clin. Oncol.
  doi: 10.1007/s00432-011-1137-3
  contributor:
    fullname: Bai
– volume: 7
  start-page: 83
  year: 2014
  ident: 10.1016/j.semcancer.2021.03.014_bib0435
  article-title: MicroRNA-binding site polymorphisms in hematological malignancies
  publication-title: J. Hematol. Oncol.
  doi: 10.1186/s13045-014-0083-3
  contributor:
    fullname: Dzikiewicz-Krawczyk
– volume: 33
  start-page: 1294
  issue: 7
  year: 2012
  ident: 10.1016/j.semcancer.2021.03.014_bib0705
  article-title: miR-181a/b significantly enhances drug sensitivity in chronic lymphocytic leukemia cells via targeting multiple anti-apoptosis genes
  publication-title: Carcinogenesis
  doi: 10.1093/carcin/bgs179
  contributor:
    fullname: Zhu
– volume: 14
  start-page: 185
  year: 2015
  ident: 10.1016/j.semcancer.2021.03.014_bib1165
  article-title: miR-377-dependent BCL-xL regulation drives chemotherapeutic resistance in B-cell lymphoid malignancies
  publication-title: Mol. Cancer
  doi: 10.1186/s12943-015-0460-8
  contributor:
    fullname: Al-Harbi
– volume: 135
  start-page: 253
  issue: 2
  year: 2014
  ident: 10.1016/j.semcancer.2021.03.014_bib0580
  article-title: The network of P-glycoprotein and microRNAs interactions
  publication-title: Int. J. Cancer
  doi: 10.1002/ijc.28500
  contributor:
    fullname: Lopes-Rodrigues
– volume: 52
  start-page: 1787
  issue: 9
  year: 2011
  ident: 10.1016/j.semcancer.2021.03.014_bib0835
  article-title: Bone marrow stromal cells protect myeloma cells from bortezomib induced apoptosis by suppressing microRNA-15a expression
  publication-title: Leuk. Lymphoma
  doi: 10.3109/10428194.2011.576791
  contributor:
    fullname: Hao
– volume: 14
  start-page: 143
  issue: 1
  year: 2016
  ident: 10.1016/j.semcancer.2021.03.014_bib0290
  article-title: Regulatory mechanisms of microRNA expression
  publication-title: J. Transl. Med.
  doi: 10.1186/s12967-016-0893-x
  contributor:
    fullname: Gulyaeva
– volume: 20
  start-page: 2278
  issue: 11
  year: 2016
  ident: 10.1016/j.semcancer.2021.03.014_bib0255
  article-title: MicroRNA-202 induces cell cycle arrest and apoptosis in lung cancer cells through targeting cyclin D1
  publication-title: Eur. Rev. Med. Pharmacol. Sci.
  contributor:
    fullname: Jiang
– volume: 30
  start-page: 656
  issue: 4
  year: 2019
  ident: 10.1016/j.semcancer.2021.03.014_bib0410
  article-title: Extracellular miRNAs: from biomarkers to mediators of physiology and disease
  publication-title: Cell Metab.
  doi: 10.1016/j.cmet.2019.07.011
  contributor:
    fullname: Mori
– volume: 2
  start-page: 182
  issue: 3
  year: 2011
  ident: 10.1016/j.semcancer.2021.03.014_bib0610
  article-title: Role for microRNAs in regulating glucocorticoid response and resistance in multiple myeloma
  publication-title: Horm. Cancer
  doi: 10.1007/s12672-011-0072-8
  contributor:
    fullname: Tessel
– volume: 110
  start-page: 1140
  issue: 4
  year: 2019
  ident: 10.1016/j.semcancer.2021.03.014_bib1045
  article-title: Development of miRNA-based therapeutic approaches for cancer patients
  publication-title: Cancer Sci.
  doi: 10.1111/cas.13965
  contributor:
    fullname: Takahashi
– volume: 234
  start-page: 5451
  issue: 5
  year: 2019
  ident: 10.1016/j.semcancer.2021.03.014_bib0235
  article-title: An overview of microRNAs: biology, functions, therapeutics, and analysis methods
  publication-title: J. Cell. Physiol.
  doi: 10.1002/jcp.27486
  contributor:
    fullname: Saliminejad
– volume: 105
  start-page: 12885
  issue: 35
  year: 2008
  ident: 10.1016/j.semcancer.2021.03.014_bib0445
  article-title: MicroRNAs regulate critical genes associated with multiple myeloma pathogenesis
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
  doi: 10.1073/pnas.0806202105
  contributor:
    fullname: Pichiorri
– volume: 96
  start-page: 1783
  issue: 12
  year: 2011
  ident: 10.1016/j.semcancer.2021.03.014_bib1180
  article-title: Integrative nucleophosmin mutation-associated microRNA and gene expression pattern analysis identifies novel microRNA - target gene interactions in acute myeloid leukemia
  publication-title: Haematologica
  doi: 10.3324/haematol.2011.046888
  contributor:
    fullname: Russ
– volume: 7
  start-page: 60074
  issue: 37
  year: 2016
  ident: 10.1016/j.semcancer.2021.03.014_bib1210
  article-title: Upregulation of miR-181c inhibits chemoresistance by targeting ST8SIA4 in chronic myelocytic leukemia
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.11054
  contributor:
    fullname: Zhao
– volume: 98
  start-page: 66
  issue: Pt A
  year: 2016
  ident: 10.1016/j.semcancer.2021.03.014_bib0995
  article-title: Extracellular miRNAs as biomarkers in cancer
  publication-title: Food Chem. Toxicol.
  doi: 10.1016/j.fct.2016.06.010
  contributor:
    fullname: Barger
– volume: 20
  start-page: 333
  issue: 6
  year: 2006
  ident: 10.1016/j.semcancer.2021.03.014_bib0805
  article-title: Tumor microenvironment and drug resistance in hematologic malignancies
  publication-title: Blood Rev.
  doi: 10.1016/j.blre.2005.08.003
  contributor:
    fullname: Li
SSID ssj0009414
Score 2.4995217
SecondaryResourceType review_article
Snippet Despite improvements in the therapeutic approaches for hematological malignancies in the last decades, refractory disease still occurs, and cancer drug...
SourceID proquest
crossref
pubmed
elsevier
SourceType Aggregation Database
Index Database
Publisher
StartPage 283
SubjectTerms Cancer drug resistance
Drug sensitivity
Hematological malignancies
microRNAs
Title miRNAs mediated drug resistance in hematological malignancies
URI https://dx.doi.org/10.1016/j.semcancer.2021.03.014
https://www.ncbi.nlm.nih.gov/pubmed/33757848
https://search.proquest.com/docview/2504777404
Volume 83
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lj9MwELa6uxLigmCXx_KSkRCXKFUcu3lwqyCoILGHdpF6sxLbqYJoitoGwb9n_Eq6wAoQ4hK1bp1Ynsn4G8_MZ4Se04QlFH4Kc5XIkGUkCSulolDIepIKWpPMhGJmi_Rimb0uWDEaeaqKoe2_ShraQNa6cvYvpN3fFBrgM8gcriB1uP6R3NfN_GK6sxUhGk3KbbcKwKfWOFG_xE0bGJ7W3uitAYmv7CG9u0OoutC0I-D26h5Cd90GjrFpMKfN1w1gV1kGi-bTl9LvMA9xDbCnRk9m3WoTzMe97690BejeHuQ875o-CajT1Bcmdk-VD1DYUH5QjA83KMC39elxbtfMV84MaUra0EaMhZPUHKML65Bry5OQJpaI1lvnjB6aV_fNrtTU1Gr_vAjY_Qhds7-20zOGYRHDZWsLVn9g2F7oweixxMRAtOUROonBboHZPJm-LZbvBhZnZsji-8FfSRj85eOugzvXuTMG1lzeRrecP4KnVpHuoJFqT9HZtAUFWX_DL7DJEDZSP0U33rtEjDPk1Ax7NcNazfCgZrhp8RU1w4dqdhd9eFNcvpqF7iSOUNCU7EOWGuAsVMpEnqtKspqAqU_iOqoqmSkA7RFLRFVLUUYlU0kV19AnI3VZkQqkdg8dt5tWPUA4l3lUl5OcZCVlGgxRKgB3yyqjTJQxPUeRnzD-2RKucJ-J-JH3c8z1HPOIcpjjc_TSTyx3uNHiQQ4a8fvOz7woOFhWHS4rW7XpdlyT-6XgHUXwn_tWRv2IKNXnQLDs4b88-hG6Obwvj9HxftupJ-hoJ7unTvG-A6R0pe8
link.rule.ids 315,782,786,27933,27934
linkProvider Elsevier
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=miRNAs+mediated+drug+resistance+in+hematological+malignancies&rft.jtitle=Seminars+in+cancer+biology&rft.au=Peixoto+da+Silva%2C+Sara&rft.au=Caires%2C+Hugo+R.&rft.au=Bergantim%2C+Rui&rft.au=Guimar%C3%A3es%2C+Jos%C3%A9+E.&rft.date=2022-08-01&rft.pub=Elsevier+Ltd&rft.issn=1044-579X&rft.eissn=1096-3650&rft.volume=83&rft.spage=283&rft.epage=302&rft_id=info:doi/10.1016%2Fj.semcancer.2021.03.014&rft.externalDocID=S1044579X2100064X
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1044-579X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1044-579X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1044-579X&client=summon